Joel D. Kopple, M.D.
Professor of Medicine and Public Health
Department of Medicine
Division of Nephrology and Hypertension
http://www.nephrology.rei.edu/goldhr.gif

Office Address:

1124 W. Carson St.
C-1 Annex
Torrance, CA 90502-2064

Office Phone:

(310) 222-3891

Fax:

(310) 782-1837

Lab Address:

Same as office

Email Address:

jkopple@labiomed.org

http://www.nephrology.rei.edu/goldhr.gif

 

 

 

EDUCATION AND TRAINING:

 

Undergraduate, Northwestern University, Illinois, 1955-1958

M.D. - University of Illinois, College of Medicine, 1958-1962

Rotating Intern, University of Illinois Research and Educational Hospitals, Chicago, IL,1962-1963

Assistant Resident in Medicine, Department of Internal Medicine, VA Wadsworth Medical Center, 1963-1965

Resident, Department of Internal Medicine, VA Wadsworth Medical Center, 1965-1966

Fellow in Nephrology and Metabolism, Division of Nephrology, VA Wadsworth Medical Center, 1966‑1967

 

 

BOARD CERTIFICATION:

Diplomate, American Board of Internal Medicine, 1969

Diplomate, American Board of Internal Medicine, Subspecialty of Nephrology, 1974

Diplomate in Clinical Nutrition, American Board of Nutrition, 1980

            Specialist in Clinical Hypertension, American Society for Hypertension, 2001

 

 

PROFESSIONAL EXPERIENCE:

 

            Chief, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA, January 1982-2007.

            Director, Nutrition Program, VA Wadsworth Medical Center, 1979-1981

            Professor of Medicine and Public Health, David Geffen School of Medicine at UCLA and the UCLA School of Public health, 1978-present

            Medical Investigator, VA Wadsworth Medical Center, 1976-1981

Associate Professor of Medicine and Public Health, UCLA Schools of Medicine and Public Health, 1976- 1978

            Chief, Chronic Dialysis Unit, VA Wadsworth Medical Center, 1973-1975

Assistant Professor of Medicine and Public Health, UCLA Schools of Medicine and Public health, 1973-1976

            Clinical Investigator, VA Wadsworth Medical Center, 1970-1973

            Acting Chief, Metabolic Unit, VA Wadsworth Medical Center, 1970-1973

            Assistant Professor of Medicine, UCLA School of Medicine, 1969-1973

            Attending Physician, Harbor-UCLA Medical Center, Torrance, CA, 1969-present

            Research and Education Associate, VA Wadsworth Medical Center, 1968-1970

            Clinical Instructor in Medicine, UCLA School of Medicine, Los Angeles, CA, 1963-1967

 

 

MEMBERSHIP IN SOCIETIES:

 

Fellow, American College of Physicians, 1972

American Society of Nephrology, 1969

American Federation for Clinical Research, 1969

National Kidney Foundation of Southern California, 1972

International Society of Nephrology, 1972

American Institute of Nutrition, 1972

American Society for Clinical Nutrition, 1973

American Society for Artificial Internal Organs, 1973-1984

Western Society for Clinical Research, 1974

American Society for Clinical Investigation, 1977

American Society for Parenteral and Enteral Nutrition, 1977

Western Society for Clinical Investigation, 1981

American Society for Renal Biochemistry and Metabolism, 1987

International Society for Renal Nutrition and Metabolism, 1988

Association of American Physicians, 1994

International Federation of Kidney Foundations, 2000

 

 

 

SERVICE IN PROFESSIONAL AND SCHOLARLY SOCIETIES:

 

National Kidney Foundation of Southern California

 

Member, Research Committee, 1971-1973

Chairman, Direct Services Committee, 1973-1974

Chairman, Research Committee, 1975-1977

Chairman, Dialysis and Transplantation Committee, 1974-1975

Member, Scientific Advisory Council Executive Committee, 1975-1985; 1986-1987

Secretary, Scientific Advisory Council, 1974

Chairman, Scientific Advisory Council, 1978-1980

Chairman, Nominating Committee, 1980-1982

National Kidney Foundation

 

Member, Scientific Advisory Board, 1979-1984; 1988-1994

Member, Scientific Advisory Board Executive Committee, 1980-1984

Chairman, Public Information Committee, Scientific Advisory Board, 1980-1984

Region V Vice President (this is now entitled Region V President), 1984-1986

Member, Health and Scientific Affairs Committee, 1985-1986, 1988-Present

Vice Chairman, National Medical Advisory Board, 1986-1988

Member, Executive Committee, Council on Clinical Nephrology, Dialysis and

  Transplantation, 1987-1990

Vice Chairman, Scientific Advisory Board, 1988-1990

Co-Chairman, Annual Scientific Meeting, 1989

Program Chairman, 1990 Annual Scientific Meeting

Chairman, Scientific Advisory Board, 1990-1992

Past-Chairman, Scientific Advisory Board, 1992-1994

Chairman, National Kidney Foundation Spring Clinical Meeting, 1992

Chairman, Search Committee for Editor of the American Journal of Kidney Disease, 1990

Member, Board of Directors, 1990-present

Member, Prevention and Early Intervention Initiative Task Force, 1991-1992

Member, Research Endowment Board, 1991-1993

Member, Search Committee for Editor of Dialysis Journal, 1992-1993

Chairman, Task Force on Morbidity and Mortality in Dialysis Patients, 1992-1993

Chairman, Young Investigator Grant Committee, 1994, 1995 and 1996

Chairman, Task Force on Intradialytic Parenteral Nutrition, 1995

Chairman, Committee for Practice Guidelines for Nutritional Therapy of Maintenance   Dialysis Patients, 1995-1996

Vice-President, 1996-1998

President, 1998 to 2000

 

Council of American Kidney Societies (CAKS)

 

Member of Council, 1996 to 2000

President, 1998 to 1999

Chairman, National Kidney Disease Education Program Subcommittee, 1998 to 2000

 

American Society of Nephrology

 

Member, Program Committee, 1990 Annual Scientific Meeting        

American Society for Parenteral and Enteral Nutrition

Member, Standards Committee, 1985-1986

Treasurer, 1986 to 1988

Vice-President, 1988-1989

President Elect, 1989-1990

President, 1990-1991

Past President, 1991-1992

Member, Research Foundation Fund Raising Committee, 1992-1994

Chairman, Ad Hoc Committee on Intradialytic Parenteral Nutrition, 1995

 

American Board of Nutrition

Member, Board of Directors, 1984-1990

Chairman, Nominating Committee, 1986-1988

Chairman, Credentials Committee, 1988-1990

Member, Nominating Committee, 1990

 

American Society for Clinical Nutrition

 

            Member, Continuing Education Committee, 1988-1991

            Member, Committee on Clinical Issues in Health and Disease, 1988-1991

Member, American Institute of Nutritional/American Society for Clinical Nutrition Political Action Committee, 1991-1992, 1993-1994

Member, American Society for Parenteral and Enteral Nutrition/American Society for Clinical Nutrition Political Action Committee, 1994-1995

Member, Public Affairs Committee, 2000-2003

 

American Society for Renal Biochemistry and Metabolism

 

            Councilor, 1987-1994

International Society for Renal Nutrition and Metabolism

           

Founder of Organization

President, 1988-1991

Past President, 1991-1994

Member, Council, 1988-1994

Ex-Officio Member of Council, 1994 to present

Member, Scientific Program Committee for the International Congresses of Renal Nutrition and Metabolism in 1988, 1991, 1994, 1996, 1998, 2006, 2008 and 2010

 

International Society of Nephrology

 

Member, Commission on International Clinical Trials, 1997 to 1999

 

 

International Federation of Kidney Foundations

 

Founder of Organization 1998-2000

President, September, 2000-September, 2002, November, 2002– June, 2003

Member, Executive Committee 2000-2008

Co-chair, Kidney Foundation Development Committee 2003-2010

           Ambassador for the International Federation of Kidney Foundations 2010 - present

 

International Society for Uremic Toxicity

 

            Member, Council 2002 to 2008

 

 

SCHOLARLY SERVICE ACTIVITIES

 

Member, Masters and Doctoral Committee for the Degree of Master or Doctor of Public Health, UCLA School of Medicine, 1970-1980

Member, Doctoral Committee for the Degree of Doctor of Philosophy in Geophysics, UCLA School of Medicine, 1972-1974

Chairman, Kidney Foundation of Southern California Annual Symposium on Dietetics, 1973 and 1974

Member of the Committee for Evaluation of Nutritional Factors for Adequacy of Dialysis, Artificial Kidney-Chronic Uremia Program, NIAMDD, Fall-Winter, 1974.

Member, First Level Review Committee, Artificial Kidney-Chronic Uremia Program, NIAMDD, 1974

Chairman, Kidney Foundation of Southern California.  Seminar in Nephrology and Transplantation, May 15, 1975

Chairman, National VA Workshop on Dialysis and Renal Failure, Washington, DC, Nov., 1975

Chairman, Organizing Committee, First International Congress on Nutrition in Renal    Disease, Würzburg, Germany, May 1977

Member, Advisory Committee, National Cooperative Dialysis Study, Artificial Kidney- Chronic Uremia Program, NIAMDD, Washington, DC, 1977-1981

Chairman, Organizing Committee, Second International Congress on Nutrition in Renal  Disease, Bologna, Italy, June 13-15, 1979.

Chairman, ASPEN Los Angeles Regional Symposium, November, 1979

Chairman, Organizing Committee, Third International Congress on Nutrition and Metabolism  in Renal Disease, Marseilles, France, September 1-4, 1982

Member, Organizing Committee, IX International Congress on Nephrology

Member Organizing Committee, First International Workshop on Nutritional Assessment in Hospitalized Patients, Venice, Italy, April, 1985

Chairman, Organizing Committee, Fourth International Congress on Nutrition and Metabolism in Renal Disease, Williamsburg, VA, October, 1985

Chairman, Third A.S.P.E.N. Research Workshop on Nutrition in Acute Renal Failure,   New Orleans, LA, February 1, 1987

Chairman, Organizing Committee, Fifth International Congress on Nutrition and Metabolism in Renal Disease, Strasbourg, France, September, 1988

Member, NIH ad Hoc Review Committee, for Clinical Nutrition Research Unit applications (NIDDKD), 1989

Consultant, NIH Ad Hoc Review Committee, 1989

Member, NIH Ad Hoc Review Committee for Telephone Review of NIH grant application, 1990

Member, Veterans Administration Merit Review Board for Nephrology, 1992-1995.

Member, the National Kidney and Urologic Diseases Advisory Board Review Committee 

  on the George M. O'Brien Kidney and Urologic Centers, 1994

Member, Organizing Committees for the Sixth (1991), Seventh (1994), Eighth (1996) and Ninth (1998) International Congresses on Renal Nutrition and Metabolism

Member, External Advisory Committee for NIH-funded clinical trial, “HEMO Study,” 1995 to present

Chairman, Ad Hoc Committee to review an NIH RO1 grant application, 1997

Member, Organizing Committee, Strategies for Care in End-Stage Renal Disease Meeting, Washington, DC, 1998

Member, Program Committee, NIH meeting entitled, “Critical Issues in the Care of the Dialysis Patient,” Baltimore, MD, 1998

Member, Research Grant Review Committee, Genzyme, Corporation 2002-2005

Member, National Kidney Foundation Consensus Conference on Carnitine, 2002

Chairman, Ad Hoc Review Committee, National Institutes of Health, 2002

Member, Advisory Board, VA Homocysteine (HOST) Study, 2001-2006

Acting Chair, Advisory Board, VA Homocysteine (HOST) Study, 2003

Chair, Advisory Board, VA Homocysteine (HOST) Study, 2003-2006

Member, Doctoral Committee for Kamyar Kalantar-Zadeh for Ph.D. in Epidemiology, University of California, Berkeley, 2003-2004

Member, Advisory Board, Fundacion Mexicana del Rinon A.C., 2006-present

Member, Belding H. Scribner Award Committee of the American Society of Nephrology, 2007-2009

Member, Doctoral Committee for Christian Shinaberger for Doctor of Public Health in Epidemiology, UCLA School of Public Health, 2005-2008

Member, Program Committee for the International Congresses on Renal Nutrition and Metabolism, 2004, 2006 and 2008

Member Ad Hoc Review Committee, National Institutes of Health, 2008 and 2009

Member, Doctoral Committee for Youngmee Kim for Ph.D. in Nursing, UCLA School of Nursing, 2006-2009

Chair, Scientific Advisory Board for the OPPORTUNITY Trial on growth hormone treatment of maintenance hemodialysis patients, funded by Novo Nordisk, 2006-2009

 

 

Editorial Board Member:

 

Newsletter "Nutrition and the M.D.," 1974 to 1986

Nephron, 1976 to 1980’s

Mineral and Electrolyte Metabolism, 1978 to 1999

Clinical Nephrology, 1978 to1981

American Journal of Nephrology, 1981 to 2003

Seminars in Dialysis 1980’s

Journal of Renal Nutrition, 1996 to about 2006

Aktuality V Nefrologii

Advances in Clinical and Experimental Medicine (International Advisory Board)

Clinical Journal of the American Society of Nephrology (CJASN), 2008 to present

Current Opinion in Clinical Nutrition, 2008 to present

Nefrologia i Dializoterapia Polska (Polish Nephrology and Dialysis Therapy) 2010 to present

 

 

Editorial Reviewer:

 

American Journal of Clinical Nutrition

American Journal of Physiology

Kidney International

Nephron

Journal of Laboratory and Clinical Medicine

Metabolism

Mineral and Electrolyte Metabolism

American Journal of Nephrology

American Journal of Kidney Diseases

Journal of Parenteral and Enteral Nutrition

Journal of Clinical Investigation

Renal Failure

New England Journal of Medicine

Journal of Renal Nutrition

Journal of the American Society of Nephrology

 

 

HONORS AND AWARDS:

 

Phi Eta Sigma, Northwestern University, Illinois, 1956

Alpha Omega Alpha, University of Illinois, College of Medicine, 1961

Research and Education Associate, Veterans Administration Center, Los Angeles, CA, 1968-1970

Clinical Investigator, VA Wadsworth Medical Center, Los Angeles, 1970-1973

Medical Investigator, VA Wadsworth Medical Center, 1976-1981

Volunteer Service Award, National Kidney Foundation, 1983

Distinguished Service Award, National Kidney Foundation, 1984

President's Award, National Kidney Foundation, 1986

Louis Pasteur Medal and Award, University of Strasbourg, France, 1988

President's Award, National Kidney Foundation, 1992

Honorary Member, Czech and Slovak Society of Nephrology, 1993

Honorary Member, Italian Society of Nephrology, 1993

David M. Hume Memorial Award of the National Kidney Foundation, 1993

Honorary Member, Slovak Society of Internal Medicine, 1994

Honorary Member, Polish Society of Internal Medicine, 1994

Delivered the Annual Rhoads Lecture of the American Society for Parenteral and Enteral Nutrition in 1995

Doctor Honoris Causa, P.J. Sfarik University, Kosice, Slovak Republic, 1995

E.V. McCollum Award, American Society for Clinical Nutrition, 1996

Annual Tribute Dinner Honoree, National Kidney Foundation of Southern California, 1996

Thomas Addis Medal, International Society for Renal Nutrition and Metabolism, 1996

Honorary Member, Czech Society of Nephrology, 1998

Corresponding Member of the German Society of Nephrology, 2000

Malpighi Medal of the University of Messina, Italy, 2000

First recipient and lecturer of the Annual Joel D. Kopple Lectureship and Award, 2001

Designated as a Specialist in Clinical Hypertension by the American Society of Hypertension starting May 16, 2001

Doctor Honoris Causa, University of Szeged, Szeged, Hungary, 2002

Robert H. Herman Award of the American Society of Clinical Nutrition, 2004

Sándor Korányi Award of the Hungarian Society of Nephrology, 2005

Fellow of the American Society of Nutrition, 2006

            Belding H. Scribner Award of the American Society of Nephrology, 2006

Lifetime Achievement Award in Peritoneal Dialysis from the Annual Dialysis Conference, 2007

Lifetime Achievement Tribute Dinner presented by the Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, June, 2008

Delivered the Dr. M.D. Motashaw  Oration in Nephrology on September 19, 2008 at the KEM University Hospital, Mumbai, India

Two Awards established in the Kopple name:

    1.  Annual Joel D. Kopple Lectureship and Award established by the National Kidney Foundation Council on Renal Nutrition, 2001

    2. Annual Joel Kopple, M.D. Award established by the International Federation of Kidney Foundations to be given to an individual or organization for excellence in kidney disease prevention, detection or care, established in 2009. First Award given in 2010.

Doctor Honoris Causa from the Universite d’Auvergne, Clermont-Ferrand, France, awarded in March, 2010

Appointed Ambassador for the International Federation of Kidney Foundations, 2010-present

William Cade Visiting Professor at the University of Florida, Gainesville, Florida, February, 2011

           Honorary President, XVI International Congress on Renal Nutrition and Metabolism, Honolulu, Hawaii, June 26-29, 2012

Paul Teschan 2013 Teschan Lectureship guest speaker at Vanderbilt University,   Nashville Tennessee, February, 2013

 

 

 

 

 

 

 


RESEARCH GRANTS AND FELLOWSHIPS RECEIVED:

Source

Direct Costs

Dates

Purpose

1. NIH R01 DK061389-01A1                                   05/16/03–01/31/08                     20%

“Dietary Protein Requirements     in Hemodialylsis Patients”  (PI: Joel D. Kopple)

$294,247/year

5/16/03-01/31/08

A study to determine dietary protein requirements in maintenance hemodialysis patients.

2.NIH-NIDDK DK45426-10 "African American Study of Kidney Disease and  Hypertension and Cohort Study" (PI at Harbor-UCLA Medical Center: Joel D. Kopple)

 

 

$100,000/year

9/30/92-5/31/2008

The proposed research is a part of a multicenter, prospective, double- masked randomized clinical trial examining the effect of three drug regimens (ACEI, CCB and B-blockers) and two different levels of MAP control (<92 versus 102-107 mmHg). Thus, the study will follow a three by two factorial design.  The outcome of the study will estimate the changes in GFR in a fixed time period among the three treatment arms and the two levels of blood pressure control.

 

3. NIH-RO1 DK54457-01A1

   “Anabolic Effects of  Exercise Training in  Hemodialysis” (PI: Joel D. Kopple)

 

$261,261/year

6/1/2001-

5/30/2004

(no cost extension requested to 2006)

This project examines the primary hypothesis that in MHD patients strength training (ST), Endurance Training (ET) or a combination of ST and ET (EST), as compared to no training (NT), leads, in muscle, to decreased mRNA for myostatin and increased MRNA for a number of growth factors.

4. 1-K23 DK61162-01

“Nutritional and Inflammatory Evaluations in Dialysis Patients” (PI: K. Kalantar-Zadeh; Mentor: Joel D. Kopple)

$125,000/year

8/1/2001 - 7/31/2006

An epidemiological study of risk factors for morbidity and mortality in Maintenance Hemodialysis patients.

5 National Kidney Foundation of Southern California Institutional Training Grant (PI:  Joel D. Kopple)

 

$12,400/year

2000 -2003

This is an institutional grant to provide research training for Nephrology fellows. This grant program was discontinued by the NKF in 2003.

6. NKF Young Investigator Grant (PI: K. Kalantar-Zadeh; Co-Inves: Joel D. Kopple)

$50,000/year

7/03 – 12/05

Will examine cardiovascular risks in a national database

7.  Satellite Research

    “Effect of Arterial pH on N-balance of Patients Undergoing Automated Peritoneal Dialysis”

(PI: Rajnish Mehrotra; Co-Investigator: Joel D. Kopple)

$50,000/year

01/01/03-12/31/06

Metabolic nitrogen balance study in chronic peritoneal dialysis patients to test the hypothesis that maintaining a high-normal arterial blood pH is associated with greater protein anabolism then a low-normal arterial blood pH.

8. Sigma-Tau

“Gentamicin Renal Toxicity Rat Study” (PI: Joel D. Kopple)

Total of $50,000

9/1/98- 06/30/2005

A study to test whether will ameleorate or prevent the acute renal injury caused by Gentomycin.

 

 

9. Amgen, Inc.

“Impact of Inflammation and Malnutrition on Erythropoietin Resistance, Refractory Anemia and Iron Metabolism in Maintenance Hemodialysis Patients”(PI: K. Kalantar-Zadeh; Co-Investigator: Joel D.Kopple)

Total of $40,400

11/19/01-1/18/04

This study will be performed to find out is inflammation and malnutrition, which are common among dialysis patients, interfere with the treatment of anemia in hemodialysis patients.

 

 

 

 

Lectures Presented, Sessions Chaired and Other Scientific and Professional Meetings During the Past Eight Years 

 

 

1.         April 1, 2002, Baxter Healthcare Symposium, Tokyo Japan, Lecture entitled, “Skeletal    Muscle Metabolism and Exercise Training in Chronic Renal Failure”

 

2.         April 17, 2002, National Kidney Foundation Clinical Nephrology Meetings, Chicago, IL,    Lecture entitled, “Assessing the Nutritional Status of the Dialysis Patient”

           

3.         April 17, 2002, National Kidney Foundation Clinical Nephrology Meetings, Chicago, IL, Lecture entitled, “Issues Regarding the Nutritional Management of the Dialysis Patient”

 

4.         April 24, 2002, First International Congress on Transthyretin in Health and Disease, Strasbourg, France, Poster oral, entitled, “Serum Prealbumin has the Strongest Combined Association with Measures of Protein Intake, Inflammation and Anemia in Hemodialysis Patients”

 

5.         April 25, 2002, co-chaired a plenary session at the meeting, Strasbourg, France

 

6.         April 25, 2002, First International Congress, Strasbourg, France, Lecture entitled, “The National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transthyretin in Chronic Renal Failure”

 

7.         April 26, 2002, Accademia dei Concordi Rovigo Workshop on Uremic Toxicity, Rovigo, Italy, Lecture entitled, “The Effect of Hydrogen Ion Concentration on Protein Synthesis and Degradation in Skeletal Muscle Cells”

 

8.         May 2, 2002, P.J. Safatik University Medical Faculty, Kosice, Slovak Republic, Lecture entitled, “The National Kidney Foundation K/DOQI Guidelines on Dietary Protein and Energy Intake in Chronic Renal Failure and Dialysis Patients”

 

9.         May 2, 2002, P.J. Safatik University Medical Faculty, Kosice, Slovak Republic, Lecture entitled, “Exercise Training and Skeletal Muscle Metabolism in Maintenance Hemodialysis Patients”

 

10.       June 4-5, 2002, Grant reviewer for the Genzyme G.R.I.P. (Genzyme Renal Innovations Program) Meeting, Paris, France

 

11.       June 7, 2002, National Academy of Medicine, Permanent Committee on Chronic Renal Insufficiency, Third Academic Forum, Mexico City, Mexico, Lecture entitled, “The International Federation of Kidney Foundations and National Kidney Foundations”

 

12.       2001-2002, Appointed as member of the Data and Safety Monitoring Board (DSMB) for the Homocysteinemia in Kidney and End Stage Renal Disease Study (HOST Study) conducted by the Department of Veterans Affairs

 

13.       June 11, 2002, Boston, MA, I attended a meeting of the Data and Safety Monitoring Board of the Homocysteinemia in Kidney and End Stage Renal Disease Study (HOST Study)

 

 

14.       June 17-18, 2002, La Terapia Conservativa nella Progressione del Danno Renale: Mito o Realta Scientifica del Terzo Millennio?, Castello Monaci, Salice Salentino, Italy, Lecture entitled, “I Limiti Nutrizionali della Terapia Dietetica”

 

15.       June 21, 2002, Polycystic Kidney Disease Foundation. 13th Annual Conference on PKD, Portland, OR, Lecture entitled, “Nutrition and PKD”

 

16.                   June 25, 2002, University of California Davis Medical Center Renal Grand Rounds, Sacramento, CA, Lecture entitled, “Nutritional Management of Chronic Renal Disease”

 

17.                   June 26, 2002, University of California San Francisco Medical Center Renal Grand Rounds, San Francisco, CA, Lecture entitled, “Nutritional Issues in the Management of Chronic Renal Disease”

 

18.       July 18-20, 2002, Third Annual Meeting of the International Federation of Kidney Foundations (IFKF), Prague, Czech Republic, Chaired Third Annual Meeting of the IFKF

 

19.                   July 19, 2002, Third Annual Meeting of the International Federation of Kidney Foundations (IFKF), Prague, Czech Republic, Lecture entitled, “Introduction and Malnutrition and Inflammation”

 

20.       August 26, 2002, Official ASN 7th Annual Board Review Course and Update Workshop entitled, “Complications of Hyperalimentation:  Case Vignettes”, San Francisco, CA

 

21.                   September 11-14, 2002, Consulted with the leadership of the Kidney Foundation of Paraguay (Foundacion Renal del Paraguay (FREPA)) to better organize the foundation, Asuncion, Paraguay

 

22.                   September 12, 2002, National Kidney Foundation Carnitine Consensus Conference, Asuncion, Paraguay, Lecture entitled, “Motivos para su Organizaacion”

 

23.                   September 12, 2002, National Kidney Foundation Carnitine Consensus Conference, Asuncion, Paraguay, Lecture entitled, “El voluntariado exitoso en la Funcacion del Rinon:  Cuales son sus elementos claves?”

 

24.                   September 13, 2002, National Kidney Foundation Carnitine Consensus Conference, Asuncion, Paraguay, Lecture entitled, “Evaluacion del estado nutricional en el paciente con dialysis cronica”

 

25.                   September 13, 2002, National Kidney Foundation Carnitine Consensus Conference, Asuncion, Paraguay, Lecture entitled, “Rationale for dietary therapy for CRF patients not undergoing dialysis treatment”

 

26.                   September 13, 2002, National Kidney Foundation Carnitine Consensus Conference, Asuncion, Paraguay, Lecture entitled, “Ejercicios de entrenamiento y sus efectors en la musculatura de los pacientes con insuficiencia renal cronica”

 

 

27.                   September 27, 2002, Prevention in Renal Disease an International Conference, Toronto, Canada, Lecture entitled, “Is There a Ride for Dietary Protein Restriction in Chronic Progressive Renal Disease”

 

28.                   September 27, 2002, Prevention in Renal Disease an International Conference, Toronto, Canada, Co-chaired plenary session entitled, “Glomerular Disease Part II”

 

29.                   October 17-19, 2002, V1 National Congress of the Mexican Society of Transplantation, Guadalajara, Mexico, Lecture entitled, “Nutrition and Metabolism in Renal Transplantation”

 

30.                   October 24, 2002, Long Beach Comprehensive Health Center, Long Beach, CA, Lecture entitled, “The Use of Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor II Blockers for the Treatment of Hypertension”

 

31.                   October 31, 2002, COMGAN Workshop, Philadelphia, PA, Lecture entitled, “Commission on Global Assistance in Nephrology”

 

October 30-November 4, 2002, Annual American Society of Nephrology Meeting, Philadelphia, PA, The following poster presentations were given:

 

32.                   Kalantar-Zadeh K, Kopple JD.  Total Plasma Homocysteine may be a Nutritional Marker in Maintenance Hemodialysis Patients

 

33.                   Kalantar-Zadeh K, Kopple JD.  Association between Appetite and Inflammation, Anemia, EPO Dose, and Quality of Life in Dialysis

 

34.                   Humphreys MH, Kopple JD.  Association between type of Dialysis Access and Quality of Life in Maintenance Hemodialysis Patients

 

35.                   Pillon L, Piccoli A, Kopple JD.  Biompedance Vector Analysis, Adequacy of Ultrafiltration, and Kt/V

 

36.                   Appel LJ, Bakris G, Douglas-Baltimore J, Greene T, Kopple JD, Massry S, Wang X, for the AASK Research Group. NIDDK.  The Relationship between Achieved Blood Pressure (BP) and Renal Outcomes in the African American Study of Kidney Disease (AASK)

 

37.                   Kalantar-Zadeh K, Lehn RS, McAllister CJ, Kopple JD.  Impact of Malnutrition-Inflammation Complex Syndrome and Ace Inhibitors on Erythropoietin Hyporesponsiveness in Hemodialysis Patients

 

38.                   Mehrotra R, Supasyndh O, Kaysen GA, Das D, Hurst L, Leonardi M, Bross R, Kopple JD. Relationship between Demographic, Laboratory and Nutritional Measures and Co-Morbidity in Maintenance Hemodialysis (MHD): No Relationship with Markers of Inflammation

 

 

39.                   Supasyndh O, Mehrotra R, Hurst L, Leonardi M, Bross R, Kopple JD.  Predictors of Morbidity in Maintenance Hemodialysis

 

40.     Supasyndh O, Mehrotra R, Das D, Hurst L, Leonardi M, Bross R, Kopple JD. Relation between Serum Parathyroid Hormone and Age in Maintenance Hemodialysis Patients

 

November 12, 2002, The Hemo Study, The University of Szeged, Szeged, Hungary, I gave a seminar on “Hemo Study”

 

41.                   November 12, 2002, The Hemo Study, The University of Szeged, Szeged, Hungary, Lecture entitled, “The Recent Clinical Trials In Hypertension.  What Are They Telling Us?”

 

42.                   February 5, 2003, XXII Egypt Society of Nephrology Congress, Sharm El Sheikh, Egypt, Lecture entitled, “The Role of Nutrition in Hypertension”

 

43.                   February 5, 2003, XXII Egypt Society of Nephrology Congress, Sharm El Sheikh, Egypt, Lecture entitled, “Diabetic Nephropathy”

 

44.                   February 7, 2003, XXII Egypt Society of Nephrology Congress, Sharm El Sheikh, Egypt, Lecture entitled, “The Effect of Ramipril vs. Amlodipine and Metoprolol on Renal Outcomes in African-American Patients with Hypertensive Nephrosclerosis”

 

45.                   March 27-29, 2003, Hemodialysis VII Vanguard Trends 2003 (Hemodialysis VII Tendencies De Vanguardia 2003) Meeting, Guadalajara, Mexico, Lecture entitled, “Nutrition in Hemodialysis”

 

46.                   March 27-29, 2003, Hemodialysis VII Vanguard Trends 2003 (Hemodialysis VII Tendencies De Vanguardia 2003) Meeting, Guadalajara, Mexico, Lecture entitled, “Kidney Foundations”

 

47.                   March 27-29, 2003, Hemodialysis VII Vanguard Trends 2003 (Hemodialysis VII Tendencies De Vanguardia 2003) Meeting, Guadalajara, Mexico, Lecture entitled, “Exercise Training in Maintenance Hemodialysis Patients”

 

48.                   May 28, 2003, St. Mary Medical Center, Long Beach, CA, Lecture entitled, “Nutrition and Blood Pressure”

 

49.                   June 4, 2003, Fourth International Meeting of the International Federation of Kidney Foundations, Amsterdam, Netherlands, I chaired the meeting of the IFKF Executive Committee

 

50.                   June 5, 2003, Fourth International Meeting of the International Federation of Kidney Foundations, Amsterdam, Netherlands, I co-chaired the introductory session for the meeting

 

 

 

51.                   June 6, 2003, Fourth International Meeting of the International Federation of Kidney Foundations, Amsterdam, Netherlands, Lecture entitled, “Where is the IFKF Going? ‘Our Vision’ The Options”

 

52.                   June 7, 2003, Fourth International Meeting of the International Federation of Kidney Foundations, Amsterdam, Netherlands, I chaired the business meeting of the IFKF

 

53.                   June 10, 2003, World Congress of Nephrology, Berlin, Germany, I co-chaired the session entitled, “Kidney Foundations”

 

54.       June 10, 2003, World Congress of Nephrology, Berlin, Germany, Lecture entitled,  "The Concept of a Kidney Foundation"

 

55.                   October 15, 2003, Yonsei University, Seoul, Korea, Lecture entitled, “Cardiovascular Disease in Individuals with End-stage Renal Disease”

 

56.                   October 15, 2003, Yonsei University, Seoul, Baxter Korea, Lecture entitled, “Nutrineal”

 

57.                   October 16, 2003, Korean Society of Nephrology, Jeju, Island, Korea, Lecture entitled, “Skeletal Muscle Metabolism in Chronic Renal Failure”

 

58.                   October 17, 2003, Korean Society of Nephrology, Jeju, Island, Korea, Lecture entitled, “The Physiology and Potential Uses of Carnitine in Maintenance Dialysis Patients”

 

59.                   October 23, 2003, Gambro Wet Region II Annual Physician Quality Management  Forum, Pasadena, CA, Lecture entitled, “Current Indications for the Use of Levocarnitine and CEM Guidelines”

 

November 14-17, 2003, Annual American Society of Nephrology Meeting, San Diego, CA, The following poster presentations were given:

 

60.                   Keith Norris, Tom Greene, Joel Kopple, Janice Lea, Michael Lipkowitz, EdgarMiller, Annie Richardson, Stephen Rostand, Xuelei Wang, the AASK Study Group, Baseline Predictors of Renal Disease Progression in the African American (AA) Study of Hypertension and Kidney Disease (AASK)

 

61.       Hy Wang, Joel Kopple, W. Taylor, T. Storer, R. Casaburi, Gene Expression for Myostatin is Increased in Skeletal Muscle of Maintenance Hemodialysis (MHD) Patients

 

62.                   Joel D. Kopple, M. Fournier, Hy Wang, A. Cohen, T. Storer, R. Casaburi, M.I. Lewis, Skeletal Muscle Structure and Oxidative Capacity in Maintenance Hemodialysis (MHD) Patients

 

63.                   Hy Wang, Joel D. Kopple, W. Taylor, H. Eleil, T. Storer, R. Casaburi, Gene Expression for Insulin-Like Growth Factors (IGF) in Skeletal Muscle of Maintenance Hemodialysis (MHD) Patients

 

 

64.                   Kamyar Kalantar-Zadeh, Naoko Maekawa, Sara Colman, Joel D. Kopple, Gladys Block, Is Hyperphosphatemia an Indicator of a Better Dietary Protein and Calorie Intake in Hemodialysis Patients?

 

65.                   Kamyar Kalantar-Zadeh, Gladys Block, Michael H. Humphreys, Joel D. Kopple, A Low, and Not a High, Total Plasma Homocysteine is a Mortality Risk Factor in Hemodialysis Patients

 

66.                   Kamyar Kalantar-Zadeh, Matthew J. Budoff, Sara Colman, Joel D. Kopple, Charles J. McAllister, Exploring the Morality-Predictability of Serum Phosphorus in Hemodialysis Patients

 

67.                   Keith Norris, Jacques Bourgoignie, Jennifer Gassman, Lee Hebert, John Middleton, Robert Phillips, Otelio Randall, Stephen Rostand, Susan Sherer, Robert Toto, Jackson Wright, Xuelei Wang, Joel Kopple, Julia Lewis, Tom Greene, The AASK Study Group, Cardiovascular Outcomes in the African American (AA) Study of Hypertension and Kidney Disease (AASK)

 

68.                   Kamyar Kalantar-Zadeh, Charles J. McAllister, Enwu Liu, Robert S. Lehn, Joel D. Kopple, Low, and Not High, Serum Iron Store Indices Predict Mortality in Hemodialysis Patients

 

69.                   Kamyar Kalantar-Zadeh, Gladys Block, Charles J. McAllister, Michael H. Humphreys, Joel D. Kopple, Self-Reported Subjective Appetite Correlates with Inflammation, Nutrition, and Anemia and Predicts Quality of Life and Mortality in Dialysis Patients

 

70.                   Kamyar Kalantar-Zadeh, Robert S. Lehn, Joel D. Kopple, High Total WBC Count and Low Lymphocyte Percentage Predict Prospective Mortality in Hemodialysis Patients

 

71.                   Kamyar Kalantar-Zadeh, Joel D. Kopple, Michael H. Humphreys, Gladys Block, Comparing Mortality-Predictability of Serum Interleukin-6, Tumor Necrosis Factor, C-Reactive Protein, and Malnutrition-Inflammation Score in Hemodialysis Patients

 

72.       December 17, 2003, National Cooperative Growth Study (NCGS)/National  Cooperative Somatotropia Surveillance (NCSS) 2003 Annual Invetigator Meeting hosted by Genentech Corporation, Baltimore, Maryland (By Telephone from Los Angeles, CA), Lecture entitled, “Growth Hormone Treatment for Adults With Chronic Renal Failure”

 

73.       December 17, 2003, Endocrinology Grand Round, City of Hope, Duarte, CA, Lecture entitled, “Management of Hypertension in Diabetic Patients”

 

74.       April 18, 2004, Annual Experimental Biology Meeting, Washington DC, Lecture entitled, “The Saga of Nephrology and Nutrition”

 

75.       April 21, 2004, Visiting Professor, St. Mary Medical Center, Long Beach, CA, Lecture entitled, “ACE Inhibitors, ARBs and the Management of Hypertension”

 

 

76.       April 23, 2004, Montage Resort and Hotel, Laguna Beach, CA, Lecture entitled, “Controversies in Carnitine Deficiency”

 

77.       May 10, 2004, Western Galilee Hospital, 10th International Nahariya Update Meeting on Emergency, Circulatory Metabolic and Renal Disorders, Nahariya, Israel, Lecture entitled, “The Effect of Exercise Training on Growth Factors in Skeletal Muscle in Maintenance Hemodialysis Patients”

 

78.       May 15, 2004, 41st Annual Meeting of the EDTA/ERA Symposium, Lisbon, Portugal, Lecture entitled, “Risks of Chronic Metabolic Acidosis in Patients with Chronic Kidney Disease”

 

79.       May 18, 2004, Renal Grand Rounds, Cedars-Sinai Medical Center - Los Angeles, CA, Lecture entitled, “Nutrition in the Etiology and Management of Hypertension”

 

80.       June 11, 2004, Baxter Peritoneal Dialysis University, Newport Beach, CA, Lecture entitled, “Nutrition in (Peritoneal) Dialysis Patients”

 

81.       August 30, 2004, 5th International Meeting of the International Federation of Kidney Foundations (IFKF), Adelaide, Australia, Lecture entitled, “Recommended Dietary Protein and Energy Intakes in Chronic Renal Failure”

 

82.       August 31, 2004, 5th International Meeting of the International Federation of Kidney Foundations (IFKF), Adelaide, Australia, Lecture entitled, “Physicians as Volunteers”

 

83.       September 6, 2004, Peruvian Society of Nephrology Meeting, Lima, Peru, Lecture entitled, “Methods of Preventing the Progression of Chronic Renal Disease”

 

84.       September 9, 2004, Meeting of the Kidney Foundation of Northeast Argentina, Resistencia, Argentina, Lecture entitled, “The Relationship between the International Federation of Kidney Foundations and Local Kidney Foundations”

 

85.       September 10, 2004, Meeting of XIV Franco Paraguayas Days of Nephrology, III National Scientific Congress of Medical Students of Paraguay, II Symposium of Nutrition in Renal Disease, and II International Conference of the Kidney Foundation of Paraguay, Asuncion Paraguay, Lecture entitled, “Skeletal Muscle Metabolism in Chronic Renal Insufficiency”

 

86.       September 10, 2004, Meeting of XIV Franco Paraguayas Days of Nephrology, III National Scientific Congress of Medical Students of Paraguay, II Symposium of Nutrition in Renal Disease, and II International Conference of the Kidney Foundation of Paraguay, Asuncion Paraguay, Lecture entitled, “Epidemiology of Cardiovascular Disease, Role of ACE Inhibitors and Angiotensin Receptor Blockers”

 

87.       September 10, 2004, Meeting of XIV Franco Paraguayas Days of Nephrology, III National Scientific Congress of Medical Students of Paraguay, II Symposium of Nutrition in Renal Disease, and II International Conference of the Kidney Foundation of Paraguay, Asuncion Paraguay, Lecture entitled, “The Media and the Growth and Dissemination of Voluntary Work in Foundations”

 

88.                   September 11, 2004, Meeting of XIV Franco Paraguayas Days of Nephrology, III National Scientific Congress of Medical Students of Paraguay, II Symposium of Nutrition in Renal Disease, and II International Conference of the Kidney Foundation of Paraguay, Asuncion Paraguay, Lecture entitled, Lecture entitled, “Protein Requirements and Chronic Renal Insufficiency”

 

89.                   September 11, 2004, Meeting of XIV Franco Paraguayas Days of Nephrology, III National Scientific Congress of Medical Students of Paraguay, II Symposium of Nutrition in Renal Disease, and II International Conference of the Kidney Foundation of Paraguay, Asuncion Paraguay, Lecture entitled, “Role of Physical Training in Hemodialysis Patients”

 

90.                   September 18, 2004, National Kidney Foundation of Southern California Annual Scientific Symposium, Temecula, CA, Lecture entitled, “Exercise Training of Maintenance Hemodialysis Patients”

 

91.                   September 18, 2004, National Kidney Foundation of Southern California Annual Scientific Symposium, Temecula, CA, Lecture entitled, “ The Sale of Kidneys for Transplantation Should be Legalized”

 

92.                   October 5, 2004, L’Opera Restaurant, Long Beach, CA, Lecture entitled, “Carnitine in Dialysis Patients

 

93.     October 19, 2004, 3rd Meeting of the Sicilian Society of Nephrology, Scillato (PH), Sicily, Lecture entitled, “Issues Regarding Dietary Management of Non-Dialyzed Patients with Chronic Kidney Disease”

 

94.                   October 21, 2004, XVI National Congress of the A.D.I. (Italian Association of Dietetics and Clinical Nutrition), Giardini Naxos (ME), Sicily, Lecture entitled, “Malnutrition Inflammation Syndrome (sig, in chronic renal failure)”

 

95.                   October 21, 2004, XVI National Congress of the A.D.I. (Italian Association of Dietetics and Clinical Nutrition), Giardini Naxos (ME), Sicily, Lecture entitled, “Issues Regarding Dietary Management of Non-Dialyzed Patients with Chronic Kidney Disease”

 

96.     October 27-28, 2004, American Society of Nephrology, Postgraduate Education/Course, St. Louis, MO, Lecture entitled, “Diet and Progression”

 

97.     October 31, 2004, American Society of Nephrology, Postgraduate Education/Course, St. Louis, MO, Lecture entitled, “Anabolic Effects of Exercise Training in Dialysis Patients”

 

 

October 27-November 1, 2004, American Society of Nephrology Renal Week, St. Louis, MO, The following abstracts were presented as Free Communications:

 

98.       Time-Dependent Association between Dialysis Dose and Cardiovascular Mortality in Hemodialysis Patients.  Kilpatrick RD, Greenland S, McAllister CJ, Kopple JD, Kalantar-Zadeh K. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:2A, 2004

 

October 27-November 1, 2004, American Society of Nephrology Renal Week, St. Louis, MO, The following abstracts were presented as Poster Presentations:      

 

99.     Time-Dependent Association between Dialysis Dose and Cardiovascular Mortality in Hemodialysis Patients.  Kilpatrick RD, Greenland S, McAllister CJ, Kopple JD, Kalantar-Zadeh K, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:2A, 2004

 

100.   Time-Dependent Association between Body Mass Index and Cardiovascular Mortality in Hemodialysis Patients.  Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Kopple JD, Greenland S, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:126A, 2004

 

101.    Association between Novel “HDL Inflammatory/Anti-Inflammatory Properties” with Body Mass Index in Hemodialysis Patients.  Kalantar-Zadeh K, Kamranpour N, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:172A, 2004

 

102.   Serum Paraoxonase and LDL Oxidation Measurement in Maintenance Hemodialysis Patients.  Kalantar-Zadeh K, Kamranpour N, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:173A, 2004

 

103.     A Low, Rather Than a High, Serum LDL Cholesterol Is Associated with Increased Mortality in Hemodialysis Patients Even after Controlling for Inflammation.  Kalantar-Zadeh K, Horwich TB, Fonarow GC, Anker SD, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:173A, 2004

 

104.     A Matched Comparison of Serum Lipid Levels in Hemodialysis Patients vs. Non-ESRD Controls.  Kalantar-Zadeh K, Kopple JD, Stringer WW, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:192A, 2004

 

105.   An Anti-Inflammatory and Anti-Oxidant Nutritional Supplement for Hypoalbuminemia Dialysis Patients.  Kalantar-Zadeh K, Chow J, Braglia A, Cockram DB, Kuwae N, Kwon O, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:192A, 2004

 

106.   Malnutrition-Inflammation Complex Confounds Associations between Serum Phosphorus and Calcium and Mortality in Hemodialysis Patients.  Kuwae K, Kilpatrick RD, McAllister CJ, Budoff MJ, Kopple JD, Kalantar-Zadeh K, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:381A, 2004

 

107.     Population Attributable Mortality Risk for Albumin ≤3.8 g/dL: How Many Lives Can Be Saved If Hypoalbuminemia Can Be Corrected in Hemodialysis Patients?  Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Gjertson DW, Greenland S, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:382A, 2004

 

108.     Exploring Time-Dependent Associations between Urea Dynamic Calculated Protein Intake and Cardiovascular Mortality in Hemodialysis Patients.  Shinaberger CS, Kilpatrick RD, McAllister CJ, Kopple JD, Kalantar-Zadeh K, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:385A, 2004

 

109.     Impact of Malnutrition-Inflammation on the Association between Serum Potassium Level and Mortality in Hemodialysis Patients.  Kuwae N, McAllister CJ, Kopple JD, Kalantar-Zadeh K, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:391A, 2004

 

110.     A Low, Rather Than a High, Systolic Blood Pressure Is Associated with Increased Mortality among Hemodialysis Patients.  Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:586A, 2004

 

111.   The Effect of Very Low Protein on Progression of Kidney Disease and Mortality in Modification of Diet in Renal, Disease Study B.  Levey, AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, Kopple JD, 37th annual conference of the American Society of Nephrology, J Am Soc Neph 15:586A, 2004

 

112.    Effect of Low Protein Diet on Progression of Kidney Disease in the Modification of Diet in Renal Disease Study A: Long-Term Follow-Up.  Levey, AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, Kopple JD, 37th annual conference of the American Society of Nephrology, J Am Soc Neph 15:586A, 2004

 

113.    Comparing Four Body Composition Assessment Methods for Body Fat Measurement in Dialysis Patients.  Kalantar-Zadeh K, Bross R, Zitterkoph J, Colman S, Gjertson DW, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:591A, 2004

 

114.    Association between Hepatitis C Infection and Malnutrition-Inflammation Complex Syndrome in Maintenance Hemodialysis Patients.  Kalantar-Zadeh K, Daar ES, Kopple JD, Miller LG, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:622A, 2004

 

115.   Skeletal Muscle Insulin-Like Growth Factor-I (IGF-I) and IGF-I mRNA in Maintenance Hemodialysis Patients.  Wang H, Taylor WE, Kopple JD, 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:624A, 2004

 

116.     November 11, 2004, Meeting of the New York Council on Renal Nutrition, Long Island College Hospital, Brooklyn, NY, Lecture entitled, “Increased Dietary Intake, Higher Blood pH and Exercise to Promote Anabolism in Maintenance Dialysis Patients”

 

117.   November 13 and 14, 2004, Netherlands Meeting, Prevention of Progressive Renal Failure Its Global Impact, Amsterdam, Lecture entitled, “Strategies for Implementation of Prevention Programs-Perspective of Kidney Foundations”

 

118.   May 6, 2005, 12th Annual International Medicine Research Day, The Texas A & M University System Health Science Center, Temple, TX, Lecture entitled, “Management of Progressive Renal Failure”

 

119.              May 6, 2005, 12th Annual International Medicine Research Day, The Texas A & M University System Health Science Center, Temple, TX.  I was one of four judges for the best poster presentation

 

120.              International Scientific Committee, XIII International Congress on Nutrition and Metabolism in Renal Disease, Merida, Yucatan, March 1-4, 2006

 

121.  April 15-17, 2006.  Trip from Lyon to Sicily to meet with Professors Guido Bellinghieri and Vincenzo Savica to review matters concerning the 7th International IFKF meeting and a forthcoming Papal audience.

 

122.   April 23, 2006, Chicago, Illinois.  Meeting with IFKF and ISN representatives to review and develop World Kidney Day activities.

 

123.  April 25, 2006, Paris, France.  Two-hour satellite symposium sponsored by Amgen at the Actualities Nephrologiques Jean Hamburger Hopital Necker.  The satellite symposium was entitled, “Risk Factors for Progression of Morbidity and Mortality in CRF Patients”.  I was one of three speakers and gave a 40 minute talk (including about 2 minutes of discussion) entitled, “Role of Inflammation and Nutritional Factors”.

 

124.    April 27, 2006, Copenhagen Denmark. I served as a consultant concerning a possible new drug venture for a pharmaceutical company.  The meeting was called, “Adult Patients in Chronic Dialysis Advisory Board Meeting”. I gave a 30 minute talk to this advisory group entitled, “Malnutrition and Treatment Modalities in Dialysis”.

 

125. May 15, 2006, Tehran, Iran.  I Met with patients in the Kidney Foundation and had   discussions with officers and members of the Board of Directors, interviews with journalists, television interview and filming (I apparently was on national television), and toured facilities. I Met with Mrs. Hashemni (Director)and members of Charitable Foundation for Special Diseases.

 

126. May 16, 2006, Shiraz, Iran. University Medical School. Lecture 8:00 am to 9:00 am entitled, “Malnutrition and Inflammation in Chronic Kidney Failure”.

 

127. May 19-20, 2006.  Umrea, Iran. 10th Annual Meeting of the Iranian Society of Nephrology. I gave a 30 minute lecture at the opening ceremony, which was entitled, “How will Chronic Dialysis Therapy be Changed in the Next 15 Years?”

 

127. May 20, 2006. Umrea, Iran. Lecture entitled, “Malnutrition and Inflammation in Chronic Kidney Failure”.

 

128. May 20, 2006. Umrea, Iran. Lecture entitled, “Effect of Exercise Training on Muscle Metabolism in Maintenance Hemodialysis Patients”.

 

129. May 21, 2006, Tehran, Iran. I worked in The Kidney Foundation of Iran where I helped the Foundation members to apply for membership in the International Federation of Kidney Foundations.

 

130.   May 30, 2006. Tassin, France, Tassin Chronic Dialysis Unit.  Lecture entitled, “Dietary Protein Requirements in Maintenance Hemodialysis Patients”.

 

March 17, 2007.  Tokyo, Japan.  International Kidney Evaluation Association,   Japan (IKEAJ), Tokyo, Japan.  Open Medical Lecture Meeting:  Two lectures:

 131.  Lecture, entitled, “Why is there a need for WORLD KIDNEY DAY?”

 132.  Lecture, entitled, “CKD and Nutrition”.

 

April 16-19, 2007.  Curitiba, Brazil.  The 8th International Meeting of the International Federation of Kidney Foundations (IFKF).

134.  I co-chaired two sessions at the meeting.

135.  Talk giving closing reflections on the state of the IFKF.

 

April 21-25, 2007.  Rio de Janeiro, Brazil, World Congress of Nephrology.

135.  April 23, 2007.  Novo Nordisk Symposium – Improving Biomarkers for Morbidity and Mortality in Chronic Hemodialysis Patients. Lecture followed by discussion entitled, “Biomarkers for Morbidity and Mortality in Patients on Chronic Hemodialysis – Focus on Markers of Nutrition”.

 

136.  April 25, 2007.  Symposium – Nutrition and Inflammation in Dialysis.  I gave a 20 minute lecture and discussion entitled, “Nutrition Assessment in Dialysis Patients: Is There a Gold Standard?”

 

137.  May 9, 2007.  University of Southern California School of Medicine, Los Angeles, California.  USC Renal Grand Rounds.  Lecture entitled, “Dietary Protein Requirements in Chronic Kidney Failure”.

 

138.  June 29-30, 2007. Aix la Chapelle, Germany.  University D’Ete de la Societe Francophone de Dialyse. Lecture entitled, “Causes of Malnutrition in Chronic Kidney Failure”.

 

139. July 13, 2007.  Novo Nordisk Investigator Meeting Orlando, FL.  Lecture entitled, “Biomarkers for Morbidity and Mortality in Patients on Chronic Hemodialysis – Focus on Markers of Nutrition.”

 

August 3-5, 2007, Hua Hin, Thailand.  Annual Meeting of the Nephrology Society of Thailand.

140. Lecture entitled, “Nutritional Assessment  and Therapy for Hemodialysis Patients”.

141. Lecture plus several minutes of discussion entitled, “Effect of Exercise Training on Exercise Capacity and Muscle Metabolism in Maintenance Hemodialysis Patients.”

 

141. August 13, 2007.  Anaheim, California.  Fourth Annual NIH-NIDDK Undergraduate Research Symposium organized by Charles Drew Postgraduate University of Medicine and Science.  I was the Keynote Speaker and gave a lecture entitled, “How a Combination of Many Small Research Findings Changed How Scientists, Physicians and Governments View Chronic Kidney Disease.”

 

142. August 31, 2007.  Copenhagen, Denmark.  Novo Nordisk OPPORTUNITY Study Investigator Meeting. Lecture entitled, “Biomarkers for Morbidity and Mortality in Patients on Chronic Haemodialysis – Focus on Markers of Nutrition.”

 

143. September 7, 2007.  Guadalajara, Mexico. Academic Day celebrating 2000 Renal Transplants performed at the UMAE Hospital de Especialidades, CMNO Curso Pre-Jornadas Academicas del 20 Aniversario. Presentation entitled, “ Overview of the Division of Nephrology and Its Collaboration with Transplants at HE CMNO-IMSS (I.E., Social Security Hospital in Guadalajara).”

 

144. October 5-6, 2007.  Phoenix, Arizona. Novo Nordisk APCD Norditropin® Clinical Trial.  I gave a 25-minute talk entitled, “Biomarkers for Morbidity and Mortality in Patients on Chronic Hemodialysis – Focus on Markers of Nutrition.”

 

145. October 7-9, 2007.  Boston, Massachusetts, the Charles Hotel.  AstraZeneca Expert Advisory Meeting on Cachexia.  Lecture entitled, “ESRD Associated Cachexia”.

 

October 24, 2007. Long Beach, California. Visiting Professor Rounds at St. Mary Medical Center.

146. I discussed a clinical case presentation.

147. Lecture entitled, “The Epidemic of Chronic Kidney Disease and its Consequences.”

 

November 2, 2007. San Francisco, CA. Annual Meeting of the American Society of Nephrology.

148. I co-moderated an evening symposium entitled, “Malnutrition in the Chronic Hemodialysis Patient.”

149. Lecture entitled, “Therapy of the Malnourished Dialysis Patient.”

150. Editorial Board Breakfast for the Clinical Journal of the American Society of Nephrology.

151. I co-moderated a symposium entitled, “Functional Decline and Frailty in Chronic Kidney Disease.”

 

152. February 29, 2008.  Aran Mantegna Hotel, Rome, Italy.  NovoNordisk Investigators Meeting. Lecture entitled entitled, “Biomarkers of Nutrition in Maintenance Hemodialysis Patients.”

 

153. March 13, 2008.  Newark, New Jersey. I chaired the meeting of the Steering Committee of the OPPORTUNITY Trial sponsored by NovoNordisk.

 

154. March 14, 2008.  Newark, New Jersey.  Lecture entitled, “The OPPORTUNITY Trial, Rationale and Design.” sponsored by Novo Nordisk.

 

155. March 13 and 15, 2008.  I led a team of academicians, lay volunteers and National Kidney Foundation of Southern California and Kaiser Permanente professional staff to develop a series of World Kidney Day activities in Los Angeles on these two days.

 

 

156. March 15, 2008. World Kidney Day Clinical Symposium for general internists, family practitioners, clinical nurse practitioners and case managers from Los Angeles County Department of Health Services and Kaiser Permanente. Rand Corporation, Santa Monica, California.  Lecture entitled, “World Kidney Day Overview.”

 

157. March 28-29, 2008.  Guadalajara, Mexico.  XII Tendencias de Vanguardia 2008.

Lecture entitled, “World Kidney Day: Rationale, Impact and Future.”

158. Lecture entitled, “The Effects of Different Types of Exercise Training on Exercise Capacity in Patients on Hemodialysis.”

 

159. April 12, 2008. Las Vegas, Nevada. The OPPORTUNITY Trial Investigator Meeting. Lecture entitled, “Biomarkers for Morbidity and Mortality in Patients on Chronic Hemodialysis: Focus on Markers of Nutrition.”

 

May 6-9, 2008. Mainz, Germany. 9th Annual Meeting of the International Federation of Kidney Foundations.

160. I participated in a 30 minute two person debate on “Should Foundations Help More with Moving the Public Health Agenda?”

161. I moderated the one hour Poster Discussion Session and also led the judging for the prizes for the best posters.

 

162. May 10-13, 2008. Stockholm, Sweden.  45th ERA-EDTA Congress. I chaired a 90 minute symposium entitled, “Mortality of ESRD Patients with Hypoalbuminemia: the OPPORTUNIY Trial.”

 

June 11-15, 2008.  Marseilles, France.  XIVth International Congress on Nutrition and metabolism in Renal Disease.

163.  June 11, 2008.  Workshop on Muscle Protein Metabolism in Renal Disease.  Lecture entitled, “Effects of Different Types of Exercise Training on Exercise Capacity in Maintenance Hemodialysis Patients.”

164. June 12, 2008.  I co-chaired asession of Free Communications entitled, “Nutrition and Outcome Assessment 2”.

165.  June 12, 2008.  I co-chaired the symposium 1 entitled, “Exercise in Hemodialysis Patients”.

166.  June 12, 2008.  I co-chaired the Novo Nordisk symposium entitled, “The OPPORTUNITYTM Trial: Will Growth Hormone Reduce Mortality in ESRD Patients with Hypoalbuminemia?”

167.  June 14, 2008.  Symposium entitled, “Late Breaking Topics”:  Lecture entitled, “Dietary Protein Requirement in Hemodialysis Patients”.

 

August 29, 2008.  Munich, Germany.

168. I represented the International Federation of Kidney Foundations (IFKF) at the internationally organized High Blood Pressure Stakeholders Meeting.

169. I participated in a pre3\sentation with a hypertensionologist from Canada (Dr. Arun Chockalingam) entitled, “ Public Awareness Campaigns”. This presentation was the outgrowth of an initiative that I conceived of to create a collaborative effort between World Kidney Day and other international health days that either may cause kidney disease or be related to the adverse consequences of kidney disease.  International health days that fall into this category include World Hypertension Day, World Diabetes Day and World Heart Day.  The first effort in this regard was with World Hypertension Day.  This year, for the first time, World Kidney Day and World Hypertension Day advertised the etiological and sequelae of the other disease condition as it related to their own health day.  The result was considered to be highly successful by both organizations, and for the year 2010, we plan to link World Kidney Day and World Diabetes Day in the same fashion.

 

September 8-22, 2008.  India.

170. September 9, 2008. Mumbai, India. Business meeting with the Executive Committee of the National Kidney Foundation of India.

171.. September 10, 2008. Mumbai. Meeting with the Vice-Chair of the National Kidney Foundation of India to discuss the possibility of an international meeting sponsored by this organization.

 

September 11, 2008. Lucknow, India. DIALYSISCON-2008 meeting.

172.  Lecture entitled, “How to retard the Rate of Progression of Chronic Kidney Disease.”

173.  Lecture entitled, “How Kidneys may be Ethically and Effectively Procured for Renal Transplantation.”

 

September 16, 2008. Teaching Hospital in Nadiad, India.

174. Lecture entitled, Causes and Management of Malnutrition, Inflammation and Wasting in CKD.”

175. Seminar: I discussed for two hours research projects that were presented to me.

176. Lecture entitled, “Assessment of Nutritional Status of a CKD Patient:  How Do I Do It in the Clinic?”

177. Seminar: I discussed for two hours clinical cases in nephrology that were presented to me.

 

178. September 19, 2008. KEM Hospital, Mumbai, India. I delivered the Dr. M.D. Motashaw Oration in Nephrology.

 

179. September 19,2008. Gopikrishna Piramal Memorial Hospital, Mumbai.  Seminar for one hour with students who had just been graduated from the Dialysis Technology Course.

 

180. September 19, 2008. The Piramal Life Sciences Auditorium, Goregaon, Mumbai. I participated in a media interview and than gave lecture entitled, “The Importance of Prevention in Taking on Diabetes, Hypertension, Dyslipidemia and Arthritis.”

 

September  20, 2009 Pune, India. KEM Hospital.

181. One hour lecture entitled, “The Phenomenon of Altered Risk Factor Patterns in Chronic Kidney Disease Patients.”

182. Seminar for two hours discussing clinical cases.

 

183. October 3, 2008.  Los Angeles, CA.  Lecture at a Dinner at the Marriott Hotel for investigators and potential investigators in Southern California concerning the OPPORTUNITY Trial of the effect of growth hormone injections on mortality in hypoalbuminemic maintenance hemodialysis patients.

 

October 16, 2008. Sturbridge, Massachusetts.  20th Annual Meeting of the ESRD Network of New England.

184. Lecture entitled, “Altered Metabolism in Advanced Chronic Kidney Failure: How It Affects Nutrition in  Dialysis Patients.”

185. Lectgure entitled “Nutritional Management of the Maintenance Dialysis Patient: So What Do We Do Now?”

 

186. November 6-9, 2008. Philadelphia, PA. Annual Meeting of the American Society of Nephrology. Editorial Board Meeting of the Clinical Journal of the American Society of Nephrology.

 

187. February, 2009.  Los Angeles.  In response to the request of The Hashemite University in Zarqa, Jordan, I examined the academic record of Remma Tayyem, Ph.D. and submitted a written evaluation of her qualifications for promotion to Associate Professor at the University.

 

188. February 7, 2009.  Miami, Florida. The American Society of Nephrology (ASN) Renal Weekend.  These weekends, which are held in various cities around the United States, are used to provide a review of the information presented at the annual ASN meeting for nephrologists who did not attend the annual ASN meeting.  I gave a lecture entitled, “Protein-Energy Wasting and Low Serum Albumin in Dialysis Patients.”

 

189. February 21, 2009. San Francisco, CA.  The American Society of Nephrology (ASN) Renal Weekend.  I gave a lecture entitled, “Protein-Energy Wasting and Low Serum Albumin in Dialysis Patients.”

 

190. March 21, 2009.  Chicago, IL. The American Society of Nephrology (ASN) Renal Weekend. I gave a lecture entitled, “Protein-Energy Wasting and Low Serum Albumin in Dialysis Patients.”

 

191. April 15, 2009.  Los Angeles. Lecture at Renal Grand Rounds at the University of Southern California School of Medicine entitled, "Effect of Nutritional Factors on Blood Pressure".

 

192. April 17, 2009.  Orange County, CA.  Lecture at Medical Grand Rounds at the Hoag Hospital entitled, "Nutritional Causes and Therapies for Hypertension."

 

May 14-15, 2009. Albena, Bulgaria.   IXth Annual Conference “Dialysis in the XXI Century” I gave the following two lectures:

193. “Effects of Different Types of Exercise Training on Exercise Capacity in Maintenance Hemodialysis Patients”.

194. “Effects of Growth Hormone Treatment in Adults with Advanced Chronic Kidney Disease.”

 

195. May 17-20, 2009. Istanbul, Turkey. 10th Annual Meeting of the International Federation of Kidney Foundations.  I chaired a poster-discussion session, moderated the discussion by the authors of the posters that they presented, and led the judging for the prizes for the best posters.

 

May 22-26, 2009.  Milan, Italy.  World Congress of Nephrology 2009 which was organized by the ERA-EDTA and the ISN (International Society of Nephrology).

196. I chaired a symposium on nutrition in kidney disease.

197. Lecture entitled, "Optimizing nutrition in CKD patients not on dialysis".

 

June 5-7, 2009.  Yokohama, Japan. The 54th Annual Meeting of the Japanese Society for Dialysis Therapy.  I gave the following two lectures:

198. June 5, 2009.  “The Global challenge of Chronic Kidney Disease.”

199. June 6, 2009. “Challenges and Advances in the Nutritional and Metabolic Management of Maintenance Dialysis Patients.”

 

200. June, 19, 2009. Paris, France.  I chaired the Executive Committee meeting of the Scientific Advisory Board for the OPPORTUNITY Trial that was sponsored by Novo Nordisk.

 

201. June 20, 2009. Paris, France.  I chaired the Scientific Advisory Board meeting for the OPPORTUNITY Trial sponsored by Novo Nordisk.

 

202. July 18, 2009. Anaheim Hilton Hotel, Anaheim, CA. Lecture at the Kaiser Permanent/National Kidney Foundation of Southern California Nephrology Symposium entitled, “Obesity in Chronic Kidney Disease.”

 

203.  October 3, 2009. PKD Foundation Educational Seminar Meeting; Harbor-UCLA Medical Center. Lecture to a lay audience entitled, “Hypertension and Polycystic Kidney Disease”.

 

204.  October 19, 2009, Romania.  6th International Congress on Uremia Research and Toxicity. Lecture entitled, “Obesity and Chronic Kidney Disease”.

 

205. October 21, 2009. Valek Symposium; Visoky Tatry Mountains, Tatranska Lomnica, Slovak Republic. Lecture entitled, “Obesity, Hypertension and Chronic Kidney Disease”.

 

November 9-12, 2009. Guatemala City, Guatemala.  I gave a course on nutrition and kidney disease to about 50 - 60 dietitians, Ph.D. nutritionists and nephrologists.  The course consisted of lectures and case discussions and lasted three days. Except for one discussion led by a local person, I was the sole lecturer and discussant and gave the following lectures:

206. “Pathogenesis of Protein-Energy Wasting and Vitamin and Mineral Malnutrition in CKD”

207. “Methods for Assessing Protein, Energy, Vitamin and Mineral Status of the Patient with Kidney Disease and Kidney Failure”.

208. “The Interaction of Nutrition, Obesity, Diabetes Mellitus, Hypertension and CKD”.

209. “Nutritional Management of the Patient with CKD”.

210. “Nutritional Management of the Maintenance Hemodialysis and Chronic Peritoneal Dialysis Patient”.

211.  “Intradialytic Parenteral Nutrition and Provision of Nutrition Through Hemodialysate and Peritoneal Dialysate”.

212. “Exercise Training for Patients with Chronic Kidney Failure”.

 

213. November 16, 2009. Henry Ford Hospital, Detroit Michigan. Lecture entitled, “Causes, Prevention and Treatment of Protein-Energy Wasting in the Chronic Dialysis Patient”.

 

214. Montreal, Quebec, Canada. Lecture entitled, “Mechanisms, Assessment and Management of Protein-Energy Wasting”.

 

215. January 27, 2010. University of Southern California Renal Grand Rounds. Lecture entitled, “Can Prevention or Treatment of Obesity Prevent or Reverse Hypertension or CKD?”.

 

March 3-8, 2010.  Patan Academy of Health Sciences (PAHS) and Patan Hospital, Patan, Nepal. 

216. March 3-8, 2010. I, along with Naomi Glick, M.D., visited PAHS and Patan Hospital to examine the possibility that the two of us could establish the first nephrology fellowship training program in Nepal.  We met with many members of the staff and faculty as well as the Minister of Health of Nepal and the President of the Nepal Medical Council.

I also gave the following four lectures, each for 45 – 60 minutes.

217. March 5, 2010. I gave a lecture entitled, “The Global Epidemic of CKD”.

218. March 5, 2010. I gave a lecture entitled, “Nutrition, Obesity, Sodium and Hypertension”.

219. March 5, 2010. I gave a lecture entitled, “Altered Risk Factor Patterns in Chronic Renal Failure”.

220. March 5, 2010. I gave a lecture entitled, “ Acute Kidney Injury”.

 

March 11-13, 2010. World Kidney Day activities in Los Angeles.

221. I informally served as the coordinator for the various World Kidney Day activities that were held in Los Angeles.

222. March 11, 2010. Holman United Methodist Church, Los Angeles, CA.  Healthy African American Families II. Building Bridges to Optimum Health.  I gave a lecture, to lay people entitled, “ Why a World Kidney Day?”.

March 13, 2010.  2010 World Kidney Day Symposium for Nurse Practitioners and Case Managers. 

  223. I presented an overview entitled, “Welcome and World Kidney Day Overview”.

  224. I gave a lecture entitled, “Obesity Diabetes and Kidney Disease”.

 

225. March 18, 2010.  University of Auvergne, Clermont-Ferrand, France.  Ceremony: Doctor Honoris Causa de l'Universite d'Auvergne.  During the ceremony, I gave a short lecture on the cyclic history history of nutrition in renal disease.

 

226. March 20, 2010.  Clermont-Ferrand, France. First International Congress of Translational Research in Human Nutrition.  I co-chaired a session.

 

227. April 14, 2010. Walt Disney World Swan and Dolphin Hotels, Orlando, Florida.  2010 National Kidney Foundation Spring Clincial Meetings. I gave a 90 minute lecture, including 10-15 minutes of discussion, entitled, “Are We Doing Enough to Detect and Treat Vitamin Deficiences in the Renal Population?”

 

May 9-12, 2010; Annual IFKF (International Federation of Kidney Foundations) Meeting in Kuala Lumpar Malaysia. 

   228. May 9, 2010.  Lecture entitled, “The Relationship of the

Epidemic of Obesity to Hypertension, Diabetes Mellitus and CKD.  What Can Be Done?

   229. May 10, 2010. I chaired and led the poster discussions in the Poster Discussion Session and chaired the committee that selected the First, Second and Third Prizes for the posters presenting kidney foundation activities and also the posters presenting World Kidney Day activities.

 

May 25-28, 2010.  XV International Congress on Renal Nutrition and Metabolism, Lausanne, Switzerland.

   230. I was a member of the Scientific Committee for the General Program.

   231. May 26, 2010.  I co-chaired a symposium.

   232. May 27, 2010.  Lecture entitled, The Contribution of Obesity to Hypertension and CKD: A call to Action

   233. May 28, 2010. I co-chaired a free communication session.

 

May 29, 2010. Lausanne, Switzerland.

   234. I served on the Advisory Board for an all day meeting by Abbott Nutrition

   235. I gave a 45 minute presentation (including discussion) at this meeting.

 

236. June 8, 2010. KidneyWise Meeting, Washington D.C. I attended, as a member of their Advisory Board,  a summit meeting for KidneyWise, a not-for-profit foundation wholly owned by the Polycystic Kidney Disease Foundation that is dedicated to preventing the development and progresiion of chronic kidney disease.

 

237. June 10, 2010.  CKD QIOSC Community of Practice Teleconference Call.  QIOSC is the Quality Improvement Organizers Support Center, which is an organization contracted with by the Center for Medicare and Medical Services.  I gave a 40 minute presentation followed by 20 minutes of questions and answers concerning how to create and grow a community based not-for-profit volunteer organization devoted to health care matters.

 

238. December 9, 2009. 12:00 pm - 1:00 pm; Endocrine Conference at Harbor-UCLA Medical Center; Lecture entitled, “Relationship between Obesity and Chronic Kidney Disease”.

 

 239. January 29, 2010. The West Los Angeles VA Medical Center; Endocrinology Grand Rounds. Lecture entitled, “The Relationship between Obesity and Chronic Kidney Disease”.

 

240. April 12, 2010. Harbor-UCLA Medical Center; Renal Grand Rounds.  Lecture entitled, Obesity and Chronic Kidney Disease”.

 

241. June 15, 2010. Cedars-Sinai Medical Center; Renal Grand Rounds. Lecture entitled, "Obesity and CKD".

 

DATA SUMMARY FOR PROFESSORIAL ADVANCEMENT  NAME:  JOEL D. KOPPLE, M.D.

_______________________________________________________________________________________                                                                                                                                                

 

1.         July 8, 2002, Harbor-UCLA Medical Center, Torrance, CA, Division of Nephrology and Hypertension, Lecture entitled, “Uremia”

 

2.         July 8, 2002, Harbor-UCLA Medical Center, Torrance, CA, Renal Grand Rounds, Lecture entitled, “Nutritional Management of Chronic Renal Disease”

 

3.         July 10, 2002, Harbor-UCLA Medical Center, Torrance, CA, Division of Nephrology and Hypertension, Lecture entitled, “Nutritional Disorders in Renal Failure and Their Management”

 

4.         July 20, 2002, Harbor-UCLA Medical Center, Torrance, CA, Parlow Library Auditorium, Case Discussion

 

5.         August 20, 2002, Harbor-UCLA Medical Center, Torrance, CA, Medical Grand Rounds, Lecture entitled, “The New Clinical Trials Concerning Treatment of Hypertension and Progressive Renal Disease:  What Are They Telling Us?”

 

6.         September 18, 2002, Harbor-UCLA Medical Center, Torrance, CA, Endocrine Clinical Conference, Lecture entitled, “Metabolic Complications of Total Parenteral Nutrition”

 

7.         September 20, 2002, Wadsworth VA Hospital, Los Angeles, CA, Basic Science in Nephrology Course, Lecture entitled, “Mechanisms of Progressive Renal Failure, Part 1”

 

8.         September 23, 2002, Peritoneal Dialysis University West (sponsored by Baxter Healthcare Inc. and the Research and Education Institute at Harbor-UCLA Medical Center) Los Angeles, CA, Marina Del Rey, Lecture entitled, “Nutritional Assessment and Treatment of Chronic Peritoneal Dialysis Patients”

 

9.         October 12, 2002, Wadsworth VA Hospital, Los Angeles, CA, Pathophysiology of Renal   Disease Course, Lecture entitled, “Mechanisms of Progressive Renal Failure II”, and         “Nutritional Management of Chronic Progressive Renal Disease”

 

10.       October 22, 2002, Harbor-UCLA Family Medicine Clinic, Torrance, CA, Lecture entitled, “The Use of Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor II Blockers for the Treatment of Hypertension”

 

11.       July 7, 2003, Harbor-UCLA Medical Center, Torrance, CA, Renal Grand Rounds, Lecture entitled, “Nutritional and Metabolic Management of Acute Renal Failure”

 

12.       August 18, 2003, Harbor-UCLA Medical Center, Torrance, CA, Medical Grand Rounds, Lecture entitled, “The Recent Clinical Trials in Hypertension:  Implications for Therapy”

 

13.       September 23, 2003, Harbor-UCLA Medical Center, Torrance, CA, Medical Grand Rounds, Lecture entitled, “Does Chronic Kidney Disease Accelerate Atherosclerosis and What Can Be Done About It”

 

14.       November 18, 2003, Harbor-UCLA Medical Center, Torrance, CA, I initiated, organized and chaired a full day international workshop entitled, “Workshop on Skeletal Muscle Metabolism and Exercise Physiology in Chronic Renal Failure”

 

15.       December 29, 2003, Harbor-UCLA Medical Center, Torrance, CA, Renal Grand Rounds, Lecture entitled, “Geriatric Issues in Nephrology”

 

16.       June 14, 2004, Harbor-UCLA Medical Center, Torrance, CA, Renal Grand Rounds, Lecture entitled, “Current Concepts Concerning the Management of Hypertension”

 

17.       July 12, 2004, Harbor-UCLA Medical Center, Torrance, CA, Nephrology Grand Rounds, Lecture entitled, “Nutritional Management of Dialysis Patients”

 

18.       August 9, 2004, Harbor-UCLA Medical Center, Torrance, CA, Renal Grand Rounds, Lecture entitled, “Uremia, Carbonyl Stress and Oxidative Stress”

 

19.       October 1, 2004, Wadsworth VA Medical Center, Los Angeles, CA, Basic science Lecture to renal fellows entitled, “Treatment of Progressive Renal Disease”, Part 1

 

20.       October 8, 2004, Wadsworth VA Medical Center, Los Angeles, CA, Basic science Lecture to renal fellows entitled “Treatment of Progressive Renal Disease”, Part 2

 

21.       October 11, 2004, UCLA School of Public Health, Los Angeles, CA, Lecture entitled, “Nutritional Aspects of Hypertension” for the Course 449, Nutrition and Chronic Disease

 

22.       October 11, 2004, UCLA School of Public Health, Los Angeles, CA, Lecture entitled, “Starvation” for the Course 449, Nutrition and Chronic Disease

 

23.       January 11, 2005, Harbor-UCLA Medical Center, Torrance, CA, Medical Grand Rounds, Lecture entitled, “Preventing Progression of Chronic Kidney Disease”

 

24.       January 13, 2005, Harbor-UCLA Medical Center, Torrance, CA, Lecture entitled, “Polycystic Kidney Disease and Blood Pressure”

 

25.     May 9, 2005, in the nutrition lecture series at Harbor-UCLA Medical Center for fellows in  gastroenterology, nephrology, pulmonary and critical care medicine, and for dieticians, I   gave a lecture entitled “Pharmacology of Total Parenteral and Enteral Nutrition”

 

26.      Discuss paper in the Journal Club of the Division of Nephrology and Hypertension,

            Harbor-UCLA, approximately once every eight weeks.

 

27.       The Division of Nephrology Weekly Case Discussion Seminar; discuss a patient management problem approximately once every 8 weeks

 

28.       Harbor-UCLA core lecture every four weeks on “The Pathogenesis of Uremia” to residents and medical students rotating on the Nephrology clinical service (13 times per year)

 

29.       Organize the Meira and Shaul G. Massry Visiting Professorship that supports once per year an eminent nephrologist to spend one week at UCLA and the other major academic institutions in Los Angeles and Orange Counties

 

 


 

J O E L   D.  K O P P L E,  M. D.

B I B L I O G R A P H Y

 

 

 

 

A.  RESEARCH PAPERS - PEER-REVIEWED

 

1.            Reeve CE, Martin DC, Gonick HC, Kaufman JJ, Rubini ME, Mimms MM, Goodwin WE, Koppel MH, Kopple JD, Goldman R:  Kidney transplantation.  A comparison of results using cadaver and related living donors.  Am J Med 47:410-420, 1969.

 

2.            Rabinowitz MB, Wetherill GW, Kopple JD:  Lead metabolism in the normal human:  Stable isotope studies.  Science 182:725-727, 1973.

 

3.            Edwards AE, Kopple JD, Kornfeld CM:  Vibrotactile threshold in patients undergoing maintenance hemodialysis.  Arch Intern Med 132:706-708, 1973.

 

4.            Dirige OV, Jacob M, Wang M, Swendseid ME, Kopple JD:  Transketolase activity in tissues of uremic rats.  J Nutr 103:1723-1726, 1973.

 

5.            Kopple JD, Coburn JW:  Metabolic studies of low protein diets in uremia.  I.  Nitrogen

and potassium.  Medicine 52:583-595, 1973.

 

6.            Kopple JD, Coburn JW:  Metabolic studies of low protein diets in uremia.  II.  Calcium, phosphorus and magnesium.  Medicine 52:597-607, 1973.

 

7.            Kopple JD, Swendseid ME, Shinaberger JH, Umezawa CY:  The free and bound amino acids removed by hemodialysis.  Trans Am Soc Artif Intern Organs 19:309-313, 1973.

 

8.            Rabinowitz M, Wetherill GW, Kopple JD:  Studies of human lead metabolism by use of stable isotope tracers.  Environ Health Perspect 7:145-153, 1974.

 

9.            Chan W, Wang M, Kopple JD, Swendseid ME:  Citrulline levels and urea cycle enzymes in uremic rats.  J Nutr 104:678-683, 1974.

 

10.            Kopple JD Swendseid ME:  Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet.  Am J Clin Nutr 27:806-812, 1974.

 

11.            Kopple JD, Coburn JW:  Evaluation of chronic uremia.  Importance of serum urea nitrogen, serum creatinine, and their ratio.  JAMA 227:41-44, 1974.

 

12.            Kopple JD, Swendseid ME:  Evidence that histidine is an essential amino acid in normal and chronically uremic man.  J Clin Invest 55:881-891, 1975.

 

13.            Wang M, Vyhmeister I, Swendseid ME, Kopple JD:  Phenylalanine hydroxylase and tyrosine aminotransferase activities in chronically uremic rats.  J Nutr 105:122-127, 1975.

 

14.            Swendseid ME, Wang M, Vyhmeister I, Chan W, Siassi F, Tam CF, Kopple JD:  Amino acid metabolism in the chronically uremic rat.  Clin Nephrol 3:240-246, 1975.

 

15.            Wang M, Tam CF, Swendseid ME, Kopple JD:  Monoamine and diamine oxidase activities in uremic rats.  Life Sci 17:653-658, 1975.

 

16.            Rabinowitz MB, Wetherill GW, Kopple JD:  Kinetic analysis of lead metabolism in healthy humans.  J Clin Invest 58:260-270, 1976.

 

17.            Wang M, Vyhmeister I, Kopple JD, Swendseid ME:  Effect of protein intake on weight gain and plasma amino acid levels in uremic rats.  Am J Physiol 230:1455-1459, 1976.

 

18.            Rabinowitz M, Wetherill G, Kopple J:  Delayed appearance of tracer lead in facial hair.  Arch Environ Health 31:220-223, 1976.

 

19.            Rabinowitz MB, Wetherill GW, Kopple JD:  Magnitude of lead intake from respiration by normal man.  J Lab Clin Med 90:238-248, 1977.

 

20.            Wang M, Kopple JD, Swendseid ME:  Effects of arginine-devoid diets in chronically uremic rats.  J Nutr 107:495-501, 1977.

 

21.            Siassi F, Wang M, Kopple JD, Swendseid ME: Plasma tryptophan levels and brain serotonin metabolism in chronically uremic rats.  J Nutr 107:840-845, 1977.

 

22.            Edwards AE, Kopple JD, Miller JM, Fields LG, Der DF:  Time perception and hemodialysis.  Nephron 19:140-145, 1977.

 

 

23.            Siassi F, Wang M, Kopple JD, Swendseid ME:  Brain serotonin turnover in chronically uremic rats.  Am J Physiol 232:E526-E528, 1977.

 

24.            Hershman JM, Krugman LG, Kopple JD, Reed AW, Azukizawa M, Shinaberger JH:  Thyroid function in patients undergoing maintenance hemodialysis:  Unexplained low serum thyroxine concentration.  Metabolism 27:755-759, 1978.

 

25.            Jones MR, Kopple JD, Swendseid ME:  Phenylalanine metabolism in uremic and normal man.  Kidney Int 14:169-179, 1978.

 

26.            Wang M, Chan W, Schutz I, Kopple JD, Swendseid ME:  Plasma arginine and ornithine levels and selected enzyme activities in uremic rats fed various amounts of arginine.  Life Sci 22:2129-2135, 1978.

 

27.            Pennisi AJ, Wang M, Kopple JD:  Effect of protein and amino acid diets in chronically uremic and control rats.  Kidney Int 13:472-479, 1978.

 

28.            Fukuda S, Kopple JD:  Evidence that the dog kidney is an endogenous source of histidine.  Am J Physiol 237:E1-E5, 1979.

 

29.            Tam CF, Kopple JD, Wang M,  Swendseid ME:  Diamine oxidase activity in plasma and urine in uremia.  Nephron 23:23-27, 1979.

 

30.            Fukuda S, Kopple JD:  Chronic uremia syndrome in dogs induced with uranyl nitrate.  Nephron 25:139-143, 1980.

 

31.            Swendseid ME, Panaqua M, Kopple JD:  Polyamine concentrations in red cells and urine of patients with chronic renal failure.  Life Sci 26:533-539, 1980.

 

32.            Wang M, Kopple JD, Swendseid E:  Metabolism of 1-14C-ornithine and 1,4-14C-putrescine in chronically uremic and control rats.  Metabolism 29:773-776, 1980.

 

33.            Fukuda S, Kopple JD:  Uptake and release of amino acids by the normal dog kidney.  Miner Electrolyte Metab 3:237-247, 1980.

 

34.            Fukuda S, Kopple JD:  Uptake and release of amino acids by the kidney of dogs made chronically uremic with uranyl nitrate.  Miner Electrolyte Metab 3:248-260, 1980.

 

35.            Rabinowitz MB, Kopple JD, Wetherill GW:  Effect of food intake and fasting on gastrointestinal lead absorption in humans.  Am J Clin Nutr 33:1784-1788, 1980.

 

36.            Pardridge WM, Duducgian-Vartavarian L, Casanello-Ertl D, Jones MR, Kopple JD:  Glucose and amino acid metabolism in neonatal rat skeletal muscle in tissue culture.  J Cell Physiol 102:91-98, 1980.

 

37.            Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW:  Protein losses during peritoneal dialysis.  Kidney Int 19:593-602, 1981.

 

38.            Pardridge WM, Duducgian-Vartavarian L, Casanello-Ertl D, Jones MR, Kopple JD:  Effects of clofibric acid on amino acid metabolism in cultured rat skeletal muscle.  Am J Physiol 240:E203-E208, 1981.

 

39.            Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, Coburn JW:  Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis.  Kidney Int 20:78-82, 1981.

 

40.            Wang M, Schutz I, Kopple J, Swendseid M:  Activities of ornithine aminotransferase and ornithine decarboxylase in chronically uremic rats.  Life Sci 28:2349-2354, 1981.

 

41.            Feinstein EI, Blumenkrantz MJ, Healy M, Koffler A, Silberman H, Massry SG, Kopple JD:  Clinical and metabolic responses to parenteral nutrition in acute renal failure.  A controlled double-blind study.  Medicine 60:124-137, 1981.

 

42.            Kopple JD, Mercurio K, Blumenkrantz MJ, Jones MR, Tallos J, Roberts C, Card B, Saltz man R, Casciato DA, Swendseid ME:  Daily requirement for pyridoxine supplements in chronic renal failure.  Kidney Int 19:694-704, 1981.

 

43.            Cianciaruso B, Jones MR, Kopple JD:  Histidine, an essential amino acid for adult dogs.  J Nutr 111:1074-1084, 1981.

 

44.            Phillips LS, Kopple JD:  Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function.  Metabolism 30:1091-1095, 1981.

 

45.            Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW:  Glucose absorption during continuous ambulatory peritoneal dialysis.  Kidney Int 19:564-567, 1981.

 

46.            Kopple JD, Swendseid ME:  Effect of histidine intake of plasma and urine histidine levels, nitrogen balance and NT-methylhistidine excretion in normal and chronically uremic men.  J Nutr 111:931-942, 1981.

 

47.            Pardridge WM, Duducgian-Vartavarian L, Casanello-Ertl D, Jones MR, Kopple JD:  Arginine metabolism and urea synthesis in cultured rat skeletal muscle cells.  Am J Physiol 242:E87-E92, 1982.

 

48.            Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW:  Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis.  Kidney Int 21:849-861, 1982.

 

49.            Jones MR, Kopple JD, Swendseid ME:  14CO2 expiration after 14C-histidine administration in normal and uremic men ingesting two levels of histidine.  Am J Clin Nutr 35:15-23, 1982.

 

50.            Wolfson M, Jones MR, Kopple JD:  Amino acid losses during hemodialysis with infusion of amino acids and glucose.  Kidney Int 21:500-506, 1982.

 

 

51.            Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW:  Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.  Am J Clin Nutr 36:395-402, 1982.

 

52.            Flugel-Link RM, Jones MR, Kopple JD:  Red cell and plasma amino acid concentrations in renal failure.  J Parent Enter Nutr 7:450-456, 1983.

 

53.            Flugel-Link RM, Salusky IB, Jones MR, Kopple JD:  Protein and amino acid metabolism in posterior hemicorpus of acutely uremic rats.  Am J Physiol 244:E615-E623, 1983.

 

54.            Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, Kopple JD:  Nutritional status of children undergoing continuous ambulatory peritoneal dialysis.  Am J Clin Nutr 38:599-611, 1983.

 

55.            Paunier L, Salusky IB, Slatopolsky E, Kangarloo H, Kopple JD, Horst RL, Coburn JW, Fine RN:  Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.  Pediatr Res 18:742-747, 1984.

 

56.            Casciato DA, McAdam LP, Kopple JD, Bluestone R, Goldberg LS, Clements PJ, Knutson DW:  Immunologic abnormalities in hemodialysis patients:  Improvement after pyridoxine therapy.  Nephron 38:9-16, 1984.

 

57.            Wolfson M, Strong CJ, Minturn D, Gray DK, Kopple JD:  Nutritional status and lymphocyte function in maintenance hemodialysis patients.  Am J Clin Nutr 39:547-555, 1984.

 

58.            Clemens RA, Kopple JD, Swendseid ME:  Metabolic effects of histidine-deficient diets fed to growing rats by gastric tube.  J Nutr 114:2138-2146, 1984.

 

59.            Dahlstrom KA, Strandvik B, Kopple J, Ament ME:  Nutritional status in children receiving home parenteral nutrition.  J Pediatr 107:219-224, 1985.

 

60.            Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD:  Nutritional requirement for taurine in patients receiving long-term parenteral nutrition.  N Engl J Med 312:142-146, 1985.

 

61.            Cianciaruso B, Fukuda S, Jones MR, Kopple JD:  Net release or uptake of histidine and carnosine in kidney of dogs.  Am J Physiol 248:E51-E57, 1985.

 

62.            Kopple JD, Monteon FJ, Shaib JK:  Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure.  Kidney Int 29:734-742, 1986.

 

63.            Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD:  Energy expenditure in patients with chronic renal failure.  Kidney Int 30:741-747, 1986.

 

64.            Wolfson M, Laidlaw SA, Flugel-Link RM, Strong CJ, Salusky IB, Kopple JD:  Effect of vitamin B-6 deficiency on plasma amino acid levels in chronically azotemic rats.  J Nutr 116:1865-1872, 1986.

 

 

65.            Vinton NE, Laidlaw SA, Ament ME, Kopple JD:  Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition.  Am J Clin Nutr 44:398-404, 1986.

 

66.            Smolin LA, Laidlaw SA, Kopple JD:  Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis.  Am J Clin Nutr 45:737-743, 1987.

 

67.            Vinton NE, Laidlaw SA, Ament ME, Kopple JD:  Taurine concentrations in plasma, blood cells, and urine of children undergoing long-term total parenteral nutrition.  Pediatr Res 21:399-403, 1987.

 

68.            Hirschberg R, Kopple JD:  Role of growth hormone in the amino acid induced acute rise in renal function in man.  Kidney Int 32:382-387, 1987.

 

69.            Laidlaw SA, Sturman JA, Kopple JD:  Effect of dietary taurine on plasma and blood cell taurine concentrations in cats.  J Nutr 117:1945-1949, 1987.

 

70.            Wolfson M, Kopple JD:  The effect of vitamin B-6 deficiency on food intake, growth and renal function in chronically azotemic rats.  J Parent Ent Nutr 11:398-402, 1987.

 

71.            Laidlaw SA, Shultz TD, Cecchino JT, Kopple JD:  Plasma and urine taurine levels in vegans.  Am J Clin Nutr 47:660-663, 1988.

 

72.            Hirschberg RR, Zipser RD, Slomowitz LA, Kopple JD:  Glucagon and prostaglandins are mediators of amino acid induced rise in renal hemodynamics.  Kidney Int 33:1147-1155, 1988.

 

73.            Hirschberg RR, Kopple JD:  Increase in renal plasma flow and Glomerular Filtration Rate during growth hormone treatment may be mediated by insulin-like growth factor I.  Am J Nephrol  8:249-254, 1988.

 

74.            Hirschberg R, Cohen AH, Kopple JD:  Effects of keto acid supplements on renal function and histology in azotemic rats fed high-protein diets.  Am J Nephrol 8:50-56, 1988.

75.            Dahlstrom KA, Ament ME, Laidlaw SA, Kopple JD:  Plasma amino acid concentrations in children receiving long-term parenteral nutrition.  J Pediatr Gastroenterol 7:748-754, 1988.

 

76.            Adler SG, Laidlaw SA, Lubran MM, Kopple JD:  Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate levels.  Am J Kidney Dis 11:260-263, 1988.

 

77.            Slomowitz LA, Hirschberg R, and Kopple JD:  Captopril augments the renal response to an amino acid infusion in diabetic adults.  Am J Physiol 255 (RFEP 24):F755-F762, 1988.

 

78.            Hirschberg R, Rabb H, Bergamo R, and Kopple JD:  The delayed effect of growth hormone on renal function in humans.  Kidney Int 35:865-870, 1989.

 

79.            Hirschberg R, Kopple JD:  Evidence that insulin-like growth factor I increases renal plasma flow and GFR in fasted rats.  J Clin Invest 83:326-330, 1989.

80.            Laidlaw SA, Dietrich MF, Vargas HI, Lamtenzan MP, Block JB, Kopple JD: Antimutagenic effects of taurine in a bacterial assay system.  Cancer Res 49:6600-6604, 1989.

 

81.            Bergamo RR, Cominelli F, Kopple JD, Zipser RD:  Comparative acute effects of aspirin, diflunisal, ibuprofen and indomethacin on renal function in healthy man.  Am J Nephrol 9:460-463, 1989.

 

82.            Cohen AH, Nast CC, Adler SG, Kopple JD:  Clinical utility of kidney biopsies in the diagnosis and management of renal disease.  Am J Nephrol 9:309-315, 1989.

 

83.            Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA Kopple JD:  Effect of energy intake on nutritional status in maintenance hemodialysis patients.  Kidney Int 35:704-711, 1989.

 

84.            Laidlaw SA, Grosvenor MB, Kopple JD:  The taurine content of common foodstuffs.  J Parent Enter Nutr 14:183-188, 1990.

 

85.            De Vecchi AF, Kopple JD, Young GA, et al.  Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients:  A multicenter study.  Am J Nephrol 10:451-456, 1990.

 

86.            Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.  Kidney Int 38:904-911, 1990.

 

87.            Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg RH, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodilaysis patients.  II. Clinical & biochemical effects. Kidney Int 38:912-918, 1990.

 

88.            Capaldo B, Cianciaruso B, Napoli R, Andreucci V, Kopple JD, Sacca Luigi:  Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure.  J Clin Endocr Metab 70:127-133, 1990.

 

89.            Kopple JD, Vinton NE, Laidlaw SA, Ament ME:  Effect of intravenous taurine supplementation on plasma, blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition.  Am J Clin Nutr 52:846-853, 1990.

 

90.            Vinton NE, Heckenlively JR, Laidlaw SA, Martin DA, Foxman SR, Ament ME, Kopple JD: Visual Function in Patients Undergoing Long-term Total Parenteral Nutrition.  Am J Clin Nutr 52:895-902, 1990.

 

91.            Block JB, Dietrich MF, Leake R, Laidlaw SA, Vinton NE, Kopple JD:  Fecapentaene excretion:  aspects of excretion in newborn infants, children and adult normal subjects and in adults maintained on total parenteral nutrition.  Am J Clin Nutr 51:698-704, 1990.

 

92.            Slomowitz LA, Bergamo R, Grosvenor M, Kopple JD:  Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria.  Am J Nephrol 10:457-462, 1990.

 

93.            Vadgama JV, Chang K, Kopple JD, Idriss JM, Adams AJ:  Characteristics of taurine transport in rat liver lysosomes.  J Cell Physiol 147:447-454, 1991.

 

94.            Hirschberg R, Kopple JD:  Response of insulin-like growth factor I and renal hemodynamics to a high- and low-protein diet in the rat.  J Am Soc Nephrol 1:1034-1040, 1991.

 

95.            Hirschberg R, Kopple JD, Blantz RC, Tucker BJ:  Effects of recombinant human insulin-like growth factor 1 on glomerular dynamics in the rat.  J Clin Invest 87:1200-1206, 1991.

 

96.            Cianciaruso B, Bellizzi V, Napoli R, Sacca L, Kopple JD:  Hepatic uptake and release of glucose, lactate, and amino acids in acutely uremic dogs.  Metabolism  40:261-269, 1991.

 

97.            Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, DiChiro J, Gentile D, Nissenson A, Sakhrani L, Brownjohn AM, Nolph KD, Prowant BF, Algrim CE, Martis L, Serkes KD: Nutritional assessment of continuous ambulatory peritoneal dialysis patients:  An international study.  Am J Kidney Dis 17:462-471, 1991.

 

98.            Jung BC, Laidlaw SA, Kopple JD:  Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis.  Am J Kidney Dis 18:74-79, 1991.

 

99.            Wolfson M, Cohen AH, Kopple JD:  Vitamin B-6 deficiency and renal function and structure in chronically uremic rats.  Am J Clin Nutr 53:935-942, 1991.

 

100.            Hirschberg R, Kopple JD:  The growth hormone-insulin-like growth factor I axis and renal glomerular function.  J Am Soc Nephrol 2:1417-1422, 1992.

 

101.            Brunori G, Kopple JD:  Experience with dietary management of progression of renal failure in humans.  In Current Nephrology, Volume 16, HC Gonick (Ed.), 1993, pp 257-278.

 

102.            Hirschberg R, Kopple JD:  The effects of growth hormone and insulin-like growth factor-I on renal glomerular and tubular function.  In: Growth Hormone and Insulin-Like Growth Factor-I in Human and Experimental Diabetes:  Basic and clinical aspects. lyvbjerg A, Orskov H, Alberti G (Eds), John Wiley and Sons, New York, 1993, pp. 229-254.

 

103.            Ding Hu, Kopple J, Cohen A, Hirschberg R:  Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287, 1993.

 

104.            Kawaguchi Y, Several other authors, Kopple JD:  Nutritional assessment of patients on continuous ambulatory peritoneal dialysis.  Jpn J Nephrol 37:843-51, 1993.

 

105.            Bergamo RR, Laidlaw SA, Kopple JD:  Fingernail creatinine as a predictor of prior renal function.  Am J Kidney Dis 22:814-821, 1993.

 

 

106.            Hirschberg R, Brunori G, Kopple JD, Guler HP:  Effects of insulin growth factor I on renal function in normal men.  Kidney Int 43:387-397, 1993.

 

107.            Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Mackenzie W:  Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the modification of diet in renal disease study.  Am J Kidney Dis 23:504-513, 1994.

 

108.            Kuhlmann MK, Shahmir E, Massarani E, Akhtar S, Thevanayagam V, Vadgama JV, Kopple JD:  A new experimental model of acute renal failure and sepsis in rats.  J Parent Ent Nutr 18: 477-485, 1994.

 

109.            Fouque D, Peng SC, Kopple JD:  Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients.  Kidney Int 47:869-875, 1995.

 

110.            Kopple JD, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, Stegink LD, Martis L, Algrim-Boyle C, Serkes KD, Vonesh E, Jones MR: Treatment of malnourished CAPD patients with an amino acid based dialysate.  Kidney Int 47:1148-1157, 1995.

 

111.            Fouque D, Peng SC, Kopple JD:  Impaired metabolic response to recombinant insulin-like growth factor 1 in dialysis patients.  Kidney Int 47:876-883, 1995.

 

112.            Fouque D, Tayek JA, Kopple JD:  Altered mental function during intravenous infusion of recombinant human insulin-like growth factor 1. J Parent Enter Nutr 19:231-233, 1995.

 

113.            Cianciaruso B, Brunori G, Kopple JD, Traverso G, Panarello G, Enia G, Strippoli P, De Vecchi A, Querques M, Viglino G, Vonesh E, Maiorca R.  Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis patients.  Am J Kidney Dis 26:475-486, 1995.

 

114.            Kopple JD, Ding H, Hirschberg R:  Effects of recombinant human insulin-like growth factor 1 on renal handling of phosphorus, calcium, and sodium in normal humans.  Am J Kidney Dis 26:818-824, 1995.

 

115.            Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR:  Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.  J Parent Ent Nutr 19:453-460, 1995.

 

116.            Ding H, Gao X-L, Hirschberg R, Vadgama JV, Kopple JD:  Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure:  Evidence for a postreceptor defect.  J Clin Invest 97:1064-1075, 1996.

 

117.            Slomowitz LA, Bergamo R, Hirschberg R, Grosvenor M and Kopple JD:  Enalapril attenuates the renal hemodynamic effect of acetazolamide in patients with diabetes mellitus: Possible implications for tubuloglomerular feedback.  Am J Nephrol 16:315-319, 1996.

 

 

118.            Kopple JD:  McCollum Award Lecture, 1996:  Protein-energy malnutrition in maintenance dialysis patients.  Am J Clin Nutr 65:1544-1557, 1997.

 

119.            Kopple JD, Gao XL, Qing DPY:  Dietary protein, urea nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients.  Kidney Int 52:486-494, 1997.

 

120.            Modification of Diet in Renal Disease Study Group prepared by:  Kopple JD, Levey AS, Greene T, Chumlea WC, Gassman JJ, Hollinger DL, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS:  Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease (MDRD) Study.  Kidney Int 52:778-791, 1997.

 

121.            Chazot C, Shahmir E, Matias B, Laidlaw S, Kopple JD:  Dialytic nutrition:  Provision of amino acids in dialysate during hemodialysis.  Kidney Int 52:1663-1670, 1997.

 

122.            The HEMO Study Group:  Dwyer JT, Cunniff PJ, Maroni BJ, Kopple JD, Burrowes JD, Powers SN, Cockram DB, Chumlea WC, Kusek JW, Makoff R, Goldstein DJ, Paranandi L:  The hemodialysis (HEMO) pilot study:  Nutrition program and participant characteristics at baseline.  J Renal Nutr 8:11-20, 1998.

 

123.            Lim VS, Wolfson M, Yarasheski KE, Flanigan MJ, Kopple JD: Leucine turnover in patients with nephrotic syndrome:  Evidence suggesting body protein conservation.  J Am Soc Nephrol 9: 1067-1073, 1998

 

124.            Bohe J, Ding H, Qing DP, Yoon K, Hirschberg R, Wolfgang GH, Kopple JD:  IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I.  Kidney Int 54:1070-1082, 1998.

 

125.            Qing DP, Ding H, Vadgama J, Wu YY, Kopple JD:  Elevated myocardial cytosolic calcium impairs IGF-I stimulated protein synthesis in chronic renal failure.  J Am Soc Nephrol 10:84-92, 1999.

 

126.            Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O’Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Haenftling K, Capra W, Pike M, Guler HP:  Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.  Kidney Int 55:2423-2432, 1999.

 

127.            Kopple JD, Zhu X, Lew N, Lowrie EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients.  Kidney Int,56:1136-1148, 1999.

 

128.            Fouque D, Peng SC, Shamir E, Kopple JD: Recombinant human IGF-1 induces an anabolic response in malnourished CAPD patients.  Kidney Int 57:646-654, 2000.

 

129.            Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch  LK, Schulman G, Wang S, Zimmer GS:  Relationship between nutritional status and GFR: Results from the MDRD study.  Kidney Int 57:1688-1703, 2000.

 

130.            Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH:  A “malnutrition inflammation score” is correlated with morbidity and mortality in maintenance hemodialysis patients.  Am J Kidney Dis 38:1251-1263, 2001.

 

131.            Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH:  Association between SF36 measured quality of life and nutrition, hospitalization and mortality in dialysis.  J Am Soc Nephrol 12:2797-2806, 2001.

 

132.            Kalantar-Zadeh K, Kopple JD:  Relative contribution of malnutrition and inflammation to survival in dialysis patients.  Am J Kidney Dis 38:1343-1350, 2001.

 

133.            Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH; Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12:2797-2806, Dec 2001.

 

134.            Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple JD, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O’Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr., Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group:  Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.  JAMA 285:2719-2728, June 2001.

 

135.            Kalantar-Zadeh K, Kopple JD, Deepak S, Block B, Block G:  Food intake characteristics of the dialysis patients as obtained by food frequency questionnaire.  J Renal Nutr 12:17-31, 2002.

 

136.            Kopple JD, Ding H, Letoha A, Ivanyi B, Qing P-Y, Dux L, Wang H-Y, Sonkodi S:  L-carnitine ameliorates gentamicin-induced renal injury in rats.  Neph, Dialysis & Transplan 17:2122-2131, 2002.

 

137.            Kopple JD, Mehrotra R, Supasyndh O, Kalantar-Zadeh K: Observations with regard to the National Kidney Foundation K/DOQI Clinical Practice Guidelines concerning serum transthyretin in chronic renal failure.  Clin Chem Lab 40:1308-1312, 2002.

 

138.            Mehrotra R, Berman N, Alistwani A, Kopple JD:  Improvement of nutritional status after initiation of maintenance hemodialysis.  Am J Kidney Dis 40:133-142, 2002.

 

139.            Kopple JD:  History of dietary protein therapy for the treatment of chronic renal disease from the mid 1800s until the 1950s.  Am J Nephrol 22:278-283, July 2002.

 

140.            Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD:  Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20.  J Ren Nutr 13:15-25, 2003.

 

141.            Mehrotra R, Marwaha T, Berman N, Mason G, Appel M, Kopple JD.  Reducing peritonitis rates in a peritoneal dialysis program of indigent ethnic minorities. Perit Dial Int 23:83-85, Jan-Feb 2003.

 

142.            Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition inflammation complex syndrome in dialysis patients: causes and consequences Am J Kid Dis; 42:864-881; Nov 2003.

 

143.            Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD; Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.  Am J Kid Dis, 42:761-773, Oct 2003.

 

144.            Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD; Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney International, 63:793-808; March 2003 [feature article of the month].

 

145.            Andreucci VE, Kerr DN, Kopple JD: Rights of Chronic Renal Failure Patients Undergoing Chronic Dialysis Therapy.  Nephrology Dialysis & Transplantation 19:30-38, Jan 2004.

 

146.            Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD; A low, rather than a high total plasma homocysteine is an indicator of poor outcome in hemodialysis patients, J Am Soc Nephrol, 15:442-453, 2004.

 

147.            Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD: A low serum iron level is a predictor of poor outcome in hemodialysis patients, Am J Kidney Dis, 43:671-684, 2004.

 

148.            Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G; Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients, Nephrol Dialysis Transplant, 19:1507-1519, 2004.

 

149.            Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients, Am J Clin Nutr, 80:299-307, 2004.

 

150.            Kalantar-Zadeh K, Fouque D, Kopple JD. Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients, J Renal Nutr, 14:64-71, 2004.

 

151.            Mehrotra R, Supasyndh O, Berman N, Kaysen G, Hurst L, Leonardi M, Das D, Kopple JD.  Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake, J Renal Nutr, 14:134-142, 2004.

 

152.            Kuwae N, Kopple JD, Kalantar-Zadeh K: A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrology, 63:22-34, 2005.

 

153.            Kopple JD, Brunori G, Leiserowitz M, Fouque D:  Growth hormone induces anabolism in malnourished maintenance hemodialysis patients, Nephrol Dialysis Transplant, 20:952-958, 2005.

 

154.            Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD:  Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population, Hypertension, 45:811-817, 2005.

 

155.            Kalantar-Zadeh K, Braglia A, Chow J, Kwon O, Kuwae N, Colman S, Cockram DB, Kopple JD: An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study, J Renal Nutr, 15:318-331, 2005.

 

156.            Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S: Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population, Am J Kidney Dis 46:489-500, 2005.

 

157.            Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction, Nephrol Dial Transplant 20:1880-1888, 2005.

 

158.            Storer TW, Casaburi R, Sawelson S, Kopple JD: Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients, Nephrol Dial Transplant 20:1429-1437, 2005.

 

159.            Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, Stringer WW: A matched comparison of serum lipids between hemodialysis patients and non-dialysis morbid controls. Hemodialysis International, 9:314-324, 2005.

 

160.            Wang H, Casaburi R, Taylor WE, Aboellail H, Storer TW, Kopple JD:  Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients, Kidney International 68:352-361, 2005.

 

161.            Savica V, Santoro D, Mazzaglia G, Ciolino F, Monardo P, Calvani M, Bellinghieri G, Kopple JD: L-Carnitine Infusions May Suppress Serum C-Reactive Protein and Improve Nutritional Status in Maintenance Hemodialysis Patients. J Renal Nutr 15:225-230, 2005.

 

162.            Kopple JD, Wang HY, Fournier M, Storer T, Zhang SM, Song HY, Lewis M: Transcriptional levels of growth factors in skeletal muscle of maintenance hemodialysis patients: J Renal Nutr 16:212-215, 2006.

 

163.            Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD.  Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771-780, 2006.

 

164.            Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, Kopple JD, Wang H, Storer T, Fournier M, Lee SW, Du J, Mitch WE:  Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol 17:3233-3239, 2006.

 

165.            Fouque D, Holt S, Guebre-Egziabher F, Nakamura K, Vianey-Saban C, Hadj-Aissa A, Hoppel CL, Kopple JD:  Relationship between Serum Carnitine, Acylcarnitines and Renal Function in Patients with Chronic Renal Disease. J Renal Nutr 16:125-131, 2006.

 

166.            Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K:  Association between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients..  J Am Soc Nephrol 17:1181-1191, 2006.

 

167.            Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Association between serum bicarbonate and death in hemodialysis patients: Is it better to be acidotic or alkalotic?  Clin J Am Soc Nephrol 1:70-78, 2006.

 

168.            Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83:202-210, 2006.

 

169.            Wang X, Lewis J, Appel L, Cheek D, Contreras G, Faulkner M, Feldman H, Gassman J, Lea J, Kopple J, Sika M, Toto R, Green T, for the AASK Investigators:  Validation of  creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol 17:2900-2909, 2006.

 

170.            Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K:  Longitudinal associations between dietary protein intake and survival in hemodialysis patients.  AJKD 48:37-49, 2006.

 

171.            Norris K, Greene T, Kopple J, Lea J, Lewis J, Liplowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ for the AASK Study Group: Baseline predictors of renal disease progression in the African American study of hypertension and kidney disease. J Am Soc Nephrol 17:2928-2936, 2006.

 

172.            Kopple JD, Cohen AH, Wang H, Qing D, Tang Z, Fournier M, Lewis M, Casaburi R, Storer T: Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Renal Nutr 16:312-324, 2006.

 

 

173.            Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K:  Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 18:293-303, 2007.

 

174.            Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S:  Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol 18:1584-1593, 2007.

 

175.            Kalantar-Zadeh K, Kopple JD, Redigor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K:  A1C and survival in maintenance hemodialysis patients. Diabetes Care 30:1049-1055, 2007.

 

176.            Kopple JD, Wang H, Casaburi R, Fournier M, Lewis MI, Taylor W, Storer TW:  Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle.  J Am Soc Nephrol 18:2975-2986, 2007.

 

177.            Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K:  Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2:999-1007, 2007.

 

178.            Kalantar-Zadeh K, Kopple JD, Kamranpour N. Fogelman AM, Navab M:  HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int 72:1149-1156, 2007.

 

179.            Castaneda-Sceppa C, Sarnak MJ, Wang X, Greene T, Madero M, Kusek JW, Beck G, Kopple JD, Levey AS, Menon V:  Role of adipose tissue in determining muscle mass in patients with chronic kidney disease. J Ren Nutr 17:314-322, 2007.

 

180.            Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R:  Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients.  Peritoneal Dialysis Int. 27:192-195, 2007.

 

181.            Vargas RB, Jones L, Terry C, Nicholas SB, Kopple J, Forge N, Griffin A, Louis M, Barba L, Small L, Norris KC; Building Bridges to Optimum Health World Kidney Day Los Angeles 2007 Collaborative. Community-partnered approaches to enhance chronic kidney disease awareness, prevention, and early intervention. Adv Chronic Kidney Dis. 15:153-161, 2008.

 

182.            Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 73:391-398, 2008.  Erratum in: Kidney Int. 74:393, 2008. Trevinho-Becerra, A [corrected to Treviño-Becerra, A].

 

183.            Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.  Am J Kidney Dis. 52:727-736, 2008.

 

184.            Shinaberger CS, Kopple JD, Kovesdy CP, McAllister CJ, van Wyck D, Greenland S, Kalantar-Zadeh K. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 3:1769-1776, 2008.

 

185.            Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 19:2193-2203, 2008.

 

186.            Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med. 168:832-839, 2008.

 

187.            Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 88:1511-1518, 2008.

 

188.            Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr. 88:1485-1494, 2008.

 

189.            Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Lange M, Mitch WE, Wanner C, Wiedemann J, Ikizler TA. OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol. 3:1741-1751, 2008.

 

190.            Aramwit P, Kobpipat N, Satirapoj B, Kopple JD, Supasyndh O. Oxymetholone ameliorates insulin sensitivity in maintenance hemodialysis patients: a randomized controlled trial. Clin Nephrol. 71:413-422, 2009.

 

191.            Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Association of Serum Total Iron-Binding Capacity and Its Changes Over Time with Nutritional and Clinical Outcomes in Hemodialysis Patients. Am J Nephrol. 29:571-581, 2009.

 

192.            Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple JD,

 

193.            Kalantar-Zadeh K. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis. 53:298-309, 2009.

 

194.            Menon V, Kopple JD, Wang X, Beck GJ, Collins AJ, Kusek JW, Greene T, Levey AS, Sarnak MJ. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 53:208-217, 2009.

 

195.            Mehrotra R, Bross R, Wang H, Appell M, Tso L, Kopple JD. Effect of high-normal compared  with low-normal arterial pH on protein balances in automated peritoneal dialysis patients. Am J Clin Nutr. 2009 90:1532-1540, 2009.

 

196.            Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson AR, Sprague SM, Kopple JD, Kalantar-Zadeh K. Association of Relatively Low Serum Parathyroid Hormone With Malnutrition-Inflammation Complex and Survival in Maintenance Hemodialysis Patients. J Ren Nutr. 2010 Jul;20(4):243-54. doi:10.1053/j.jrn.2009.10.006. Epub 2010 Mar 3. PubMed PMID: 20199875; PubMed Central PMCID: PMC3175364.

 

196. Bross R, Chandramohan G, Kovesdy CP, Oreopoulos A, Noori N, Golden S, Benner

        D, Kopple JD, Kalantar-Zadeh K. Comparing body composition assessment tests in

        long-term hemodialysis patients. Am J Kidney Dis. 55:885-896, 2010.

 

197.      Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD.

Association of dietary phosphorus intake and phosphorus to protein ratio with

mortality in hemodialysis patients. Clin J Am Soc Nephrol. 5:683-92, 2010.

 

198.       Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD: Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519-530, 2010.

 

199.       Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD: Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kid Dis 2010 Aug;56(2):338-47. doi:10.1053/j.ajkd.2010.03.022. Epub 2010 Jun 30. PubMed PMID: 20580474; PubMed Central PMCID: PMC2910783.

 

200.       Kim Y, Evangelista LS, Linda R. Phillips LR, Pavlish C, Kopple, JD:The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ):  Testing the psychometric properties in patients receiving Care at Dialysis Centers.  Nephrology Nursing Journal, July/August issue 2010Jul-Aug;37(4):377-93. PubMed PMID: 20830945; PubMed Central PMCID: PMC3077091.

 

201.       Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland

         WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA,

Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS,    Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG,

          Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group. Intensive             blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010 Sep           2;363(10):918-29. doi: 10.1056/NEJMoa0910975. PubMed PMID: 20818902.

 

203.       Kalantar-Zadeh K, Golan E, Shohat T, Streja E, Norris KC, Kopple JD. Survival

          disparities within American and Israeli dialysis populations: learning from

          similarities and distinctions across race and ethnicity. Semin Dial. 2010 Nov-Dec;  23  (6): 586-94. doi: 10.1111/j.1525-139X.2010.00795.x. Review. PubMed PMID:21175833.

 

 

204.         Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Kopple JD, Kalantar-Zadeh K: Survival-predictability of lean vs. Fat mass in men and women undergoing maintenance hemodialysis  Am J Clin Nutr 2010 Nov;92(5):1060-70. doi: 10.3945/ajcn.2010.29188. Epub 2010 Sep 15. PubMed PMID:

        20844076; PubMed Central PMCID: PMC2954443.

 

205.  Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M,

Lewis JA, Randall OS, Hebert L, Wright JT Jr, Kendrick CA, Gassman J, Bakris G,

        Kopple JD, Appel LJ; African-American Study of Kidney Disease, and Hypertension

        Study Group. Malnutrition-inflammation modifies the relationship of cholesterol

        with cardiovascular disease. J Am Soc Nephrol. 2010 Dec;21(12):2131-42. doi:

10.1681/ASN.2009121285. Epub 2010 Sep 23. PubMed PMID: 20864686; PubMed   Central PMCID: PMC3014026.

 

206.      Noori N, Kovesdy CP, Bross R, Lee M, Oreopoulos A, Benner D, Mehrotra R,

          Kopple JD, Kalantar-Zadeh K. Novel equations to estimate lean body mass in

          maintenance hemodialysis patients. Am J Kidney Dis. 2011 Jan;57(1):130-9. doi:

          10.1053/j.ajkd.2010.10.003. PubMed PMID: 21184920; PubMed Central PMCID:

          PMC3026443.

 

207.      Noori N, Kopple JD, Kovesdy CP, Feroze U, Sim JJ, Murali SB, Luna A, Gomez M, Luna C, Bross R, Nissenson AR, Kalantar-Zadeh K: Mid-arm muscle circumference with quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010 Dec;5(12):2258-68. doi: 10.2215/CJN.02080310. Epub 2010 Oct 14.

       PubMed PMID: 20947789; PubMed Central PMCID: PMC2994088.

 

208.      Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, Kalantar-Zadeh K: Association of low serum calcium levels with mortality in maintenance hemodialysis patients. Am J Nephrol 2010;32(5):403-13. doi: 10.1159/000319861. Epub 2010 Sep 3. PubMed PMID:20814200; PubMed Central PMCID: PMC2941140.

 

209.      Kalantar-Zadeh K, Streja E, Kovesdy CP, Noori N, Oreopoulos A, Jing J, Nissenson AR, Krishnan M, Anker SD, Kopple JD, Mehrotra R: Obesity paradox and mortality-predictability of surrogates of body size and muscle mass in hemodialysis patients Mayo Clin Proc 2010 Nov;85(11):991-1001. doi:10.4065/mcp.2010.0336. PubMed PMID: 21037042; PubMed Central PMCID: PMC2966362.

 

 210.     Noori N, Kovesdy CP, Dukkipati R, Feroze U, Molnar MZ, Bross R, Nissenson AR,

        Kopple JD, Norris KC, Kalantar-Zadeh K. Racial and ethnic differences in

        mortality of hemodialysis patients: role of dietary and nutritional status and

        inflammation. Am J Nephrol. 2011;33(2):157-67. doi: 10.1159/000323972. Epub 2011

        Feb 4. PubMed PMID: 21293117; PubMed Central PMCID: PMC3202917.

 

211.   Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Noori N, Murali SB, Block T,

        Norris J, Kopple JD, Block G. Design and development of a dialysis food frequency

        questionnaire. J Ren Nutr. 2011 May;21(3):257-62. doi: 10.1053/j.jrn.2010.05.013.

        Epub 2010 Sep 15. PubMed PMID: 20833073; PubMed Central PMCID: PMC3047592.       

 

 212.   Streja E, Kovesdy CP, Molnar MZ, Norris KC, Greenland S, Nissenson AR, Kopple

          JD, Kalantar-Zadeh K. Role of nutritional status and inflammation in higher

       survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis.

      2011 Jun;57(6):883-93. doi: 10.1053/j.ajkd.2010.10.050. Epub 2011 Jan 15. PubMed

      PMID: 21239093; PubMed Central PMCID: PMC3081903.

 

213.   Feroze U, Noori N, Kovesdy CP, Molnar MZ, Martin DJ, Reina-Patton A, Benner

D, Bross R, Norris KC, Kopple JD, Kalantar-Zadeh K. Quality-of-life and mortality

in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc

Nephrol. 2011 May;6(5):1100-11. doi: 10.2215/CJN.07690910. Epub 2011 Apr 28.

PubMed PMID: 21527646; PubMed Central PMCID: PMC3087777.

 

214.   Noori N, Dukkipati R, Kovesdy CP, Sim JJ, Feroze U, Murali SB, Bross R,

Benner D, Kopple JD, Kalantar-Zadeh K. Dietary omega-3 fatty acid, ratio of

omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis

patients. Am J Kidney Dis. 2011 Aug;58(2):248-56. doi: 10.1053/j.ajkd.2011.03.017. Epub 2011 Jun 12. PubMed PMID: 21658827; PubMed Central PMCID: PMC3144295.

 

215.    Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD,

Kalantar-Zadeh K. Serum albumin as a predictor of mortality in peritoneal

dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011 Sep;58(3):418-28.

doi: 10.1053/j.ajkd.2011.03.018. Epub 2011 May 20. PubMed PMID: 21601335; PubMed

Central PMCID: PMC3159826.

 

216.   Ricks J, Molnar MZ, Kovesdy CP, Kopple JD, Norris KC, Mehrotra R, Nissenson

         AR, Arah OA, Greenland S, Kalantar-Zadeh K. Racial and ethnic differences in the

         association of body mass index and survival in maintenance hemodialysis patients.

         Am J Kidney Dis. 2011 Oct;58(4):574-82. doi: 10.1053/j.ajkd.2011.03.023. Epub

        2011 Jun 12. PubMed PMID: 21658829; PubMed Central PMCID: PMC3183288.

 

217.  Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Mitch WE, Wanner C, Göthberg M, and Ikizler TA OPPORTUNITYTM: A large-scale randomized clinical trial of growth hormone in hemodialysis patients.  Nephrol Dial Transplant. 2011 Dec;26(12):4095-4103. doi:10.1093/ndt/gfr363. Epub 2011 Jul 12. PubMed PMID: 21750157.

 

218.  Kim Y, Park JC, Molnar MZ, Shah A, Benner D, Kovesdy CP, Kopple JD,

        Kalantar-Zadeh K. Correlates of low hemoglobin A1c in maintenance hemodialysis

        patients. Int Urol Nephrol. 2012 Jun 9. [Epub ahead of print] PubMed PMID: 22684796.

 

219.   Molnar MZ, Streja E, Kovesdy CP, Shah A, Huang E, Bunnapradist S, Krishnan M,

        Kopple JD, Kalantar-Zadeh K. Age and the associations of living donor and

        expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis.

        2012 Jun;59(6):841-848. doi: 10.1053/j.ajkd.2011.12.014. Epub 2012 Feb 4. PubMed

        PMID: 22305759; PubMed Central PMCID: PMC3532934.

 

220.   Lewis MI, Fournier M, Wang H, Storer TW, Casaburi R, Cohen AH, Kopple JD.

       Metabolic and morphometric profile of muscle fibers in chronic hemodialysis

       patients. J Appl Physiol. 2012 Jan;112(1):72-78. doi:

       10.1152/japplphysiol.00556.2011. Epub 2011 Oct 20. PubMed PMID: 22016372; PubMed

       Central PMCID: PMC3290422.

 

221.  Feroze U, Martin D, Kalantar-Zadeh K, Kim JC, Reina-Patton A, Kopple JD.

       Anxiety and depression in maintenance dialysis patients: preliminary data of a

       cross-sectional study and brief literature review. J Ren Nutr. 2012

       Jan;22(1):207-10. doi: 10.1053/j.jrn.2011.10.009. Review. PubMed PMID: 22200444.

 

222.  Kim Y, Evangelista LS, Phillips LR, Pavlish C, Kopple JD. Racial/ethnic

      differences in illness, perceptions in minority patients undergoing maintenance

      hemodialysis. Nephrol Nurs J. 2012 Jan-Feb;39(1):39-48; quiz 49. PubMed PMID:

      22480051; PubMed Central PMCID: PMC3390251.

 

223. Supasyndh O, Satirapoj B, Aramwit P, Viroonudomphol D, Chaiprasert A,

  Thanachatwej V, Vanichakarn S, Kopple JD. Effect of Oral Anabolic Steroid on Muscle        Strength and Muscle Growth in Hemodialysis Patients. Clin J Am Soc Nephrol.  2013  Feb;8(2):271-279. doi: 10.2215/CJN.00380112. Epub 2012 Nov 2. PubMed  PMID: 23124786;  PubMed Central PMCID: PMC3562853.

 

    224.  Kim Y, Molnar MZ, Rattanasompattikul M, Hatamizadeh P, Benner D, Kopple JD,

       Kovesdy CP, Kalantar-Zadeh K. Relative contributions of inflammation and

       Inadequate protein intake to hypoalbuminemia in patients on maintenance

       hemodialysis. Int Urol Nephrol. 2013 Feb;45(1):215-227. doi:10.1007/s11255-012-0170-8.              Epub 2012 Apr 15. PubMed PMID: 22528583. 

             

 225.  Rattanasompattikul M, Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Nissenson

        AR, Norris KC, Kopple JD, Kalantar-Zadeh K. Charlson comorbidity score is a

        strong predictor of mortality in hemodialysis patients. Int Urol Nephrol. 2012

Dec;44(6):1813-1823. doi: 10.1007/s11255-011-0085-9. Epub 2011 Nov 30. PubMed    PMID: 22134841.                      

 

226. Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple

JD, Kovesdy CP, Kalantar-Zadeh K. Serum creatinine as a marker of muscle mass in

chronic kidney disease: results of a cross-sectional study and review of

literature. J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):19-29. doi:

10.1007/s13539-012-0079-1. Epub 2012 Jul 10. PubMed PMID: 22777757; PubMed

Central PMCID: PMC3581614.

 

 

 

 

 

 

 

 

 

 

           

 

B.  RESEARCH PAPERS ‑ PEER‑REVIEWED (IN PRESS)

 

  

      

C. RESEARCH PAPERS ‑ PEER‑REVIEWED (SUBMITTED)

 

 

D. RESEARCH PAPERS-NON-PEER-REVIEWED

 

  1. Rubini ME, Sokol A, Coburn JW, Miller JH, Kopple JD, Gordon S, Mark H:  Some steady state considerations of nitrogen and acid in patients undergoing chronic dialysis.  Proc 4th Conf Eur Dialysis Transplant Assoc.  Excerpta Medica 155:231-239, 1967.

 

  1. Sorensen MK, Kopple JD:  Assessment of adherence to protein-restricted diets during conservative management of uremia.  Am J Clin Nutr 21:631-637, 1968.

 

  1. Kopple JD, Sorensen MK, Coburn JW, Gordon S, Rubini ME:  Controlled comparison of 20-g and 40-g protein diets in the treatment of chronic uremia.  Am J Clin Nutr 21:553-564, 1968.

 

  1. Rubini ME, Goldman R, Agre KL, Koppel MH, Kopple JD, Gral T, Shinaberger JH, Sokol A:  Dialysis and transplantation:  Some interactions and comparisons.  Trans Am Soc Artif Intern Organs 14:355-360, 1968.

 

  1. Kopple JD, Shinaberger JH, Coburn JW, Rubini ME:  Protein nutrition in uremia: A review.  Am J Clin Nutr 21:508-515, 1968.

 

  1. Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME:  Evaluating modified protein diets for uremia.  J Am Diet Assn 54:481-485, 1969.

 

  1. Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME:  Optimal dietary protein treatment during chronic hemodialysis.  Trans Am Soc Artif Intern Organs 15:302-308, 1969.

 

  1. Edwards AE, Kopple:  Toxicity and reaction time related to the peripheral nervous system.  Proc 78th Annual Conv, Am Psychol Assn, p 809-810, 1970.

 

  1. Rubini ME, Kopple JD:  Dietary management of end-stage uremia.  Bull NY Acad Med 46:850-868, 1970.

 

  1. Kopple JD, Coburn JW, Rubini ME:  Nitrogen requirements in chronic uremia.  In: Uremia, An International conference on pathogenesis, diagnosis and Therapy.  R. Kluthe, G. Berlyne, B. Burton (Eds).  Georg Thieme Verlag, Stuttgart, 1972, pp. 271-282.

 

  1. Sorensen MK, Kopple JD:  Dietary instruction of the chronically uremic patient.  In:  Uremia, An International conference on Pathogenesis, Diagnosis and Therapy.  R Kluthe, G. Berlyne, B. Burton (Eds).  Georg Thieme Verlag, Stuttgart, 1972, pp. 292-303.

 

  1. Kopple JD, Wang M, Vyhmeister I, Baker N, Swendseid ME:  Tyrosine metabolism in uremia.  In:  Uremia, an International Conference on Pathogenesis, Diagnosis and Therapy.  R. Kluthe, G. Berlyne and B. Burton (Eds.).  Georg Thieme Verlag, Stuttgart, 1972, pp. 150-163.

 

  1. Kopple JD, Dirige OV, Jacob M, Wang M, Swendseid ME:  Transketolase activity in red blood cells in chronic uremia.  Trans Am Soc Artif Intern Organs 18:250-256, 1972.

 

  1. Blumenkrantz MJ, Shapiro DJ, Miller JH, Barshay M, Kopple JD, Shinaberger JH, Friedler RM, Coburn JW:  Chronic peritoneal dialysis for the management of chronic renal failure.  Proc Clin Dial Transplant Forum 3:117-121, 1973.

 

  1. Swendseid ME, Kopple JD:  Nitrogen balance, plasma amino acid levels, and amino acid requirements.  Trans NY Acad Sci 35:471-479, 1973.

 

  1. Miller JH, Kopple JD, Edwards AE, Der DF, Fields LG, Gardner PW:  Assessment of central nervous system function in uremia.  Proc Clin Dial Transplant Forum 4:156-159, 1974.

 

  1. Blumenkrantz MJ, Shapiro DT, Swendseid ME, Kopple JD:  The effect of histidine supplementation of the anemia of uremia.  Proc Clin Dial Transplant Forum 4:152-155, 1974.

 

  1. Swendseid ME, Kopple JD:  Amino Acid requirements and non-specific nitrogen.  Infusions therapies 2:203-207, 1975.

 

  1. Wetherill GW, Rabinowitz MB, Kopple JD:  Stable isotope studies of human lead metabolism. In: Proc 1st Annual Nat Sci Found Trace Elements Conf, Oak Ridge National Laboratory, 1975, pp. 510-518.

 

  1. Tam CF, Kopple JD, Wang M, Swendseid ME:  Alterations of monoamine oxidase activity in uremia.  Kidney Int Suppl 3:S328-S332, 1975.

 

  1. Wetherill GW, Rabinowitz M, Kopple JD:  Sources and metabolic pathways of lead in normal humans.  International Symposium on Recent Advances in the Assessment of the Health Effects of Environmental Pollution, EUR, 5360.  Commission of the European Community, Luxemburg, 2:847-860, 1975.

 

  1. Rabinowitz M, Wetherill G, Kopple J:  Absorption, storage and excretion of lead by normal humans.  In:  Trace Substances in Environmental Health, IX.  A Symposium.  DD Hemphill (Ed), University of Missouri, Columbia, 1975, pp. 361-368.

 

  1. Kopple JD:  Treatment of renal failure with defined-formula diets.  In:  Defined Formula Diets for Medical Purposes.  ME Shils (Ed).  Publ AMA, Chicago, 1977, pp. 113-123.

 

  1. Kopple JD:  Metabolic response to amino acid diets in uremia.  Proc AMA Symposium:  Clinical; Nutrition Update:  Amino Acids.  HL Greene, MA Holliday, and HN Munro (Eds).  Publ AMA, Chicago, pp. 206-213, 1977.

 

  1. Jones MR, Kopple JD:  Valine metabolism in normal and chronically uremic man.  Am J Clin Nutr 31:1660-1664, 1978.

 

 

  1. Blumenkrantz MJ, Kopple JD, Koffler A, Kamdar AK, Healy MD, Feinstein EI, Massry SG:  Total parenteral nutrition in the management of acute renal failure.  Am J Clin Nutr 31:1831-1840, 1978.

 

  1. Kopple JD, Tam CF, Wang M, Swendseid ME:  Diamine oxidase in renal failure.  Kidney Int Suppl 8:S20-S25, 1978.

 

  1. Kopple JD:  Treatment with low protein and amino acid diets in chronic renal failure.  Proc VII Int Cong Nephrol, 1978, pp. 497-507.

 

  1. Kopple JD, Figueroa WG, Swendseid ME:  Histidine, an essential amino acid in adult humans.  Proc of First International Workshop on Histidine.  Georg Thieme Publishers, Stuttgart, Germany, 1979, pp. 8-18.

 

  1. Grodstein GP, Blumenkrantz MJ, Kopple JD:  Effects of intercurrent illnesses on nitrogen metabolism in uremic patients.  Trans Am Soc Artif Intern Organs 25:438-442, 1979.

 

  1. Kopple JD, Grodstein GP, Roberts CE, Blumenkrantz MJ:  Nutritional status of the diabetic patient with chronic uremia.  Proc Diabetic Renal-Retinal Syndrome.  EA Friedman and FA L'Esperance Jr. (Eds.).  Grune and Stratton Inc., 1980, pp. 239-252.

 

  1. Kopple JD, Cianciaruso B, Massry SG:  Does parathyroid hormone cause protein wasting?  Contrib Nephrol 20:138-148, 1980.

 

  1. Grodstein GP, Blumenkrantz MJ, Kopple JD:  Nutritional and metabolic response to catabolic stress in chronic uremia.  Am J Clin Nutr 33:1411-1416, 1980.

 

  1. Kopple JD, Henry DA, Roberts CE, Goodman WG, Blumenkrantz MJ:  Relationship between nutritional status of patients undergoing maintenance hemodialysis and duration of dialysis therapy.  In:  Uremia Pathobiology of Patients Treated for Ten Years or More.  E Friedman and C Giordano (Eds).  Wichtig Editore, Milan, Italy, pp. 25-31, 1981.

 

  1. Kopple JD, Roberts CE, Grodstein GP, Shah GM, Winer RL, Davidson WP, Henry DA, Franklin SS:  Feasibility of using low protein diets for treatment of nondialyzed patients with chronic renal failure.  Proceedings of the Symposium on Prevention of Kidney Disease and Survival over 10 years on Dialysis, Long Island, NY, 1981.

 

  1. Kopple JD, Flugel R, Jones MR:  Branched chain amino acids in chronic renal failure.  In: Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids.  M Walser and J Williamson (Eds.).  Elsevier North Holland, 1981, pp. 555-567.

 

  1. Geggel HS, Heckenlively JR, Martin DA, Ament ME, Kopple JD:  Human retinal dysfunction and taurine deficiency.  Docum Ophthal Proc Series.  Vol 31. G. Niemeyer and Ch Huber (Eds).  Dr W Junk Publishers, The Hague, 1982, pp. 199-207.

 

  38.            Sukemoto F, Gunko A, Kopple JD, Nobuhiro S:  Amino acids metabolism by the kidney.  Nippon Jinzo Gakkai Shi 24:1111-1125, 1982.

 

  1. Kopple JD, Blumenkrantz MJ:  Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis.  Kidney Int Suppl 16:S295-S302, 1983.

  1. Salusky IB, Kopple JD, Fine RN:  Continuous ambulatory peritoneal dialysis in pediatric patients: a 20- month experience. Kidney Int Suppl 15:S101-S105, 1983.

 

  1. Salusky IB, Flugel-Link RM, Jones MR, Kopple JD:  Effect of acute uremia on protein degradation and amino acid release in the rat hemicorpus.  Kidney Int Suppl 16:S43-S47, 1983.

 

  1. Feinstein EI, Kopple JD, Silberman H, Massry SG:  Total parenteral nutrition with high or low nitrogen intakes in patients with acute renal failure.  Kidney Int Suppl 16:S319-S323, 1983.

 

  1. Flugel-Link, Salusky IB, Jones MR, Kopple JD:  Enhanced muscle protein degradation and amino acid release from the hemicorpus of acutely uremic rats. Adv Exp Med Biol 167:545-555, 1984.

 

  1. Feinstein EI, Collins JF, Blumenkrantz MJ, Roberts M, Kopple JD, Massry SG:  Nutritional hemodialysis.  Progr Artif Organs 1:421-426, 1984.

 

  1. Kopple JD, Grosvenor MB, Roberts CE:  Nutritional needs for the elderly hemodialysis patient.  In Geriatric Nephrology.  The medical psychosocial, nursing, financial and ethical issues of treating end-stage renal disease in the elderly.  D.G. Oreopoulos (Ed.).  Martinus Nijhoff Publishers, pp. 127-134, 1986.

 

  1. Cianciaruso B, Sacca L, Terracciano V, Marcuccio F, Orofino G, Petrone A, Andreucci VE, Kopple JD:  Insulin metabolism in acute renal failure.  Kidney Int Suppl. 22:S109-S112, 1987.

 

  1. Wolfson M, Kopple JD:  The effects of vitamin B-6 deficiency in chronically azotemic and sham operated rats.  Kidney Int Suppl. 22:S162-S166, 1987.

 

  1. Kopple JD:  The kidney and the bible.  Festschrift anläBlich der Verleihung der Rinecker-Medaille durch die Medizinische Fakultät der Julius-Maximilians-Universität Würzburg an Professor Dr. h.c. mult, Shaul C. Massry, M.D., pp. 44-46, 1988.

 

  1. Modification of Diet in Renal Disease (MDRD) Study Group.  Prepared by Joel D. Kopple, Richard Berg, Harold Hauser, Theodore I. Steinman, Paul Teschan.  Nutritional status of patients with different levels of chronic renal insufficiency.  Kidney Int Suppl 27:S184-S194, 1989.

 

  1. Hirschman GH, Striker GE, Vernier RL, Chesney RW, Holliday MA, Ingelfinger JR, Kopple JD, Rich SS, Williams GW:  Growth failure in children with renal diseases study:  An overview from the National Institutes of Health and the Advisory Committee.  J Pediatr 116:S8-S10, 1990.

 

  1. Hirschberg R, Guler H-P, Kopple JD:  The effects of insulin-like growth factor I on renal hemodynamics.  In: Modern Concepts of Insulin-Like Growth Factors, EM Spencer, Ed., Elsevier, New York, pp. 199-206, 1991.

 

 

  52.            Kopple JD, Brunori G, Leiserowitz M, Mattimore C, Hirschberg R:  Growth hormone treatment for patients with renal failure.  In:  Nephrology Proceedings of the XIth International Congress of Nephrology (ed. M. Hatano).  Springer-Verlag, Tokyo, Volume 1, pp. 379-388, 1991. Also published in the Jpn J Nephrol 33:26-32, 1991; Nippon Jinzo Gakkai Shi 33:468-474, 1991.

 

  1. Hirschberg R, Guler H-P, Kopple JD:  The effects of insulin-like growth factor I on renal hemodynamics.  In: Modern Concepts of Insulin-Like Growth Factors, EM Spencer, Ed., Elsevier, New York, pp. 199-206, 1991.

 

  1. Fine LG, Grantham JJ, Kopple JD:  Chronic renal failure.  In:  A Quarter Century of Nephrology, Edited by the ASN Historical Committee, American Society of Nephrology, 1992, pp. 167-175.

 

  1. Kopple JD:  The biblical view of the kidney.  Am J Nephrol 14:279-281, 1994.

 

  1. Kopple JD, Ding H, Gao XL:  Altered physiology and action of insulin-like growth factor 1 on skeletal muscle in chronic renal failure.  Am J of Kidney Dis 26:248-255, 1995.

 

  1. Kopple JD: Uses and limitations of growth factors in renal failure.  Periton Dial Int 17 (Suppl 3): S63-S66, 1997.

 

  1. Kopple JD, Ding H, Qing DPY:  Physiology and potential use of insulin-like growth factor I in acute and chronic renal failure.  Nephrol Dial Transplant 13 (Suppl 1):34-39, 1998.

 

  1. Kopple JD, Ding H, Qing DPY: Physiology and potential use of insulin-like growth factor 1 in acute and chronic renal failure.  Nephrol Dial Transpl 13 (Suppl 1):34-39, 1998.

 

  1. Kopple JD: The Scientific and Professional Challenges for the National Kidney              Foundation in the 21st Century. Am J Kidney Dis 35(Suppl 1): S93-S96, 2000.

 

  1. Kopple JD: Rationale for an International Federation of Kidney Foundations.  Am J Kidney Dis 36:1059-1070, 2000.

 

  1. Kopple JD, Ding H, Letoha A, Ivanyi B, Qing DP, Sonkodi S: Rationale for a possible protective effect of L-carnitine on gentamicin-induced renal injury Gironale Italiano Nefrologia 18:S17- 49-52, 2001.

 

  1. Kopple JD: The National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure: Proceedings of the 10th International Congress on Renal Nutrition and Metabolism.  Am J Kidney Dis 37(Suppl 2):S66-S70, Jan 2001.

 

 64.    Kopple JD. How to reconcile conventional and altered risk factor patterns in

           dialysis patients. Semin Dial. 20:602-5, 2007 

 

 65.    Kopple JD. Nutrition in kidney disease: introduction. Semin Nephrol. 2009

          Jan;29(1):1-2. doi: 10.1016/j.semnephrol.2008.10.001. PubMed PMID: 19121468.

   

E.  RESEARCH PAPERS ‑ NON‑PEER REVIEWED (IN PRESS)

 

F.  RESEARCH PAPERS ‑ NON‑PEER REVIEWED (SUBMITTED)

 

 

G.  BOOKS EDITED

 

  1. Kopple JD and Massry SG:  Nutritional Management of Renal Disease, Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, 1997, pp 1-929.

 

  1. Kopple JD and Massry SG:  Nutritional Management of Renal Disease, 2nd Edition, Kopple JD and Massry SG (Eds.), Lippincott Williams and Wilkins, Baltimore, 2004, pp 1-682.

    

3.    Kopple JD, Massry SG and Kalantar-Zadeh K:  Nutritional Management of Renal   Disease, 3rd Edition, Kopple JD,  Massry SG and Kalantar-Zadeh K (Eds.), Academic Press, San Diego, 2013, pp 1-800.

 

  H.  EDITOR OF THE FOLLOWING PUBLICATIONS

 

  1. Kopple JD, Massry SG, Heidland A:  Proceedings of the First International Congress on Nutrition in Renal Disease, Am J Clin Nutr 31:1529-1711, 1139-1960, 1978.

 

  1. Kopple JD, Massry SG, Bonomini V, Heidland A:  Proceedings of the Second International Congress on Nutrition in Renal Disease, Am J Clin Nutr 33:1342-1702, 1980.

 

  1. Kopple JD, Massry SG, Olmer M, Heidland A:  Proceedings of the Third International Congress on Nutrition and Metabolism in Renal Disease, Kidney Int 24 (Suppl 16):S1-S352, 1983.

 

  1. Kopple JD, Winchester J, Massry SG, Heidland A:  An Update on Nutrition and Metabolism in Kidney Disease.  (Proceedings of the Fourth International Congress on Nutrition and Metabolism in Kidney Disease).  Kidney Int 32 (Suppl 22):S1-S258, 1987.

 

  1. Guarnieri GF, Kopple JD, Furst P:  Proceedings of the First International Workshop on Nutritional Assessment in Hospital Malnutrition.  J Parent Enter Nutr (Suppl 11):33S-137S, 1987.

 

  1. Kopple JD, Jahn H, Massry SG, Heidland A:  Nutrition and Metabolism in Renal Disease.  (Proceedings of the Fifth International Congress on Nutrition and Metabolism in Renal Disease).  Kidney Int 35 (Suppl 27):S1-S308, 1989.

 

  1. Kopple JD:  Nutrition and the Kidney (Guest Editor).  Semin Nephrol 10:431-500, 1990.

 

  1. Kopple JD, Walls J, Massry SG, Heidland A:  Nutrition and Metabolism in Renal Disease.  (Proceedings of the Sixth International Congress on Renal Nutrition and Metabolism).  Miner Electrolyte Metab 18:69-336, 1992.

 

  1. Kopple JD:  Symposium on Morbidity and Mortality in Maintenance Dialysis Patients.  Am  J Kidney Dis 24:967-1032, 1994.

 

  1. Kopple JD, Massry SG, Bergstrom J, Alvestrand A, Heidland A (Editors):  Nutrition and Metabolism in Renal Disease.  Proceedings of the 7th International Conference on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 22:1-202, 1996.

 

  1. Kopple JD, De Santo NG, Capasso G, Massry SG:  Nutrition in Renal Disease.  Proceedings of the 8th International Congress on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 23:127-313, 1997.

 

  1. Kopple JD, Massry SG, Druml W, Horl WH: Proceedings of the 9th International Congress on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 25:215-406, 1999.

 

  1. Kopple JD, Hamm L, Kaysen GK: National Kidney Foundation 50th Anniversary Commemorative Issue.  Am J Kidney Dis 35(Suppl):S1-S169, 2000.

 

  1. Kopple JD, Symposium on Renal Nutrition. Advances in Renal Replacement Therapy. 10:153-221, 2003.

 

  15.            Kopple JD, Nutrition in Kidney Disease (Guest Editor).  Seminars in Nephrology. 29:1-93, 2009

 

 

 
I. SPECIAL PUBLICATIONS

 

  1. Chairman of the Work Group on the National Kidney Foundation K/DOQIJ Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.  Am J Kidney Dis 35(Suppl 2):S1-S140, 2000.

 

J. CHAPTERS

 

  1. Rabinowitz MB, Wetherill GW, Kopple JD:  Human uptake of dietary and atmospheric lead:  Stable isotope and balance study.  In:  Proc 2nd Nat Sci Found RANN Trace Contaminants Conf, 1974, pp. 308-315.

 

  1. Kopple JD:  Chapter 15, Dietary requirements.  In: Clinical Aspects of Uremia and Dialysis.  SG Massry and Al Sellers (Eds).  Charles C. Thomas, 1976, pp. 453-489.

 

  1. Kopple JD:  Chapter 9, Metabolic and endocrine abnormalities:  C.  Nitrogen metabolism.  In Clinical Aspects of Uremia and Dialysis.  SG Massry and AL Sellers (Eds).  Charles C Thomas, 1976, pp. 241-273.

 

  1. Coburn JW, Hartenbower DL, Brickman AS, Massry SG, Kopple JD:  Intestinal absorption of calcium, magnesium and phosphorus in chronic renal insufficiency.  In;  Calcium Metabolism in Renal Failure and Nephrolithiasis.  DS David (Ed).  John Wiley & Sons, Inc., 1977, pp. 77-109.

 

  1. Kopple JD, Blumenkrantz MJ:  Chapter 10, Parenteral Fluid Therapy:  Section II.  Fluid and Electrolyte Therapy.  In:  Clinical Disorders of Fluid and Electrolyte Metabolism (3rd Ed).  MH Maxwell and CR Kleeman (Eds).  New York, McGraw-Hill, 1979, pp. 459-498.

 

  1. Kopple JD:  Nutrition and the kidney. In: Nutrition:  Metabolism and Clinical Applications.  Human Nutrition, Vol 4.  New York, Plenum Publishing Corp, 1979, pp. 409-457.

 

  1. Massry SG, Kopple JD:  Chapter 15, Dietary therapy of renal failure.  In:  A Quick Reference to Applied Therapeutic Nutrition.  A Guide for Physicians.  Seymour L Halpern and RG Mazlen (Eds).  Philadelphia, J.B. Lippincott Co., 1979, pp. 223-234.

 

  1. Kopple JD, Blumenkrantz MJ:  Chapter 10, Parenteral Fluid Therapy:  Section I.  Total Parenteral Nutrition.  In:  Clinical Disorders of Fluid and Electrolyte Metabolism, 3rd Ed. MH Maxwell and CR Kleeman (Eds).  New York, McGraw-Hill, 1979, pp. 413-458.

 

  1. Kopple JD:  Nutrition in Kidney Failure.  In:  The Kidney:  Diagnosis & Management.  NS Bricker and MA Kirschenbaum (Eds).  John Wiley & Sons, New York,  pp. 333-352, 1983.

 

  1. Kopple JD:  Nitrogen metabolism.  In:  Textbook of Nephrology.  SG Massry and RJ Glassock (Eds).  Elsevier North Holland Inc., 1983, pp. 7.79-7.87.

 

  1. Kopple JD, Cianciaruso B:  Nutritional therapy of acute renal failure.  In:  Surgical Nutrition.  JE Fischer (Ed).  Little, Brown and Co., Boston, pp. 567-589, 1983.

 

  1. Kopple JD:  Nutritional management in renal failure.  In:  Textbook of Nephrology.  SG Massry and RJ Glassock (Eds).  Elsevier North Holland Inc., 1983, pp. 8.3-8.12.

 

  1. Kopple JD:  Acute renal failure:  Conservative, nondialytic management.  In:  Current therapy in Internal Medicine 1984-1985.  TM Bayless, MC Brain and RM Cherniack (Eds).  B.C. Decker Inc., Philadelphia, pp. 1157-1163, 1984.  (Also published in Current Therapy in Nephrology and Hypertension 1984 - 1985, R. J. Glassock (Editor), B.C. Decker, publishers, pp. 236-242.

 

  1. Feinstein EI, Wolfson M, Kopple JD:  Parenteral Nutrition in the treatment of acute renal failure.  In:  Current Nephrology 1984.  Gonick H (Ed).  John Wiley & Sons, Inc., New York, pp. 175-195.

 

  1. Kopple JD:  Chronic Renal Failure:  Nutritional and Nondialytic Management.  In:  Current Therapy in Internal Medicine 1984-1985.  TM Bayless, MC Brain and RM Cherniack (Eds).  B.C. Decker Inc., Philadelphia, pp. 1169-1177, 1984.  (Also published in Current Therapy in Nephrology and Hypertension 1984 - 1985, R.J. Glassock (Ed.), B.C. Decker, publishers, pp. 252-260.

 

  1. Kopple JD, Cianciaruso B:  The role for nutrition in acute renal failure.  In:  Acute renal failure Pathophysiology, Prevention and Treatment.  V. Andreucci (Ed).  Martinus Nijhoff Publishing, Boston, pp. 423-446, 1984.

 

  1. Kopple JD:  Nutritional requirements with CAPD.  In Frontiers in Peritoneal Dialysis.  J.F. Maher and J.F. Winchester, (Eds.).  Field, Rich and Associates, New York, pp. 389-399, 1986.

 

  1. Kopple JD:  Chronic Renal Failure:  Nutritional and Nondialytic Management.  In: Current Therapy in Internal Medicine - 2, 1987.  T.M. Bayless, M.C. Brain and R.M. Cherniack (Eds.).  B.C. Decker, Inc., Philadelphia, pp. 1140-1148.  Also published In:  Current Therapy in Nephrology and Hypertension - 2, Glassock RJ (Ed.), B.C. Decker, Inc., Philadelphia, pp. 235-242, 1987.

 

  1. Kopple JD:  Acute Renal Failure:  Conservative Nondialytic Management.  In:  Current Therapy in Internal Medicine - 2, 1987.  T. M. Bayless, M.C. Brain and R.M. Cherniack (Eds.). B.C. Decker, Inc., Philadelphia, pp. 1129-1135.  Also published In:  Current Therapy in Nephrology and Hypertension - 2, Glassock RJ (Ed.), B.C. Decker, Inc., Philadelphia, pp. 209-214, 1987.

 

  1. Inadomi DW, Kopple JD:  Fluid and electrolyte disorders in total parenteral nutrition. In:  Clinical Disorders of Fluid and Electrolyte Metabolism (Fourth Edition), 1987.  MH Maxwell, CR Kleeman and RG Narins (Eds.).  McGraw-Hill Book Co., New York, pp. 945-966.

 

  1. Massry SG, Kopple JD:  Diet therapy of renal failure.  In: Quick Reference to Clinical Nutrition (2nd Edition).  Seymour L. Halpern, M.D. (Ed.).  J.B. Lippincott Company, Philadelphia, 1987.

 

  1. Kopple JD:  Kidney diseases (primary author) in The Surgeon General's Report on Nutrition and Health, U.S. Department of Health and Human Services, DHHS (PHS), Publication No. 88-50210, pp. 381-402, 1988.

 

  1. Kopple JD:  Nutrition, diet and the kidney.  In:  Modern Nutrition in Health and Disease (7th Edition).  M.E. Shils and V.R. Young (Eds.).  Lea and Febiger, Philadelphia, pp. 1230-1268, 1988.

 

  1. Hirschberg R, Kopple JD:  Requirements for protein, calories, and fat in the predialysis patient.  In: Nutrition and the Kidney. W. Mitch and S. Klahr (Eds).  Little, Brown, Boston,  pp, 131-153, 1988.

 

  1. Kopple JD:  Dietary considerations in patients with advanced chronic renal failure, acute renal failure and transplantation.  In: Diseases of the Kidney (Fourth Edition).  C. Gottschalk and R. Schrier (Eds.), Little Brown and Co., Boston, pp. 3387-3436, 1988.

 

  1. Kopple JD:  Standards for nutritional assessment in dialysis.  In Current Therapy in Nephrology.  V.E. Andreucci and A. Dal Canton (Eds.), Kluwer Academic Publishers, Boston, pp. 259-271, 1989.

 

  1. Kopple JD:  Nitrogen metabolism.  In section on Uremia and Effects of Dialysis in Textbook of Nephrology. 2nd Edition.  SG Massry and RJ Glassock (Eds.).  Williams and Wilkins, Baltimore, London, pp. 1238-1247, 1989.

 

  1. Kopple JD:  Chronic renal failure.  In section on Nutritional Management in Textbook of Nephrology. 2nd Edition.  SG Massry and RJ Glassock (Eds.).  Williams and Wilkins, Baltimore, London, pp. 1344-1358, 1989.

 

  1. Hirschberg R, Kopple JD:  Enteral nutrition and renal disease.  In Clinical Nutrition Enteral and Tube Feeding.  2nd Edition.  Rombeau J (Eds.).  Caldwell M and W.B. Saunders Co., Philadelphia, pp. 400-415, 1990.

 

  1. Kopple JD:  Nutritional requirements for protein and energy in nondialyzed patients with chronic renal insufficiency.  In Principles and Practice of Nephrology, Chapter 122. (eds. HR Jacobson, S Klahr and G. Striker).  B.C. Decker, Philadelphia, pp. 721-728, 1991.

 

  1. Hirschberg RR, Kopple JD:  Nutritional therapy in patients with renal failure.  In:  Care of the Renal Patient, Second Edition, Levine DZ (Ed.), W.B. Saunders Co, Philadelphia, pp. 169-180, 1991.

 

  1. Kopple JD:  Dietary considerations in patients with advanced chronic renal failure, acute renal failure, and transplantation.  In: Diseases of the Kidney, Fifth Edition, Volume III, RW Schrier and CW Gottschalk, Eds., Little, Brown and Company, 1992, Boston, pp. 3167-3210.

 

  1. Kopple JD:  Chronic renal failure:  Nutritional and nondialytic management.  In:  Current Therapy in Nephrology and Hypertension, Third Edition, Glassock RJ, Ed., B. C. Decker, Missouri, 1992, pp. 297-306.

 

  1. Inadomi DW, Kopple JD:  Fluid and electrolyte disorders in total parenteral nutrition.  In Maxwell & Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism (R.G. Narins (ed)), Fifth Edition, McGraw Hill, pp. 1437-1462, 1993.

 

 

 

  1. Kopple JD:  Physiology and treatment with growth hormone and insulin-like growth factor-I in adults with renal failure.  In:  Current Therapy in Nephrology 1992.  Andreucci VE and Dal Canton A (Eds.).  Wichtig Editore, Milan, 1993, pp. 267-280.

 

  1. Massry SG, Kopple JD:  Requirements for calcium, phosphorus and vitamin D.  In:  Nutrition and the Kidney, 2nd Edition.  Mitch W and Klahr S (Eds.).  Little, Brown, 1993, pp. 96-113.

 

  1. Kopple JD, Hirschberg R:  In:  Nutrition and peritoneal dialysis.  In Nutrition and the Kidney, 2nd Edition, Mitch W. and Klahr S (Eds.).  Little, Brown, 1993, pp. 290-313.

 

  1. Wolfson M, Kopple JD:  Nutritional management of acute renal failure.  In:  Acute Renal Failure, third edition, Lazarus JM and Brenner BM (Eds.).  Churchill Livingstone, New York, 1993, pp. 467-485.

 

  1. Kopple JD:  Nutrition, diet and the kidney.  In:  Modern Nutrition in Health and Disease.  Eighth Edition.  Shils ME, Olson JA and Shike M (Eds.).  Lea and Febiger, 1993, pp. 1102-1134.

 

  1. Ahmed K, Kopple JD.  Nutritional management of renal disease.  In:  Primer on Kidney Diseases.  Greenberg A (Ed.). Academic Press, pp. 287-293, 1994.

 

  1. Kopple JD:  Pathogenesis of Uremic Toxicity:  Products of nitrogen metabolism and their toxicity.  In:  Massry and Glassock's Textbook of Nephrology, Volume 2, Third Edition.  Massry SG and Glassock RJ (Eds.).  Williams and Wilkins, Baltimore, pp. 1317-1324, 1995.

 

  1. Kopple JD:  Metabolic and Endocrine Disturbances in Uremia:  Amino acid and protein metabolism.  In:  Massry and Glassock's Textbook of Nephrology, Volume 2, 3rd Edition. Massry SG and Glassock RJ (Eds.).  Williams and Wilkins, Baltimore, 1995, pp. 1404-1408.

 

  1. Kopple JD:  Nutritional Management:  Acute renal failure.  In:  Massry and Glassock's Textbook of Nephrology, Volume 2, Third Edition.  Massry SG and Glassock RJ (Eds.).  Williams and Wilkins, Baltimore, pp. 1499-1512, 1995.

 

  1. Fouque D, Kopple JD:  Total parenteral nutrition and its complications.  In:  Fluid, Electrolyte, and Acid-Base Disorders, 2nd Edition, AI Arieff and RA DeFronzo (Eds.), Churchill Livingstone, New York, 1995, pp. 573-595.

 

  1. Kopple JD:  Dietary considerations in patients with advanced chronic renal failure, acute renal failure, and transplantation.  In:  Diseases of the Kidney, 6th Edition, Vol. 3, RW Schrier and CW Gottschalk (Eds.).  Little, Brown and Co., Boston, 1996, pp. 2913-2962.

 

  1. Fouque D, Kopple JD:  Malnutrition and Dialysis.  In:  Replacement of Renal Function by Dialysis, 4th Edition, Jacobs C, Kjellstrand CM, Koch KM and Winchester JF (Eds.), Kluwer Academic Publishers, Dordrecht, 1996, pp. 1271-1289.

 

  1. Hirschberg R, Kopple J:  Ernährung bei CAPD.  In:  Blutreinigungsverfahren, Franz HE and Horl WH (Eds.), Georg Thieme Verlag, Stuttgart, 1997, pp. 446-454.

 

  1. Hirschberg R, Kopple J:  Ernährung bei Hämodialyse.  In:  Blutreinigungsverfahren, Franz HE and Horl WH (Eds.), Georg Thieme Verlag, Stuttgart, 1997, pp. 116-124.

 

  1. Chazot C, Kopple JD:  Vitamin metabolism and requirements in renal disease and renal failure.  In:  Nutritional Management of Renal Disease,  Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, 1997, pp 415-478.

 

  1. Kopple JD:  Nutritional management of nondialyzed patients with chronic renal failure.  In:  Nutritional Management of Renal Disease,  Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, 1997, pp 479-532.

 

  1. Kopple JD:  Nutritional management of acute renal failure.  In:  Nutritional Management of Renal Disease,  Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, 1997, pp 713-753.

 

  1. Ahmed KR, Kopple JD:  Nutrition in maintenance hemodialysis patients.  In:  Nutritional Management of Renal Disease,  Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, 1997, pp. 563-600.

 

  1. Kopple JD:  Nutritional nondialytic management of chronic renal failure.  In:  Current Therapy in Adult Medicine.  4th Edition.  Kassirer JP and Greene HL II (Eds.),  St. Louis, Mosby, 1997, pp. 1154-1161.

 

  1. Kopple JD: Dietary considerations in patients with advanced chronic renal failure, acute renal failure, and transplantation.  In: Diseases of the Kidney.  6th Edition.  Volume 3.  Schrier RW and Gottschalk CS (Eds.).  Little, Brown and Company, Boston, pp. 2913-2962, 1997.

 

  1. Kopple JD: Dietary management of nondialyzed patients with chronic renal failure: In: Nutritional Management of Renal Disease.  Kopple JD and Massry SG (Eds.), Williams and Wilkins, Baltimore, pp. 479-531, 199
  2. Ambler C, Kopple JD:  Nutrition support for patients with renal failure. In:  The ASPEN Practice Manual, A.S.P.E.N., Silver Spring, MD, pp. 16-1 to 16-11, 1998.

 

  1. Kopple JD: Nutrition, Diet and the Kidney.  In: Modern Nutrition in Health and       Disease.  9th Edition.  M.E. Shils, J.A. Olson, M. Shike, and A.C. Ross (Eds.). Lea & Febiger, Philadelphia, pp. 1439-1472, 1999.

 

  1. Kopple JD:  Products of Nitrogen Metabolism.  In: Massry and Glassock’s Textbook of         Nephrology.  Fourth Edition. Eds. SG Massry and RJ Glassock, Lippincott, Williams and Wilkins, 2001, pp. 1262-1269.

 

  1. Kopple JD:  Acute Renal Failure.  In: Massry and Glassock’s Textbook of Nephrology.  Fourth Edition. Eds. SG Massry and RJ Glassock, Lippincott, Williams and Wilkins, 2001, pp. 1449-1454.

 

  1. Kopple JD:  Chronic Renal Failure.  In: Massry and Glassock’s Textbook of Nephrology.  Fourth Edition. Eds.SG Massry and RJ Glassock, Lippincott, Williams and Wilkins, 2001, pp. 1454-1473.

 

  1. Kopple JD: Amino Acid and Protein Metabolism in Chronic Renal Failure. In:  Massry and Glassock’s Textbook of Nephrology.  Fourth Edition. Eds. SG Massry and RJ Glassock, Williams and Wilkins, pp 1356-1361, 2001.

 

  1. Kopple JD: Dietary considerations in patients with chronic renal failure, acute renal failure, and transplantation.  In: Diseases of the Kidney.  7th Edition.  R.W. Schrier (Ed.), Williams & Wilkins, pp 3085-3138, 2001.

 

  1. Mehrotra R, Kopple JD. Causes of protein-energy malnutrition in chronic renal failure. In Kopple JD, Massry SG (eds). “Nutritional Management of Renal Disease”. Lippincott Williams & Wilkins. Baltimore, pp 167-182, 2004.

 

  1. Mehrotra R, Kopple JD. Nutrition and anemia in end-stage renal disease. In Kopple JD, Massry SG (eds). “Nutritional Management of Renal Disease”. 2nd   Edition, Lippincott Williams & Wilkins. Baltimore, pp 369-377, 2004.

 

  1. Kalantar-Zadeh K, Kopple JD;  Malnutrition as a risk factor of morbidity and mortality in patients undergoing maintenance dialysis. In Kopple JD, Massry SG (eds).  “Nutritional Management of Renal Disease”.  2nd Edition, Lippincott Williams & Wilkins.  Baltimore, pp 183-198, 2004.

 

  1. Kalantar-Zadeh K, Kopple JD; Nutritional management of patients undergoing maintenance hemodialysis.  In Kopple JD, Massry SG (eds).  “Nutritional Management of Renal Disease”.  2nd Edition, Lippincott Williams & Wilkins.  Baltimore, pp 433-466, 2004.

 

  1. Chazot C, Kopple JD; Vitamin Metabolism and Requirements in Renal Disease and Renal Failure.  In Kopple JD, Massry SG (eds).  “Nutritional Management of Renal Disease”.  2nd Edition, Lippincott Williams & Wilkins.  Baltimore, pp 315-356, 2004.

 

  1. Kopple JD; Nutritional Management of Nondialyzed Patients with Chronic Renal Failure.  In Kopple JD, Massry SG (eds).  “Nutritional Management of Renal Disease”.  2nd Edition, Lippincott Williams & Wilkins.  Baltimore, pp 379-414, 2004.

 

  1. Kopple JD; Nutritional Management of Acute Renal Failure.  In Kopple JD, Massry SG (eds).  “Nutritional Management of Renal Disease”.  2nd Edition, Lippincott Williams & Wilkins.  Baltimore, pp 549-572, 2004.

 

  1. Fouque D, Kopple JD:  Malnutrition and Dialysis.  In:  Replacement of Renal Function by Dialysis, 5th Edition, Horl WH, Koch KM, Lindsay RM, Ronco C and Winchester JF (Eds), Kluwer Academic Publishers, Dordrecht/Boston/London, pp. 1013-1039, 2004.

 

  71.            Kopple JD: Nutrition and Blood Pressure.  In Sagliker Y (ed).  “Nephrology and Hypertension in the New Millenium and Its Modern Theraphy”.  Akgun Printing House, Adana, Turkey, pp119-132, 2005.

 

  1. Kopple JD:  Dietary considerations in patients with chronic renal failure, acute renal failure, and transplantation.  In: Diseases of the Kidney. 8th Edition, R.W. Schrier (Ed.) Lippincott Williams & Wilkins, Philadelphia, November 2006.

 

  1. Kalantar-Zadeh K, Kopple JD:  Cachexia in Chronic Kidney Disease:  Malnutrition-Inflammation Complex and Reverse Epidemiology.  In:  Cachexia and Wasting a Modern Approach, G. Mantovani (Ed.), Springer, 2006.

 

  74.            Kopple JD: Nutrition, Diet and the Kidney.  In: Modern Nutrition in Health and Disease.  10th Edition.  M. Shike, A.C. Ross, B. Caballero, R.J. Cousins (Eds.). Lippincott Williams & Wilkins, Philadelphia, pp. 1475-1511, 2006.

 

  75.            Kopple JD, Kalantar-Zadeh K:  Malnutrition and intradialytic parenteral nutrition in patients with end-stage renal disease. in Principles  and Practice of Dialysis.   ed. WL Henrich, Fourth Edition. Lippincott Williams and Wilkins, Philadelphia, 2009, pp 473-488.

 

  76.            Kalantar-Zadeh K, Kopple JD: Chronic Renal Failure and the Uremic Syndrome:     Nutritional Issues. In: Lerma EV, Nissenson AR, Berns JS, eds. Current Diagnosis &   Treatment in Nephrology and Hypertension: Lange Medical Publication; 2009.

 

  77.            Kopple JD, Kalantar-Zadeh K: Malnutrition and intradialytic parenteral nutrition in end-stage renal disease patients; in Henrich WL (ed): Principles & practice of dialysis, Lippincott Williams & Wilkins, 2009.

 

  78.            Mandayam SA, Mitch WE, Kopple, JD:   Dietary Factors in the Treatment of Chronic Kidney Disease; in Schrier R Diseases of the Kidney and Urinary Tract, 2012.

 

  79.            Kopple JD:  Nutrition, Diet, and the Kidney; in Ross AC, Caballero B, Cousins, RJ, Tucker KL and Ziegler TR (eds): Modern Nutrition in Health and Disease, 11th Edition Lippincott Williams and Wilkins  pp. 1330–1371, 2013.

 

  80.            Chazot C, Kopple JD: Vitamin Metabolism and Requirements in Renal Disease and Renal Failure; in

      Kopple JD, Massry SG and Kalantar-Zadeh K (eds)  Nutritional Management of Renal Disease,   3rd Edition,  Academic Press, 2013, pp 351-382.

 

  1. Kopple JD: Nutrition and Blood Pressure; in Kopple JD, Massry SG and Kalantar-Zadeh K (eds)  Nutritional Management of Renal Disease, 3rd Edition,  Academic Press, 2013, pp 415-443.

 

  1. Kalantar-Zadeh K, Kopple, JD: Nutritional Management of Maintenance Hemodialysis Patients; in; Kopple JD, Massry SG and Kalantar-Zadeh K (eds)  Nutritional Management of Renal Disease,   3rd Edition,  Academic Press, 2013, pp 503-538.

 

 

 

 

 

K. LETTERS TO THE EDITOR, Forward for Book, LAY OR    SEMI‑PROFESSIONAL PUBLICATIONS, MISCELLANEOUS

 

  1. Kopple JD, Massry SG, Heidland A:  Introduction (for the Proceedings of the First International Congress on Nutrition in Renal Disease).  Am J Clin Nutr 31:1531, 1978.

 

  1. Kopple JD, Massry SG and Bonomini V:  Introduction (for the Proceedings of the Second International Congress on Nutrition in Renal Disease).  Am J Clin Nutr 33: 1342, 1980.

 

  1. Kopple JD, Massry SG, Olmer M and Heidland A:  Introduction to the Proceedings of the Third International Congress On Nutrition and Metabolism in Renal Disease.  Kidney Int 24 (Suppl 16): S-1, 1983.

 

  1. Adler SG and Kopple JD:  Dietary factors influencing progression of renal failure.  Nutrition & the M.D.  Vol X, pp. 1-3, April 1984.

 

  1. Kopple JD, Winchester J, Massry SG, Heidland A:  Introduction to the Proceedings of the Fourth International Congress on Nutrition and Metabolism in Renal Disease.  Kidney Int 32 (Suppl 22): S1, 1987.

 

  1. Kopple JD:  Introduction to the Symposium, Nutrition and the Kidney. Semin Nephrol 10:431-500, 1990.

 

  1. Kopple JD, Walls J, Massry SG, Heidland A:  Introduction to Nutrition and Metabolism in Renal Disease (Proceedings of the Sixth International Congress on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 18: 73-74, 1992.

 

  1. Kopple JD:  Discussion of whether dietary therapy retards progression of renal disease.  In: Current Therapy in Nephrology 1992.  Andreucci VE and Canton AD (Eds.).  Wichting Editore Milano, 1993, pp. 33-34.

 

  1. Kopple JD:  Introduction (to symposium on reducing morbidity and mortality of U.S. maintenance dialysis patients).  Am J Kidney Dis 24: 967, 1994.  

 

  1. Kopple JD, Massry SG, Bergstrom J, Alvestrand A, Heidland A: Introduction to the Proceedings of the 7th International Conference on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 22: 7-8, 1996.

 

  1. Kopple JD, De Santo NG, Capasso G, Massry SG: Introduction to Nutrition in Renal Disease.  Proceedings of the Eighth International Conference on Renal Nutrition and Metabolism.  Miner Electrolyte Metab 23: 129, 1997.

 

  1. Kopple JD: Introduction to Nutrition and Outcomes.  Am J Kidney Disease, 32:6:S96, 1998.

 

  1. Kopple JD: Discussant of the K/DOQI Clinical Practice Guidelines.  Nephrology Incite Issue, 58: 4-10, Winter, 2001.

 

  1. Kalantar-Zadeh K, Mehrotra R, Kopple JD:  Quality of Care in Profit vs Not-For-Profit Dialysis Centers. JAMA 289:3089, 2003. (Letter to Editor)

 

  1. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD:  Kidney Int 64:2323-4, 2004 (Response to Letter to Editor)

 

  1. Kalantar-Zadeh K, Kopple J: Inflammation in Renal Failure, in UpToDate (since Oct 2002), edited by Rose B, Wellesley, MA, UpToDate, Inc, 2004.

 

  1. Kalantar-Zadeh K, Kopple JD; Inflammation in Renal Failure. Invited chapter for UpToDate, (since version 10.2), first published in Oct 2002, UpToDate, Inc (with thrice-per-year updates), last updated 2005.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD: Reverse Epidemiology of Blood Pressure in Dialysis Patients. Kidney Int 67:2067, 2005; author reply 2067-2068, 2005.

 

  1. Kalantar-Zadeh K, Kopple JD:  Body Mass Index and Risk for End-Stage Renal Disease. Ann Intern Med 144:701, 2006.

 

  1. Kalantar-Zadeh K, Kopple JD:  Osteodystrophy and Dialysis Survival. Kidney Int [letter reply]71:953-954, 2007.

 

 21.       Kalantar-Zadeh K, Kopple JD: Response to 'Adynamic Bone Disease and MICS'.      Kidney Int [letter reply];71:1327, 2007.

 

 22.    Kalantar-Zadeh K, Kovesdy CP, Kopple JD: Inflammation in Renal Insufficiency  in Rose BD (ed): Uptodate (a computer-based reference source for the clinical practice of  nephrology), UpToDate in Waltham, MA, 2008

 

23.   Kopple JD. Nutrition in Kidney Disease: Introduction. Semin Nephrol. 29:1-2, 2009.

 

24.   Kopple Joel D. Forward (Apresentacao) to book Nutricao e o Rim by Riella MC and Martins C: Second Edition (Portuguese) Guanabara Koogan LTDA, Rio de Janeiro 2013

 

L.  REVIEWS

 

1.       Kopple JD, Swendseid ME:  Vitamin nutrition in patients undergoing maintenance hemodialysis. Kidney Int Suppl 2:S79-S84, 1975.

 

2.       Kopple JD, Swendseid ME:  Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis.  Kidney Int Suppl 2:S64-S72, 1975.

 

3.       Kopple JD, Swendseid ME, Holliday MA, Alfrey AC, Gulyassy PF:  Recommendations for nutritional evaluation of patients on chronic dialysis.  Kidney Int Suppl 2:S249-S252, 1975.

 

4.       Swendseid ME, Wang M, Chan W, Kopple JD:  The urea cycle in uremia.  Kidney Int Suppl 3:S280-S284, 1975.

 

5.       Kopple JD, Rabinowitz MB, and Wetherill GW:  The relative contributions of inspired and dietary lead to body lead burden.  In:  Clinical Implications of Air Pollution Research.  AJ Finkel and WC Duel (Eds.) Publishing Sciences Group, Inc., 1976, pp. 247-255.

 

6.       Kopple JD and Blumenkrantz MJ:  Nutritional therapy of the urologic patient.  Urol Clin North Am 3: 403-421, 1976.

 

7.       Kopple JD and Swendseid ME:  Amino acid and ketoacid diets for therapy in renal failure. Nephron 18: 1-12, 1977.

 

8.       Kopple JD:  Abnormal amino acid and protein metabolism in uremia.  Kidney Int 14: 340-348, 1978.

 

9.       Kopple JD:  Nutritional management of chronic renal failure.  Postgrad Med 64: 135-144, 1978.

 

10.     Swendseid ME, Wang M, Schutz I, and Kopple JD:  Metabolism of urea cycle intermediates in chronic renal failure.  Am J Clin Nutr 31: 1581-1586, 1978.

 

11.     Kopple JD, Jones M, Fukuda S, Swendseid ME:  Amino acid and protein metabolism in renal failure.  Am J Clin Nutr 31:1532-1540, 1978.

 

12.     Blumenkrantz MJ, Roberts CE, Card B, Coburn JW, Kopple JD:  Nutritional management of the adult patient undergoing peritoneal dialysis.  J Am Diet Assoc 73:251-256, 1978.

 

13.     Kopple JD, Jones MR:  Amino acid metabolism in patients with advanced uremia and in patients undergoing chronic dialysis.  In: Advances in Nephrology, MH Maxwell (Ed).  Chicago, Year Book Medical Publishers, 1979, pp. 233-268.

 

14.     Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW:  Methods for assessing nutritional status of patients with renal failure.  Am J Clin Nutr 33:1567-1585, 1980.

 

15.     Kopple JD, Fukuda S:  Effects of amino acid infusion and renal failure on the uptake and release of amino acids by the dog kidney.  Am J Clin Nutr 33:1363-1372, 1980.

 

16.     Kopple JD:  Etiology of wasting and malnutrition in renal failure:  Proc Second Prague Symposium on Chronic Renal Failure: 35-46, 1980.

 

17.     Kopple JD:  Nutrition therapy in kidney failure.  Nutr Rev 39: 193-206, 1981.

 

18.     Kopple JD: Amino acid metabolism in chronic renal failure.  Proc of Ajinomoto Conference on Amino Acids.  In: Amino Acid Metabolism and Medical Applications.  John Wright - PSG Inc., Massachusetts, pp, 451-472, 1982.

 

19.     Kopple JD, Feinstein EL:  Nutritional therapy for patients with acute renal failure.  Proc 2nd Int Symposium.  MTP Press Limited, England, pp. 113-122, 1982.

 

20.     Adler SG, Kopple JD:  Factors influencing the progression of renal insufficiency.  Semin Nephrol 3:335-343, 1983.

 

21.     Teschan PE, Abel RM, Conger JD, Kopple JD, Kramer P, Snider MT:  Acute renal failure versus nutrition:  No free lunch in the ICU.  Trans Am Soc Artif Intern Organs 29:764-769, 1983.

 

22.     Kopple JD, Feinstein EI:  Current problems in amino acid therapy for acute renal failure.  Proc Eur Dial Transplant Assoc 19:129-140, 1983.

 

23.     Kopple JD:  Nutrition in renal failure.  Causes of catabolism and wasting in acute or chronic renal failure.  In:  Nephrology Volume II.  Proceedings of the IXth International Congress of Nephrology) RR Robinson (Ed).  Springer-Verlag, New York, pp. 1498-1515, 1984.

 

24.     Kopple JD and Blumenkrantz MJ:  Nutrition in adult patients undergoing continuous ambulatory peritoneal dialysis.  Perspect Perit Dial 2: 1-9, 1984.

 

25.     Feinstein EI, Kopple JD:  Severe wasting and malnutrition in patient undergoing maintenance dialysis.  Am J Nephrol 5:398-405, 1985.

 

26.     Ament ME, Geggel HS, Heckenlively JR, Martin DA, Kopple JD:  Taurine supplementation in infants receiving long-term total parenteral nutrition.  J Am Coll Nutr 5:127-135, 1986.

 

27.     Laidlaw SA, Kopple JD:  Newer concepts of the indispensable amino acids.  Am J Clin Nutr 46: 593-605, 1987.

 

28.     Hirschberg R and Kopple JD:  Effects of growth hormone on GFR and renal plasma flow in man. Kidney Int Suppl 22:S21-S24, 1987.

 

29.     Laidlaw SA, Smolin LA, Davidson WD, Kopple JD:  Sulfur amino acids in maintenance hemodialysis patients.  Kidney Int Suppl. 22:S191-S196, 1987.

 

30.     Kopple JD:  Uses and limitations of the balance technique.  J Parent Ent Nutr 11 (Suppl 5): 79S-85S, 1987.

 

31.     Kopple JD, Massry SG:  Is there an association between neoplasia and primary or secondary hyperparathyroidism?  Am J Nephrol 8:437-448, 1988.

 

32.     Kopple JD:  Nutrition and protease activity.  Adv Exp Med Biol 240:411-419, 1988.

 

33.     Hirschberg R, Kopple JD:  Effects of growth hormone and IGF-I on renal function.  Proceedings of the Fifth International Congress on Nutrition and Metabolism in Renal Disease.  Kidney Int 36 (Suppl 27): S20-S26, 1989.

 

34.     Kuhlmann MK and Kopple JD:  Amino acid metabolism and the kidney.  Semin Nephrol 10: 445-457, 1990.

 

35.     Kopple JD:  Clinical experience with parenteral nutrition in acute renal failure.  In Nutritional Support in Organ Failure.  T. Tanaka and A. Okada (Eds.), Excerpta Medica, Elsevier Science Publishers, Amsterdan, pp. 393-404, 1990.

 

36.     Kopple JD, Hirschberg R:  Physiological effects of growth hormone and insulin-like growth factor I on the kidney.  Miner Electrolyte Metab 16:82-88, 1990.

 

37.      Hirschberg RR, Kopple JD:  Energy requirements in patients with renal failure.  Contrib      Nephrol 81:124-135, 1990.

 

38.      Kopple JD:  Special Report - The competitive marketplace for research funding. J Parent Enter Nutr 15: 363-370, 1991.

 

39.      Brunori G, Leiserowitz M, Shamir E, Kuhlmann M, Vadgama J, Kopple JD:  Nutritional and metabolic implications of acute renal failure.  In Renal Nutrition -Report of the 11th Ross Roundtable on Medical Issues, pp. 58-64, 1991.

 

40.      Kopple JD:  The rationale for the use of growth hormone or insulin-like growth factor I in adult patients with renal failure.  Miner Electrolyte Metab 18: 269-275, 1992.

 

41.      Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Serkes KD, Vonesh E, Kopple JD:  Amino acid solutions for CAPD: Rationale and clinical experience.  Miner Electrolyte Metab 18:309-315, 1992.

 

42.      Kopple JD:  Potential role of intraperitoneal amino acids in dialysis practice.  In: Optimum Nutrition for the Peritoneal Dialysis Patient.  Monograph published by Educational Services under a grant from Baxter Renal Division, 1993, pp. 25-27.

 

43.      Ahmad S, Brass EP, Hoppel C, Kopple JD, Lasagna L, Lundin AP, Schreiner GE, Sheridan MJ:  Role of L-carnitine in treating renal dialysis patients.  Dialy Transplantation 23: 177-181, 1994.

 

44.      Massry SG and Kopple JD:  Laudatio: Professor August Heidland.  Nephrol Dial Transplant 3: 1-2, 1994.

 

45.      Kopple JD:  Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 24: 1002-1009, 1994.

 

46.      Kopple JD:  Does diet slow progression of renal disease?  Nutrition and the M.D. 20: 1-3, 1994.

 

47.      Hirschberg R and Kopple JD:  IGF-I and Renal Function.  Diabetes Rev 3: 177-195, 1995.

 

48.      Kopple JD:  Current status of nutritional support for patients with acute renal failure.  In:  XXX World Congress of the International College of Surgeons, Kyoto, Japan, November 25-29, 1996, Abe O, Inokuchi K and Takasaki K (Eds.), Monduzzi Editore, Bologna, Italy, pp. 177-186.

 

49.      Kopple JD:  Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients.  ASAIO J 43: 246-250, 1997.

 

50.      Ding H, Qing DP, Kopple JD:  IGF-I resistance in chronic renal failure:  Current evidence   and possible mechanisms.  Kidney Int 52 (Suppl 62): S45-S47, 1997.

 

51.      Kopple JD: Dietary protein and energy requirements in ESRD patients. Am J Kidney     Disease, 32(Suppl 4): S97-S104, 1998.

 

52.      Kopple JD:  Pathophysiology of protein-energy wasting in chronic renal failure.  J Nutr 129(Suppl): 247S-251S, 1999.

 

53.      Kopple JD: Therapeutic approaches to malnutrition in chronic dialysis patients: The different modalities of nutritional support.  Am J Kidney Dis. 33:180-185, 1999.

 

54.      Kopple JD: Impaired Exercise Capacity and its Potential Causes in ESRD: Taormina Proceedings, 2000.

 

55.      Lim VS, Kopple JD: Perspectives in renal medicine: Protein metabolism in patients with chronic renal failure: role of uremia and dialysis.  Kidney Int 58:1-10, 2000.

 

56.      Mehrotra R, Kopple JD: Nutritional management of maintenance dialysis patients: why aren’t we doing better?  In: McCormick D (eds.).  Annual Review of Nutrition.  Annual Review Nutrition 21:343-379, 2001.

 

57.      Kopple JD: The National Kidney Foundation K/DOQI Clinical Guidelines for Dietary Protein Intake for Chronic Dialysis Patients.  Am J Kidney Dis 38(Suppl 1):S68-S73, Oct. 2001.

 

58.      Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD:  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.  Kidney Int 63:793-808, 2003.

 

59.      Mehrotra R, Kopple JD, Wolfson M.  Metabolic Acidosis in Maintenance Dialysis Patients:  Clinical Considerations, Kidney Int suppl 64(suppl 88):S13-S25, Dec. 2003.

 

60.      Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD; Inflammation and nutrition in renal insuficiency.  In Symposium on Renal Nutrition. Adv Ren Replacement Ther 10:155-169, July 2003.

 

61.      Mehrotra R, Kopple JD.  Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis.  In Symposium on Renal Nutrition. Adv Ren Replacement Ther. 10:194-212, July 2003.

 

62.      Kalantar-Zadeh K, Kopple JD; Trace elements and vitamins in maintenance dialysis patients. In Symposium on Renal Nutrition. Adv Ren Replacement Ther, 10:170-182, July 2003.

 

63.      Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD: Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure, Seminars in Dialysis, 17:455-465, 2004.

 

64.      Kopple JD, Kalantar-Zadeh K: Malnutrition and inflammation in chronic renal failure and maintenance dialysis patients.  ADI Magazine (Associazione Italiana di Dieteticale Nutrizione Clinica) 8:315-318, 2004.

 

65.      Kopple JD, Storer T, Casaburi R:  Impaired exercise capacity and exercise training in maintenance hemodialysis patients, Journal of Renal Nutrition, 15:44-48, 2005.

 

66.      Kopple JD, Kalantar-Zadeh K, Mehrotra R:  Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney International 67:S21-S27, 2005.

 

67.     Kopple JD:  The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure.  [Robert H Herman Award in Clinical Nutrition Lecture], Am J Clin Nutr 81:1257-1266, 2005.

 

68.     Kalantar-Zadeh K, Kopple JD:  Obesity paradox in patients on maintenance dialysis.  Contrib Nephrol 151:57-69, 2006.

 

69.     Kopple JD:  Phenylalanine and tyrosine metabolism in chronic kidney failure.  J Nutr 137:1586S-1590S, 2007.

 

70.     Kopple JD:  How to reconcile conventional and altered risk factor patterns in dialysis patients. Seminars in Dialysis 20:602-605, 2007.

 

71.     Chiu YW, Kopple JD, Mehrotra R. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies. Semin Nephrol. 29:67-74, 2009.

 

72.     Dukkipati R, Kopple JD. Causes and prevention of protein-energy wasting in chronic kidney failure. Semin Nephrol.29:39-49, 2009.

 

73.     Noori N, Sims JJ, Kopple JD, Shah A, Colman S, Shinaberger CS, Bross R,

                 Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Organic and inorganic dietary phosphorus                        and its management in chronic kidney disease. Iran J Kidney Dis. 4:89-100, 2010.

 

      74.       Noori N, Kopple JD. Effect of diabetes mellitus on protein-energy wasting and

                protein wasting in end-stage renal disease. Semin Dial. 23:178-84, 2010.

    

74.     Feroze U, Martin DJ, Reina-Patton A, Kalantar-Zadeh K, Kopple JD: Mental health, depression and anxiety in maintenance dialysis patients. Iran J Kid Dis 2010 Jul;4(3):173-80. Review. PubMed PMID: 20622304..

 

75.     Bross R, Noori N, Kovesdy CP, Murali SB, Benner D, Block G, Kopple JD, Kalantar-Zadeh K: Dietary assessment of individuals with chronic kidney disease. Semin Dial 2010 Jul-Aug;23(4):359-64. doi: 10.1111/j.1525-139X.2010.00743.x.

 

76.     Kopple JD. Obesity and Chronic Kidney Disease. J Renal Nutr 2010:Sep;20(5

          Suppl):S29-30. doi: 10.1053/j.jrn.2010.05.008. Review. PubMed PMID: 20797567.

 

77.       Dukkipati R, Noori N, Feroze U, Kopple JD. Dietary protein intake in patients

 with advanced chronic kidney disease and on dialysis. Semin Dial. 2010 Jul-Aug; 23(4):365-72. doi: 10.1111/j.1525-139X.2010.00753.x. Review. PubMed PMID: 20701715. 

 

78.     Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood

pressure. Annu Rev Nutr. 2010 Aug 21;30:365-401. doi:

10.1146/annurev-nutr-010510-103954. Review. PubMed PMID: 20645853.

 

     79.      Kopple JD, Feroze U. The effect of obesity on chronic kidney disease. J Ren

Nutr. 2011 Jan;21(1):66-71. doi: 10.1053/j.jrn.2010.10.009. Review. PubMed PMID:

21195923.

 

     80.      Steiber AL, Kopple JD. Vitamin status and needs for people with stages 3-5

chronic kidney disease. J Ren Nutr. 2011 Sep;21(5):355-68. doi:10.1053/j.    jrn.2010.12.004. Epub 2011 Mar 25. Review. PubMed PMID: 21439853.

 

     81.      Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in

                elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013

                Feb;24(3):337-51. doi: 10.1681/ASN.2012010047. Epub 2012 Dec 20. PubMed PMID:

                23264684.

 

 

 

 

 

M. EDITORIALS

 

  1. Kopple JD, Hakim RM, Held PJ, Keane WF, King K, Lazarus JM, Parker TF, Teehan BP. Recommendations for reducing the high morbidity and mortality of U.S. maintenance dialysis patients.  Am J Kidney Dis 24: 968-973, 1994.

 

  1. Kopple JD, Jones MR, Keshaviah PR, Bergstrom J, Lindsay RM, Moran J, Nolph KD and Teehan BP:  A proposed glossary for dialysis kinetics.  Am J Kidney Dis 26: 963-981, 1995.

 

  1. Kopple JD, Foulks CJ, Piraino B, Beto J and Goldstein J:  NKF position paper on proposed HCFA guidelines for reimbursement of enteral and parenteral nutrition.  Am J Kidney Dis 26: 995-997, 1995.

 

  1. Heidland A, Kokot F, Kopple JD:  Shaul G. Massry, Los Angeles, USA.  Nephrol Dial Transplant 11: 901, 1996.

 

  1. Walser M, Mitch WE, Maroni BJ, Kopple JD: Should protein intake be restricted in pre-dialysis patients?  Kidney Int 55:771-777, 1999.

 

      6.            Collins AJ, Couser WG, Dirks JH, Kopple JD, Reiser T, Riella MC, Robinson S, Shah SV, Wilson A: World Kidney Day: An idea whose time has come. J Am Soc Nephrol 17:600-601, 2006.  Also published in Kidney Int, 69:781-782, 2006; Am J Kidney Dis, 47:375-377, 2006; Nephrology 11:1-2, 2006; Clin Exp Nephrol 10:89-90, 2006; Natl Med J India 19:55-57, 2006.

 

      7.            Couser  WG, Shah S, Kopple J, Beerkens P, Wilson A, Feehally J, Reiser T,

         Riella M. A call to action on World Kidney Day, 8 March 2007. Kidney Int.  71:369-370, 2007.  Also published in Nephrology 12:1-2, 2007 and other journals.

 

  1. Shah SV, Feehally J, Couser WG, Davis J, Kopple J, Reiser T, Riella M, Wilson A; World Kidney Day Steering Committee. The Third World Kidney Day: looking back and thinking forward. Nephrology. 13:51-52, 2008. Also published in Transplantation. 85:495-498, 2008, and other journals.

 

9.      Kopple J. World Kidney Day 2008: a message to the kidney community of Iran. Iran J       Kidney Dis. 2:108-109, 2008.

 

 10.    Kopple JD. Do low-protein diets retard the loss of kidney function in patients with diabetic nephropathy?. Am J Clin Nutr. 88:593-594, 2008.

 

   11.    Dukkipati R, Kalantar-Zadeh K, Kopple JD. Is there a role for intradialytic

            parenteral nutrition? A review of the evidence.  Am J Kidney Dis. 55:352-64, 2010.

 

   12.  Norris KC, Kalantar-Zadeh K, Kopple JD. The role of race in survival among

          patients undergoing dialysis. Nephrol News Issues. 2011 Dec;25(13):13-4, 16.

          PubMed PMID: 22308829.

   

  13.   Kopple JD. Physical Performance and All-Cause Mortality in CKD. J Am Soc

         Nephrol. 2013 Apr 18. [Epub ahead of print] PubMed PMID: 23599383.

 

 

N.  PAPERS IN PREPARATION (RESEARCH COMPLETED)

 


 

O.  ABSTRACTS

 

  1. Kopple JD, Sorenson MK, and Rubini ME:  Controlled evaluation of rigid protein restriction in uremia (Modified Giovannetti diet).  Am J Clin Nutr 20:369, 1967.

 

  1. Kopple JD, Sorensen MK, Coburn JW, Gordon S and Rubini ME:  A controlled comparison of 20 and 40 grams protein diets in the management of chronic uremia.  Clin Res 16:138, 1968.

 

  1. Koppel MH, Agre KL, Kopple JD, Coburn JW, Mims MM, Goldstein H, Boyle JD and Rubini ME:  Recovery of function in renal homotransplant from donors with hepatorenal syndrome.  Clin Res 16:166, 1968.

 

  1. Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, and Rubini ME:  Optimal dietary protein in the treatment of chronic uremia.  Clin Res 17:436, 1969.

 

  1. Kopple JD, Shinaberger JH, Swendseid ME, Umezawa CY, and Rubini ME:  Amino acid metabolism during hemodialysis.  3rd Annual Mtg, Am Soc Nephrol, p36, 1969.

 

  1. Kopple JD, Shinaberger JH, and Swendseid ME:  Amino acid metabolism during hemodialysis.  4th Annul Mtg, Am Soc Nephrol, p 43, 1970.

 

  1. Kopple JD, Kornfeld CM, and Edwards AE:  Vibratory threshold, a sensitive index of uremic status.  Clin Res 19:151, 1971.

 

  1. Kopple JD, Shinaberger JH, Rubini ME, and Coburn JW:  Metabolic studies during protein restriction in uremic man.  Clin Res 19:152, 1971.

 

  1. Wang M, Vyhmeister I,  Jacob M, Swendseid ME, and Kopple JD:  Nitrogen metabolism in chronically uremic rats.  Fed Proc 30:216, 1971.

 

  1. Kopple JD, Wang M. Baker N, and Swendseid ME:  Tyrosine metabolism in uremia.  2nd Annual Mtg, Western Dial Transpl Soc, 1971.

 

  1. Kopple JD, Gordon S, and Wang M:  Effect of chronic uremia, protein intake and hemodialysis on guanidinosuccinic acid levels.  5th Annual Mtg, Am Soc Nephrol, p 41, 1971.

 

  1. Kopple JD, Wang M, Baker N, and Swendseid ME:  Mechanism of adaptation to restricted protein intake in chronic uremia.  5th Annual Mtg, Am Soc Nephrol, p 41, 1971.

 

  1. Kopple JD, Swendseid ME, and Paniagua M:  Plasma amino acids and nitrogen balance in chronic uremics receiving essential amino acid diets.  Clin Res 20:247, 1972.

 

  1. Dirige OV, Jacob M, Swendseid ME, and Kopple JD:  Transketolase in red blood cells and brain in chronic uremia.  Clin Res 20:199, 1972.

 

  1. Vyhmeister I, Wang M, Swendseid ME, and Kopple JD:  Phenylalanine hydroxylase and tyrosine aminotransferase in uremic rats.  Fed Proc 31:683, 1972.

 

  1. Swendseid ME, Kopple JD, and Paniagua M:  Effect of essential amino acid diets on nitrogen metabolism in chronic uremia.  5th Int Cong Nephrol, Mexico City, p 176, 1972.

 

  1. Kopple JD, Wang M, and Swendseid ME:  Metabolism of tyrosine and phenylalanine in chronic uremia.  5th Int Cong Nephrol, Mexico City, p 167, 1972.

 

  1. Kopple JD and Swendseid ME:  Histidine deficiency anemia in renal failure.  Clin Res 21:266, 1973.

 

  1. Kopple JD, Swendseid ME, Paniagua M, and Wang M:  Effects of histidine deficient diets on histidine levels and oxidation rates in uremic and normal man.  Fed Proc 32:916, 1973.

 

  1. Chan W, Wang M, Swendseid M, and Kopple JD:  Urea cycle enzymes in uremic rats.  Fed Proc 32:921, 1973.

 

  1. Rabinowitz MB, Wetherill GW, and Kopple JD:  Assessing human lead metabolism by stable isotope techniques.  Fed Proc 32:930, 1973.

 

  1. Blumenkrantz MJ, Miller JH, Barshay ME, Kopple JD, Friedler RM, and Coburn JW:  Chronic peritoneal dialysis in the management of chronic renal failure. 4th Annual Mtg, Western Dial Transpl Soc, p 3, 1973.

 

  1. Kopple JD and Swendsein ME:   Histidine, an essential amino acid in uremia.  6th Annual Mtg, Am Soc Nephrol, p 61, 1973.

 

  1. Wang M, Tam CF, Swendseid ME, and Kopple JD:  Monoamine and diamine oxidase activities and amine levels in plasma of uremic patients.  6th Annual Mtg, Am Soc Nephrol, p 110, 1973.

 

  1. Chan W, Wang M, Swendseid ME, and Kopple JD:  Elevated plasma citrulline levels and urea cycle enzymes in uremic rats.  6th Annual Mtg, Am Soc Nephrol, p 20, 1973.

 

  1. Kopple JD and Swendseid ME:  Histidine, and essential amino acid in adult humans.  Clin Res 22:193A, 1974.

 

  1. Kopple JD and Swendseid ME:  Evidence for a dietary histidine requirement in normal man.  Fed Proc 33:691, 1974.

 

  1. Tam CF, Wang M, Swendseid ME, and Kopple JD:  Plasma monoamine and diamine oxidase activities in uremic patients.  Fed Proc 33:705, 1974.

 

  1. Blumenkrantz MJ, Shapiro D, Swendseid ME, and Kopple JD:  Effect of histidine supplementation on the anemia of uremia.  Kidney Int 6:24A, 1974.

 

 

  1. Kopple JD, Miller JH, Edwards SE, Der DF, Fields LG, Gardner PW:  Evaluation of time perception in uremia.  Kidney Int 6: 61A, 1974.

 

  1. Tam CF, Wang M, Swendseid ME, and Kopple JD:  Elevated monoamine oxidase activity and decreased serotonin in platelets in uremia and transplantation.  Kidney Int 6:104A, 1974.

 

  1. Kopple JD, Tam CF, Wang M, and Swendseid ME:  Elevated MAO activity and decreased serotonin content in platelets of uremic and transplanted patients.  Clin Res 23:121A, 1975.

 

  1. Blumenkrantz MJ, Shapiro DJ, Swendseid ME, Kopple JD:  Histidine supplementation for treatment of anaemia of uraemia.  Br Med J 2:530-533, 1975.

 

  1. Siassi F, Wang M, Kopple JD, and Swendseid ME:  Tryptophane oxygenase activity in experimental uremia.  Fed Proc 34:942, 1975.

 

  1. Kopple JD, Paniagua M, and Swendseid ME:  Histidine and 3-methylhistidine in plasma and urine and nitrogen balance in subjects receiving diets varying in histidine content.  Fed Proc 34:931, 1975.

 

  1. Tam CF, Wang M, Swendseid ME, and Kopple JD:  Altered amine oxidase activities in experimental uremic rats.  Fed Proc 34:943, 1975.

 

  1. Kopple JD, Mercurio KC, Card BK, Jacob M, and Swendseid ME:  Vitamin B6 in uremia.  6th Int Cong Nephrol, Florence, No. 906, 1975.

 

  1. Pennisi AJ, Kopple JD, and Swendseid ME:  Optimal amino acid diets in chronic uremia.  Kidney Int 8:416, 1975.

 

  1. Kopple JD, Mercurio KC, Saltzman RL, Card BK, Jones MR, Tallos JA, and Swendseid ME:  Vitamin B6 requirement in uremia.  Kidney Int 8:428, 1975.

 

  1. Tam CF, Kopple JD, Wang M, and Swendseid ME:  Serotonin uptake by platelets of patients undergoing maintenance hemodialysis.  Kidney Int 8:452, 1975.

 

  1. Jones MR, Swendseid ME, and Kopple JD:  Phenylalanine and tyrosine metabolism in uremia.  Kidney Int 8:459, 1975.

 

  1. Wang M, Swendseid ME, and Kopple JD:  Enzymes mediating arginine metabolism in experimental chronic uremia.  Kidney Int 8:464, 1975.

 

  1. Kopple JD, Mercurio KC, Card BK, Jacob M, and Swendseid ME:  Vitamin B6 requirement in uremia.  6th Annual Mtg, Western Dial Transpl Soc, p 12, 1975.

 

  1. Kopple JD, Tam CF, Wang M, and Swendseid ME:  Altered platelet serotonin content and serotonin uptake in kidney disease.  Clin Res 24:128A, 1976.

 

 

  1. Jones MR, Swendseid ME, and Kopple JD:  Metabolism of phenylalanine and tyrosine in chronic uremia.  Clin Res 24:128A, 1976.

 

  1. Pennisi AJ, Swendseid ME, and Kopple JD:  Optimal amino acid diets in chronic uremia.  Clin Res 24:199A, 1976.

 

  1. Wang M, Kopple JD and Swendseid ME:  14C-arginine incorporation into tissue proteins of chronically uremic rats.  Fed Proc 35:258, 1976.

 

  1. Pennisi AJ, Wang M, and Kopple JD:  Effects of low nitrogen diets in uremic and control rats.  Fed Proc 35:257, 1976.

 

  1. Clark AJ, Wang M, Kopple JD, and Swendseid ME:  Ribosome profiles and RNA, DNA content of muscle in uremia.  Fed Proc 35:596, 1976.

 

  1. Kopple JD and Swendseid ME:  Effect of protein intake and uremia on plasma amino acid levels. Kidney Int 10:560, 1976.

 

  1. Blumenkrantz MJ, Kopple JD and VA Cooperative Dialysis Study Participants:  Incidence of nutritional abnormalities in uremic patients entering dialysis therapy. Kidney Int 10:514, 1976.

 

  1. Blumenkrantz MJ, Kamdar AV, Jones MR, Kopple JD, and Coburn JW:  Serum and dialysate proteins during maintenance peritoneal dialysis.  Clin Dial Transpl Forum, 1976.

  1. Kopple JD, Gordon SI, Wang M, and Swendseid ME:  Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.  J Lab Clin Med 90: 303-311, 1977.

 

  1. Fukuda S and Kopple JD:  Renal uptake and release of amino acids in the dog.  Clin Res 25:166A, 1977.

 

  1. Fukuda S and Kopple JD:  Use of uranyl nitrate to produce chronic experimental uremia in the dog.  Clin Res 25:137A, 1977.

 

  1. Fukuda S and Kopple JD:  Uptake and release of amino acids by the dog kidney. Fed Proc 36:604, 1977.

 

  1. Kopple JD, Figueroa WG, and Swendseid ME:  The dietary histidine requirement in normal and uremic man.  Fed Proc 36:1092, 1977.

 

  1. Jones MR and Kopple JD:  Valine metabolism in normal and chronically uremic man.  Fed Proc 36:1112, 1977.

 

  1. Schutz IM, Wang M, Kopple JD, and Swendseid ME:  Activities of enzymes degrading ornithine in chronic uremia.  Fed Proc 36:1154, 1977.

 

  1. Wang M, Kopple JD, and Swendseid ME:  Metabolism of 1-14C-ornithine in chronically uremic rats.  Fed Proc 36:1111, 1977.

 

  1. Blumenkrantz M, Roberts C, and Kopple J:  Incidence of nutritional abnormalities in uremic patients entering dialysis therapy.  Proc Southeastern Dial Transpl Assn, 1977.

 

  1. Fukuda S and Kopple JD:  Renal production and degradation of amino acids in normal and uremic dogs.  Kidney Int 12:525, 1977.

 

  1. Kamdar AV, Blumenkrantz MJ, Knutson DW, Jones MR, Kopple JD, and Colburn JW:  Losses of serum proteins during maintenance peritoneal dialysis.  Kidney Int 12:483, 1977.

 

  1. Clemens RA, Kopple JD, and Swendseid ME:  Metabolic effects of histidine-free diets in rats.  Fed Proc 37:263, 1978.

 

  1. Fukuda S and Kopple JD:  Carnosine increases release of histidine by the dog kidney.  Fed Proc 37:281, 1978.

 

  1. Jones MR and Kopple JD:  Effect of uremia, hemodialysis and valine supplements on valine pools and degradation in man.  Fed Proc 37:360, 1978.

 

  1. Wang M, Kopple JD and Swendseid ME:  Metabolism of 1,4 14C-putrescine in chronically uremic rats.  Fed Proc 37:536, 1978.

 

  1. Fukuda S and Kopple JD:  Renal production and degradation of amino acids in normal and uremic dogs.  Proc VII Int Cong Nephrol, 1978, p A-8.

 

  1. Fukuda S and Kopple JD: Contribution of the kidney to histidine homeostasis in dogs.  Proc VII Int Cong Nephrol, 1978, p A-8.

 

  1. Kamdar AV, Blumenkrantz MJ, Knutson DW, Jones MR, Kopple JD and Coburn JW:  Serum protein losses during maintenance peritoneal dialysis.  Proc VII Int Cong Nephrol, 1978, p S-8.

 

  1. Blumenkrantz MJ, Chan YK, Kopple J, Roberts C, Barbour G, Shen F, Gutman R, Gandhi V, Smith B, Curtis F, and Coburn J: Frequency of nutritional abnormalities in uremic patients entering dialysis therapy. Proc VII Int Congress Nephrol, 1978, p Y-2.

 

  1. Feinstein E, Healy M, Blumenkrantz M, Koffler A, Massry S, and Kopple J:  Total parenteral nutrition in acute renal failure.  Proc VII Int Cong Nephrol, 1978, p Y-2.

 

  1. Blumenkrantz MJ, Jones MR, Coburn JW, and Kopple JD:  Albumin metabolism in patients with chronic renal failure and those undergoing peritoneal or hemodialysis.  Kidney Int 14:670, 1978.

 

  1. Feinstein E, Healy M, Blumenkrantz M, Koffler A, Silberman H, Massry SG, and Kopple J:  Total parenteral nutrition in acute renal failure. kidney Int 14:650, 1978.

 

  1. Kopple JD and Phillips LS:  Serum somatomedin activity and sulfate in adults with normal and impaired renal function.  Kidney Int 14:654, 1978.

 

  1. Swendseid ME, Panigua M, and Kopple JD:  Spermidine, spermine, and putrescine in renal failure.  Kidney Int 14:688, 1978.

 

  1. Jones MR and Kopple JD:  Valine metabolism during saline and amino acid infusion in normal and uremic man. FASEB, 63rd Annual Mtg, Dallas, 1979.

 

  1. Cianciaruso B, Fukuda S, and Kopple JD:  Metabolic response to histidine-free diets in adult dogs.  Fed Proc 38:289, 1979.

 

  1. Grodstein GP, Blumenkrantz MJ, and Kopple JD:  Effects of intercurrent illnesses of nitrogen metabolism in uremic patients.  25th Annual Mtg, ASAIO, New York, 1979.

 

  1. Swendseid ME, Shibata S, and Kopple JD:  Polyamine concentrations in the chronically uremic rat.  2nd Int Cong Nutr Renal Disease, Bologna, Italy, 1979.

 

  1. Jones MR and Kopple JD:  Valine metabolism during saline and amino acid infusion in normal and uremic man.  2nd Int Cong Nutr Renal Disease, Bologna, Italy, 1979.

 

  1. Cianciaruso B, Fukuda S, and Kopple JD:  Contribution of the dog kidney to histidine homeostasis during histidine depletion.  2nd Int Cong Nutr renal Disease, Bologna, Italy, 1979.

 

  1. Grodstein GP, Blumenkrantz MJ, and Kopple JD:  Nutritional and metabolic response to catabolic stress in chronic uremia.  2nd Int Cong Nutr Renal Disease, Bologna, Italy, 1979.

 

  1. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, and Coburn JW:  Glucose absorption during continuous ambulatory peritoneal dialysis.  Kidney Int 16:888, 1979.

 

  1. Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, and Coburn JW:  Metabolic balance studies in uremic patients undergoing continuous ambulatory peritoneal dialysis.  Kidney Int 16:882, 1979.

 

  1. Grodstein G and Kopple JD:  Urea nitrogen appearance, a simple and practical indicator of total nitrogen output.  Kidney Int 16:953, 1979.

 

  1. Wolfson M, Jones MR, and Kopple JD:  The effect of amino acid infusion during hemodialysis on amino acid losses.  Kidney Int 16:955, 1979.

 

  1. Phillips LS and Kopple JD:  Serum somatomedin activity and sulfate in adults with normal and impaired kidney function.  Int Symposium on Growth Hormone and Other Biologically Active Peptides, Milan, Italy, 1979.

 

  1. Blumenkrantz MJ, Kopple JD, Moran JK, Grodstein GP, and Coburn JW:  Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis.  Kidney Int 16:882, 1979.

 

  1. Grodstein G, Harrison A, Roberts C, Ippoliti A, and Kopple J:  Impaired gastric emptying in hemodialysis patients.  Kidney Int 16:952, 1979.

 

  1. Casciato DA, McAdam L, Knutson DW, Goldberg LS, Kopple JD, and Bluestone R:  Pyridoxine (B6) improves immunological abnormalities in hemodialysis patients.  Clin Res 28:440A, 1980.

 

  1. Kopple JD and Grodstein G:  Urea nitrogen appearance, a practical indicator of total nitrogen output in uremic and normal man.  Clin Res 28:597A, 1980.

 

  1. Flugel RM, Jones MR, and Kopple JD:  Red blood cell amino acid concentrations in chronic uremia.  Fed Proc 39:561, 1980.

 

  1. Jones MR, Blumenkrantz MJ, and Kopple JD:  Albumin pools in normal subjects and patients with renal failure.  Fed Proc 39:561, 1980.

 

  1. Shibata S, Auvenshine P, Kopple JD, and Swendseid ME:  Polyamine metabolism in the chronically uremic rat.  Fed Proc 39:728, 1980.

 

  1. Pardridge WM, Duducgian-Vartavarian L, Casanello-Ertle D, Jones MR, and Kopple JD:  Amino acid and creatinine metabolism in adult rat skeletal muscle cells in tissue culture.  Fed Proc 39:119, 1980.

 

  1. Kopple JD, Grodstein GP, Roberts CE, and Blumenkrantz MJ; Nutritional status of the diabetic patient with chronic uremia.  Proc Diabetic Renal-Retinal Syndrome, 1980, p 239.

 

  1. Kopple JD and Jones MR:  Branched chain amino acid metabolism in chronic uremia. Int Symposium on Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids, Charleston, S Carolina, 1980.

 

  1. Wolfson M, Blumenkrantz MJ, Coburn JW, and Kopple JD:  Nutritional status in apparently healthy hemodialysis patients.  Western Dialysis and Transplant  Society, San Francisco, 1980.

 

  1. Kopple JD:  Nutritional status of patients with chronic renal failure.  Third Capri Conference on Uremia, Naples, Italy, 1980.

 

  1. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, Coburn JW:  Amino acid losses during continuous ambulatory peritoneal dialysis.  Kidney Int 19:152, 1980.

 

  1. Grodstein G, Roberts C, Winer R, Shah G, Davidson W, Franklin S, Kopple JD:  Nutritional status of nondialyzed patients with chronic renal failure.  Kidney Int 19:201, 1981.

 

  1. Wolfson M and Kopple JD:  Nutritional status in apparently healthy hemodialysis patients.  Kidney Int 19:161, 1981.

 

  1. Flugel RM, Salusky IB, Jones MR, and Kopple JD:  Effect of acute renal failure on urea nitrogen appearance and muscle protein turnover in rats.  VIII Int Cong Nephrol, Athens, Greece, p 374, 1981.

 

 

 

  1. Blumenkrantz MJ, Kopple JD, Jones MR, and Moran JK:  plasma and dialysate amino acids during continuous ambulatory peritoneal dialysis.  VIII Int Cong Nephrol, Athens, Greece, p 389, 1981.

 

  1. Blumenkrantz MJ, Kopple JD, Moran JK, and Coburn JW:  Metabolic studies of protein requirements in patients undergoing CAPD.  VII Int Cong Nephrol, Athens, Greece, p 421, 1981.

 

  1. Salusky IB, Blumenkrantz MJ, Kopple JD, Moran JK, and Coburn JW:  Effect of long term peritoneal dialysis on peritoneal clearances in diabetic and non-diabetic patients.  VIII Int Cong Nephrol, Athens, Greece, p 436, 1981.

 

  1. Blumenkrantz MJ, Kopple JD, Moran JK, and Coburn JW:  Calcium, magnesium and phosphorus balance during continuous ambulatory peritoneal dialysis.  Fifth International workshop on Phosphate and Other Minerals, New York, NY, 1981.

 

  1. Geggel HS, Heckenlively JR, Martin DA, Ament ME, and Kopple JD:  Human retinal dysfunction with taurine deficiency.  Invest Ophthalmol Visual Sci 20 (Suppl):239, 1981.

  1. Kopple JD:  Recent developments concerning nutritional disorders in renal disease.  Japanese Soc Nephrol, Tokyo, Japan, 1981.

 

  1. Kopple JD:  Urea cycle metabolism in renal failure.  4th Symposium on Guanidine Compounds, Tokyo, Japan, 1981.

 

  1. Wolfson M, Minturn D, Burger DR, and Kopple JD:  Depressed lymphocyte function and malnutrition in hemodialysis patients.  Kidney Int 21:183, 1982.

 

  1. Kopple JD, Roberts CE, Grodstein GP, Shah GM, Winer RL, Davidson WD, Henry DA, and Franklin SS:  Adherence to low protein diets by chronically uremic patients.  Kidney Int 21:171, 1982.

 

  1. Flugel-Link RM, Salusky IB, Jones MR, and Kopple JD:  Enhanced muscle protein degradation and urea nitrogen appearance in rats with acute renal failure.  kidney Int 21:217, 1982.

 

  1. Geggel HS, Ament ME, Heckenlively JR and Kopple JD:  Evidence that taurine is an essential amino acid in children receiving total parenteral nutrition.  Clin Res 30:486A, 1982.

  1. Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, and Kopple JD:  Nutritional status of pediatric patients undergoing CAPD.  Kidney Int 21: 177, 1982.  

 

  1. Jones MR, Flugel-Link RM, and Kopple JD:  Lack of effect of glucagon on protein turnover in perfused posterior rat hemicorpus.  Fed Proc 41:4103, 1982.

 

  1. Paunier L, Salusky IB, Hall T, Coburn JW, Kopple JD and Fine RN:  Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis (CAPD).  Am Soc Bone and Mineral Res, 1982.

 

  1. Flugel-Link RM, Salusky IB, Jones MR, and Kopple JD:  Increased muscle protein degradation and urea nitrogen appearance in rats with acute renal failure.  Kidney Int 23:165, 1983.

 

  1. Wolfson M, Jones MR, Flugel-Link R, and Kopple JD:  Effect of vitamin B6 deficiency on plasma amino acids in chronically uremic and sham rats.  Kidney Int 23:165, 1983.

  1. Salusky IB, Fine RN, Nelson P, and Kopple JD:  Growth and nutritional status in children receiving CAPD.  Kidney Int 23:159, 1983.

 

  1. Wolfson M, Flugel-Link RM, Jones MR, Bohannon L and Kopple JD:  Vitamin B6 deficiency in chronically uremic and control rats.  Clin Res 31:66A, 1983.

 

  1. Feinstein EI, Kopple JD, Silberman H and Massry SG:  Parenteral nutrition (PN) with increased nitrogen (N) intake in the treatment of acute renal failure (ARF).  Kidney Int 23:123, 1983.

 

  1. Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ and Kopple JD:  Nutritional evaluation in children undergoing CAPD.  Kidney Int 24 (Suppl 16):S-345, 1983.

 

  1. Roberts C, Kopple J, Grodstein G, Shah G, Winer R, Davidson W, Henry D and Franklin S:  Acceptance of protein and amino acid diets by patients with chronic renal failure.  Kidney Int 24 (Suppl 16):S-350, 1983.

 

  1. Wolfson M, Flugel-Link R, Jones M, Salusky I and Kopple J:  Vitamin B6 deficiency in uremic rats.  Kidney Int 24 (Suppl 16):S-351, 1983.

 

  1. Adler SG, Laidlaw SA, Lubran MM and Kopple JD:  Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate (SPi).  Kidney Int 25:157, 1984.

 

  1. Kopple JD, Shaib JK and Monteon F:  Energy expenditure in chronic renal failure and hemodialysis patients.  Kidney Int 25:187, 1984.

 

  1. Wolfson M, Strong CJ, Kopple JD:  Essential amino acid (EAA) supplementation in hemodialysis patients.  Kidney Int 25:196, 1984.

 

  1. Pan CS, Inadomi DW, Laidlaw SA, Jones MR and Kopple JD:  Oxandrolone enhances muscle protein synthesis in acutely uremic rats.  Kidney Int 25:236, 1984.

 

  1. Salusky IB, Fine RN, Nelson P and Kopple JD:  Factors affecting growth and nutritional status in children undergoing CAPD. Kidney Int 25:260, 1984.

 

  1. Kopple JD, Mitch W, Heidland A and Giordano C:  Nutritional aspects of renal disease.  IXth International Congress of Nephrology, June 11-16, 1984.

 

  1. Cianciaruso B, Sacca L, Terracciano V, Vigorito C, Petrone A, Andreucci VE and Kopple JD:  Splanchnic glucose metabolism in chronic renal failure.  IXth International Congress of Nephrology, June 11-16, 1984.

 

  1. Salusky IB, Fine RN, Nelson P and Kopple JD:  Effects of CAPD on growth and nutritional status (NS) in children.  IXth International Congress of Nephrology, June 11-16, 1984.

  1. Monteon FJ, Shaib JK and Kopple JD:  Energy requirements in chronic renal failure and hemodialysis patients.  IXth International Congress of Nephrology, June 11-16, 1984.

  1. Cianciaruso B, Sacca L, Terracciano V, Marcuccio F, Orofino G, Andreucci VE and Kopple JD:  The liver of acutely uremic dogs is hypercatabolic.  IXth International Congress of Nephrology, June 11-16, 1984.

 

  1. Vinton N, Laidlaw S, Wu S, Ament M and Kopple J:  Plasma and platelet taurine concentrations in children receiving home total parenteral nutrition (TPN) and healthy children.  Am J Clin Nutr 41:838, 1985.

 

  1. Adler SG, Anderson PS, Bowlus CL, Cohen AH, Kopple JD and Glassock RJ:  Characteristics of unoccupied renal estradiol receptors in male and female rats.  Clin Res 33: 474A, 1985.

 

  1. Kopple JD, Laidlaw SA and Wu SHW:  Increased muscle protein catabolism in acutely uremic rats is unaffected by inhibition of prostaglandin E2 release.  Fed Proc 44: 525, 1985.

  1. Laidlaw S, Zipser R, Tasaki T, Wu SHW and Kopple J:  Inhibition of prostaglandin E2 (PGE2) release by indomethacin (IND) does not decrease muscle protein degradation in acutely uremic rats.  Kidney Int 27: 233, 1985.

 

  1. Cohen AH, Nast CC, Adler SG and Kopple JD:  The clinical usefulness of kidney biopsies in the diagnosis and management of renal disease.  Kidney Int 27: 135, 1985.

 

  1. Adler SG, Anderson PS, Bowlus CL, Rood KL, Cohen AH, Kopple JD and Glassock RJ. Unoccupied renal estradiol receptor concentration differs in male and female rats.  Kidney Int 27: 252, 1985.

 

  1. Monteon F, Raum WJ, Shaib J and Kopple JD:  Free and conjugated plasma norepinephrine in hemodialysis patients.  Kidney Int 27: 167, 1985.

 

  1. Smolin LA, Laidlaw SA, Davidson WD and Kopple JD:  Elevation of plasma protein-bound homocysteine in patients on hemodialysis.  Fed Proc 44: 80, 1985.

 

  1. Vinton NE, Laidlaw SA, Ament ME, Kopple JD:  Red cell, granulocyte and lymphocyte taurine levels in children and adults receiving home total parenteral nutrition.  Clin Res 34:67A, 1986.

 

  1. Vinton NE, Ament ME, Heckenlively JR, Foxman S, Laidlaw SA, Martin D and Kopple JD:  Visual function in patients undergoing home total parenteral nutrition.  Am J Clin Nutr 43:698, 1986.

 

 

  1. Heckenlively JR, Vinton NE, Martin DN, Ament ME, Laidlaw SA and Kopple JD:  Visual function in patients undergoing home total parenteral nutrition.  Current Development in Ophthalmology, 1986.

 

  1. Laidlaw SA, Shultz TD and Kopple JD:  Taurine in plasma and urine of vegans.  J Nutr, 1986.

 

  1. Jung BC, Laidlaw S and Kopple JD:  Taurine (Tau) concentrations in plasma and blood cells in hemodialysis (HD) patients.  Am J Kidney Dis 8: A10, 1986.

 

  1. Hirschberg R, Kleinman K, Glassock RJ and Kopple JD:  Effect of arginine infusion on renal plasma flow (RPF) and GFR in normal and growth hormone deficient man.  Kidney Int 29: 190, 1986.

 

  1. Wolfson M and Kopple JD:  The effect of vitamin B6 (B6) deficiency on renal function in azotemic rats.  Kidney Int 29: 228, 1986.

 

  1. Laidlaw SA, Sturman JA and Kopple JD:  Taurine (TAU) in feline blood cells varies with dietary TAU intake.  Fed Proc 46:573, 1987.

 

  1. Laidlaw SA, Grosvenor MB and Kopple JD:  Taurine (TAU) content of common foodstuffs.  Fed Proc 46:891, 1987.

 

  1. Kopple JD and Hirschberg R:  Role of growth hormone in the amino acid induced increase in renal plasma flow (ERPF) and glomerular filtration rate (GFR).  Fifth International Capri Conference on Uremia, Naples, Italy, September 14-17, 1986.

 

  1. Vinton NE, Kopple JD, Bier DM, Matthews DE, Laidlaw SA and Ament ME:  Kinetics of taurine metabolism in healthy adults and longterm total parenteral nutrition patients.  Clin Res 35:780A, 1987.

 

  1. Slomowitz LA, Hirschberg R and Kopple JD:  Effects of low dose captopril (CEI) on renal hemodynamics in diabetics and normals given intravenous amino acids (AA).  Xth International Congress of Nephrology (June, 1987).

 

  1. Hirschberg R, Slomowitz LA and Kopple JD:  The amino acid induced rise in RPF and GFR is partially glucagon mediated and prostaglandin dependent.  Xth International Congress of Nephrology (June, 1987).

 

  1. Rabb H, Hirschberg R, Bergamo R and Kopple JD:  Insulin-like growth factor I (IGF I) may mediate the growth hormone induced effects on renal hemodynamics in man.  Xth International Congress of Nephrology (June, 1987).

 

  1. Block JB, Dietrich MF, Jawaid SQ, Vinton NE, Laidlaw SA, Kopple JD and Leake R:  Fecapentene-12 (F) levels in normals, bowel dysfunction patients on TPN therapy and children.  ASCO Annual Meeting, May 17-19, 1987, Atlanta, Georgia.

 

 

  1. Hirschberg R and Kopple JD:  Indomethacin blocks the arginine induced rise of RPF and GFR in man.  Kidney Int 31: 201, 1987.

 

  1. Ahmad S, Golper T, Hirschberg R, Kopple J, Katz L, Kurtin P, Ashbrook D and Wolfson M:  Efficacy of L-carnitine in hemodialysis:  A multi-center controlled clinical trial.  Kidney Int 31: 226, 1987.

 

  1. Slomowitz L, Monteon F, Lam C, Laidlaw S and Kopple J:  Energy requirements in hemodialysis patients.  Kidney Int 31: 246, 1987.

 

  1. Wolfson M, Weisenger J and Kopple J:  The effect of vitamin B6 deficiency on renal function and oxalate levels in chronically azotemic (AZ) rats.  Kidney Int 31: 248, 1987.

 

  1. Bergamo RR, Laidlaw SA and Kopple JD:  Estimation of previous serum creatinine from fingernail creatinine.  Kidney Int 33:181, 1988.

 

  1. Rabb H, Hirschberg R, Bergamo RR and Kopple JD:  Temporal relationships between plasma growth hormone (GH), plasma IGF-1 and renal function after GH injection. Kidney Int 33:205, 1988.

 

  1. Slomowitz L, Bergamo R, Hirschberg R and Kopple JD:  Enalapril (E) reduces albumin excretion in diabetic patients with microalbuminuria (MA).  Kidney Int 33:209, 1988.

 

  1. Cianciaruso B, Sacca L, Terracciano V, Marcuccio F, Andreucci VE and Kopple JD:  Hepatic glucose (G) and amino acid metabolism in acutely uremic dogs.  Kidney Int 33:356, 1988.

 

  1. Kopple JD, Vinton NE, Laidlaw SA and Ament ME:  Plasma, blood cell and urine taurine in patients given longterm total parenteral nutrition (TPN) with intravenous taurine.  FASEB J 2:A1618, 1988.

 

  1. Laidlaw SA, Dietrich MF, Vargas HI, Lamtenzan MP, Block JB and Kopple JD:  Taurine blunts the mutagenic activity of carcinogens in an in vitro bacterial assay system.  FASEB J 2:A1618, 1988.

 

  1. Dietrich MF, Laidlaw SA, Vargas HI, Lamtenzan MP, Kopple JD and Block JB:  Role of taurine (T) in modulation of mutagenesis of oxidative mutagens.  Am Assoc Cancer Res 29: 510, 1988.

 

  1. Block JB, Dietrich MF, Laidlaw SA, Vargas HI, Lamtenzan MP, Dubernet T and Kopple JD:  Taurine modulation of bile enhanced fecapentene mutagenicity.  Am Assoc Cancer Res 29: 510, 1988.

 

  1. Kopple JD, Dichiro JT, McKay S, Adler SG and Laidlaw SA:  Kinetics of alloisoleucine (AIL) after ingestion of ketoacids (KA) in normal and chronic renal failure (CRF) adults.  Kidney Int 35: 195, 1989.

 

 

 

  1. Kopple JD, Klahr S, Levey A, Sandberg A, Williams G and the MDRD Study Group:  The modification of diet in renal disease (MDRD) study.  6th International Capri Conference on Uremia, September 1-4, 1989.

 

  1. Oreopoulos DG, Anderson H, Bergstrom J, Lindholm B, Brownjohn A., Young G, DeVecchi A., Kopple JD, Nolph K, Algrim C, Martis L, Serkes K and Vonesh E.  Nutritional status of CAPD patients:  An international study.  Kidney Int 35: 274, 1989.

 

  1. Hirschberg R and Kopple JD:  Evidence that IGF-I increases RPF and GFR in fasted rats.  Kidney Int 35: 312, 1989.

 

  1. Austria MM, Jung BC, Kopple JD and Vadgama JV:  Characterization of taurine transport into human platelets.  FASEB J 3: 1061, 1989.

 

  1. Laidlaw SA, Dietrich MF, Lamtenzan MP, Block JB and Kopple JD:  Taurine specifically inhibits oxidative mutagenesis in the Ames assay.  FASEB J 3: 1060, 1989.

 

  1. Vadgama JV and Kopple JD:  Regulation of taurine transport into renal tubular cells in culture.  FASEB J 3: 1060, 1989.

 

  1. Kopple JD, Vinton NE, Hofmann AE and Laidlaw SA:  Bile acid patterns in patients undergoing longterm total parenteral nutrition.  FASEB J 3: 1060, 1989.

 

  1. Kopple JD, Jahn H, Massry SG and Heidland A:  Introduction to the Proceedings of the Fifth International Congress on Nutrition and Metabolism in Renal Disease.  Kidney Int 36 (Suppl 27): S1, 1989.

 

  1. Slomowitz LA, Bergamo R, Hirschberg R, Grosvenor M and Kopple JD:  Enalapril may block tubuloglomerular feedback in patients with diabetes mellitus.  Kidney Int 37: 245, 1990.

 

  1. Kuhlmann MK, Vadgama J and Kopple JD:  A rat model of acute renal failure and sepsis.  Kidney Int 37: 278, 1990.  

 

  1. Hirschberg R, Tucker BJ, Blantz R and Kopple JD:  The acute effects of IGF-I on nephron dynamics in food-deprived rats.  Kidney Int 37: 370, 1990.

 

  1. Hirschberg R, Kopple JD, Blantz R and Tucker B:  Effects of IGF-I on Glomerular dynamics in rats.  J Am Soc Nephrol 1: 666, 1990.

 

  1. Shahmir E, Kuhlmann MK, Vadgama JV and Kopple JD.  Effects of acidemia on urea nitrogen appearance in rats with acute renal failure (ARF).  J Am Soc Nephrol 1: 341, 1990.

 

  1. Kopple JD, Leiserowitz M, Brunori G and Mattimore C:  Treatment of malnourished maintenance hemodialysis (MHD) patients with recombinant human growth hormone.  J Am Soc Nephrol 1: 364, 1990.

 

 

  1. Vadgama JV, Chang KV and Kopple JD:  Regulation of taurine transport into human and primate tubular cells in culture.  J Am Soc Nephrol 1: 733, 1990.

 

  1. Kuhlmann MK, Kopple JD and Vadgama JV:  Characterization of threonine transport into cultured primate tubular cells.  J Am Soc Nephrol 1:723, 1990.

 

  1. Brunori G, Sheth K, Laidlaw SA, Maiorca R and Kopple JD:  Abnormal response of dialysed patients to an oral cysteine load.  XXVIIth Congress of the European Dialysis and Transplant Association - European Renal Association, held September 5-8, 1990.

 

  1. Kopple JD, Blantz R and Tucker B:  Effects of IGF-I on glomerular dynamics in rats.  J Am Soc Nephrol 1:666, 1990.

 

  1. Vinton NE, Ament ME, Kopple JD and Laidlaw SA:  Effect of intravenous L-cysteine HCl supplements on sulfur amino acid status of longterm TPN patients. 15th Clinical Congress of ASPEN, January 1991.

 

  1. Brunori G, Sheth K, Laidlaw SA, Maiorca R and Kopple JD:  Altered sulfur amino acid and glutathione response to an oral cysteine HCl load in dialysis patients.  15th Clinical Congress of ASPEN, January 1991.

 

  1. Kopple JD, Bernard D, Brunori G, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Anderson GH, Oreopoulos DG, Algrim C, Jones M, Serkes K, Vonesh E and Martis L:  Nutritional effects of intraperitoneal (IP) amino acids (AA) in malnourished CAPD patients.  J Am Soc Nephrol 2:352, 1991.

 

  1. Hirschberg R, Kopple JD:  The growth hormone (GH)-IGF-I axis and glomerular function.  J Am Soc Nephrol 2:520, 1991.

 

  1. Kopple JD:  Role of diet in the progression of chronic renal failure:  Experience with human studies and proposed mechanisms by which nutrients may retard progression.  J Nutr 121:S124, 1991.

 

  1. Hirschberg R, Brunori G, Kopple JD:  Effects of recombinant human IGF-I on renal glomerular and tubular function in man.  J Am Soc Nephrol 2:268, 1991.

 

  1. Hirschberg R, Kopple JD:  rhGrowth hormone and DES (1-3)IGF-I correct the reduced nephron ultrafiltration rate in growth hormone deficient rats.  J Am Soc Nephrol 2:681, 1991.

 

  1. Leff ML, Fruto LV, Crowell DJ, Kopple JD:  Incidence of metabolic abnormalities in patients with acute renal failure receiving total parenteral nutrition.  A.S.P.E.N. Clinical Congress, January 1992.

 

  1. Jones M, Martis L, Algrim C, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Serkes K, Vonesh E, Kopple JD:  Intraperitoneal (IP) amino acids (AA)-results of a clinical trial.  The International Society for Peritoneal Dialysis, Thessaloniki, Greece, October 1-4, 1992.

 

  1. Martis L, Kopple JD, Bernard D, Brunori G, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Anderson GH, Oreopoulos DG, Algrim C, Jones M, Serkes K, Vonesh E, Baxter Healthcare Corp.:  Nitrogen balance in CAPD patients.  Peritoneal Dialysis Meeting, Seattle, February 1992.

 

  1. Jones M, Kopple JD, Bernard D, Swartz R, Messana J, Bergstrom J, Lindholm B, Lim V, Algrim C, Serkes K, Vonesh E, Martis L:  Effects of intraperitoneal (IP) amino acids (AA) on plasma AA in CAPD patients.  Peritoneal Dialysis Meeting, Seattle, February 1992.

 

  1. Ding H, Hirschberg R, Kopple JD:  Recombinant human insulin-like growth factor-I (rhIGF-I) reduces catabolic rate in rats with acute renal failure (ARF). J Am Soc Nephrol 3: 705, 1992.

 

  1. Ding H, Kopple JD, Cohen AH, Hirschberg R:  Recombinant human insulin-like growth factor-I (rhIGF-I) improves recovery from ischemic acute renal failure in rats. J Am Soc Nephrol 3: 363, 1992.

 

  1. Barba L, Devine W, DiChiro JT, Agdeppa R, Avelino L, Kopple JD:  Nutritional status of renal transplant patients.  J Am Soc Nephrol 3: 852, 1992.

 

  1. Ding H, Gao XL, Kopple JD:  Resistance to recombinant human IGF-1 in skeletal muscle of rats with chronic renal failure.  J Am Soc Nephrol 4: 768, 1993.

 

  1. Fouque D, Peng S, Kopple JD:  IGF-1 treatment in chronic renal failure:  abnormal plasma kinetics.  J Am Soc Nephrol 4: 346, 1993.

 

  1. Peng S, Fouque D, Kopple JD:  Insulin-like growth factor 1 (IGF-1) causes anabolism in malnourished CAPD patients.  J Am Soc Nephrol 4: 414, 1993.

 

  1. Wolfson M, Lim V, Cooper M, Kopple JD:  The relationship between dietary protein intake and urine urea nitrogen and total nitrogen output in proteinuric patients.  J Am Soc Nephrol 4: 290, 1993.

 

  1. Wolfson M, Lim V, Cooper M, Kopple JD:  The relationship between serum cholesterol, triglycerides and albumin, and urine protein in patients with the nephrotic syndrome.  J Am Soc Nephrol 4: 290, 1993.

 

  1. Kopple JD, Fouque D, Peng S:  Evidence for IGF-1 resistance in maintenance hemodialysis (MHD) and continuous ambulatory peritoneal dialysis (CAPD) patients.  J Am Soc Nephrol 4: 362, 1993.

 

  1. Whelton P, Lee J, Kopple JD, Faulkner M, and Charleston J, for the AASK Pilot Investigators:  Recruitment in the African American study of kidney disease and hypertension (AASK) pilot study.  J Am Soc Nephrol 5: 570, 1994.

 

  1. Wolfson M, Vallian J, Shuler CL, Kopple JD:  The effect of acidemia on protein turnover and nitrogen balance in CAPD patients.  J Am Soc Nephrol 5: 506, 1994.

 

 

  1. Ding H, Gao XL, Hirschberg R, and Kopple JD:  Mechanisms of resistance to IGF-1 in skeletal muscles of rats with chronic renal failure.  J Am Soc Nephrol 5: 941, 1994.

 

  1. Gao X-L and Kopple JD: Relationship between dietary protein, urea nitrogen appearance (UNA) and total nitrogen appearance (TNA) in patients with chronic renal failure (CRF).  J Am Soc Nephrol 5: 491, 1994.

 

  1. MMHD Study Group (Prepared by Eknoyan G, Beck GJ, Breyer JA, Kopple JD, Kusek JW, Levey AS and Striker GE:  Design and preliminary results of the mortality and morbidity of hemodialysis (MMHD) pilot study.  J Am Soc Nephrol 5: 513, 1994.

 

  1. Ahmed KR, Scognamillo B, Kopple JD:  Relationship of peritoneal transport kinetics and nutritional status in chronic peritoneal dialysis patients.  J Am Soc Nephrol 5: 487, 1994.

 

  1. MDRD Study Group (Prepared by JD Kopple, WC Chumlea, JJ Gassman, DL Hollinger, BJ Maroni, D Merrill, LK Scherch, G Schulman, GS Zimmer).  Nutritional response to diet prescription in the MDRD Study.  J Am Soc Nephrol 5: 335, 1994.

 

  1. MDRD Study Group (Prepared by JD Kopple, WC Chumlea, JJ Gassman, DL Hollinger, BJ Maroni, D Merrill, LK Scherch, G Schulman, GS Zimmer).  Relationship between GFR and nutritional status - results from the MDRD Study.  J Am Soc Nephrol 5: 335, 1994.  

 

  1. Lee JY, Smith DE, Cornell CE, Faulkner M, Kopple J, Kusek JW and Milligan S for the AASK Pilot Study Investigators.  Quality of life in the African American study of kidney disease and hypertension (AASK) pilot study.  J Am Soc Nephrol 6: 644, 1995.

 

  1. Vadgama JV, Franklin KM, Ding H, Chang KC, Hirschberg R and Kopple JD:  Serum and skeletal muscle IGF-1 and IGF-binding protein expression in rats with chronic renal failure.  J Am Soc Nephrol 6: 1033, 1995.

 

  1. Shahmir E, Peng S, Fouque D and Kopple JD:  Effect of insulin-like growth factor 1 (IGF-1) on nitrogen balance in malnourished CAPD patients.  J Am Soc Nephrol 6: 587, 1995.

 

  1. Ding H, Qing P-Y, Gao X-L, Hirschberg R and Kopple JD:  Time dependent changes in the expression of insulin-like growth factor 1 (IGF-1) and IGF-1 receptor (IGF-1R) in tissues of rats with acute renal failure (ARF).  J Am Soc Nephrol 6: 461, 1995.

 

  1. Dwyer JT, Kopple JD, Maroni BJ, Burrowes JD, Powers SN, Cockram DB, Chumlea WC, Kusek JW, Makoff R, Cunniff PJ, Goldstein DJ and Paranandi L from the Hemodialysis (HEMO) Study.  Dietary intake and nutritional status in the HEMO pilot study population.  J Am Soc Nephrol 6: 576, 1995.

 

  1. Chazot C, Shahmir E, Matias B and Kopple JD:  Provision of amino acids by dialysis during maintenance hemodialysis (MHD).  J Am Soc Nephrol 6: 574, 1995.

 

 

 

  1. Vadgama JV, Chang KC, Wu H, Ding H, Qing DP, Kopple JD:  Amino acid transport in epitrochlearis muscle and cardiomyocytes from rats with CRF is impaired in the basal state and after IGF-I stimulation.  J Am Soc Nephrol 7: 1306, 1996.

 

  1. Hirschberg R, Capra W, Kopple JD and Guler H-P:  Factors predicting poor outcome in patients with acute renal failure (ARF).  J Am Soc Nephrol 7: 1374, 1996.

 

  1. Kopple JD, Hirschberg R, Guler H-P, Pike Marilyn and Chiron Study Group:  Lack of effect of recombinant human insulin-like growth factor I (IGF-I) in patients with acute renal failure ARF.  J Am Soc Nephrol 7: 1375, 1996.

 

  1. Bohe J, King H, Hirschberg R, Yoon K, Qing DP, Wolfgang GHI and Kopple JD: Insulin-like growth factor binding proteins (IGFBPs) and IGFBP mRNAs in rats with acute renal failure (ARF) given IGF-I.  J Am Soc Nephrol 7: 1653, 1996.

 

  1. Ding H, Wolfgang GHI, Yoon K, Bohe J, Qing DP, Yamamoto R and Kopple JD: Effect of recombinant human insulin-like growth factor I (IGF-I) on nitric oxide and endothelin levels in rats with acute renal failure (ARF).  J Am Soc Nephrol 7: 1823, 1996.

 

  1. Wu Y, Chang KC, Enriquez MS, Kopple JD and Vadgama JV:  Gentamicin induces cellular and molecular changes in proximal tubular cells BSC-1.  J Am Soc Nephrol 7: 1848, 1996.

 

  1. Qing DP, Vadgama J, Ding H, Wu Y and Kopple JD:  Elevated cytosolic calcium ([Ca2+]I) impairs actions of IGF-I on myocardial cells in rats with CRF.  J Am Soc Nephrol 7: 1862, 1996.

 

  1. Kopple JD: Treatment of malnourished CAPD patients with IGF-I.  Blood Purif 14 (Suppl 1): 38-40, 1996.

 

  1. Hall WD, Wang SR, Kusek J, Rogers N, Charleston J, Kopple J and Pogue V:  African American study of kidney disease and hypertension (full-scale AASK):  Baseline clinical and demographic characteristics of the randomized participants.  International Conference on Hypertension in Blacks, London, England, July 20-24, 1997.

 

  1. Kopple JD, Lew NL, Zhu X and Lowrie EG:  Body weight predicts mortality in maintenance hemodialysis (MHD) patients.  J Am Soc Nephrol 8: 198A, 1997.

 

  1. Kopple JD, Lew NL, Zhu X and Lowrie EG:  A nutrition-oriented logistics regression equation to predict survival in MHD patients.  J Am Soc Nephrol 8: 198A-199A, 1997.

 

  1. Ding H, Qing DP, Wang SN and Kopple JD:  Alkalosis stimulates protein synthesis in cultured myocytes.  J Am Soc Nephrol 8: 613A, 1997.

 

  1. Lim VS, Wolfson M, Yarasheski KE, Flanigan MJ and Kopple JD:  Leucine (leu) kinetics in nephrotic patients (np):  Evidence suggesting protein conservation.  J Am Soc Nephrol 8: 621A, 1997.

 

 

  1. Qing DP, Ding H, Vadgama J, Wu Y and Kopple JD:  Mechanisms of resistance to the actions of IGF-I on cardiomyocytes in rats with CRF:  Role of cytosolic calcium.  J Am Soc Nephrol 8: 627A, 1997.

 

  1. Ding H, Letoha A, Ivanyi B, Qing DP, Sonkodi S, Kopple JD: Carnitine protects rat renal proximal tubular cells from gentamicin-induced injury.  J Am Soc Nephrol 9:575A, 1998.

 

  1. Ding H, Qing DP, Wang SN, Kopple JD: Effect of alkaline pH on myosin heavy chain synthesis in cultured myocytes.  J Am Soc Nephrol 9:607A, 1998.

 

  1. Ding H, Letoha A, Ivanyi B, Qing DP, Sonkodi S, Kopple JD: Carnitine protects rat renal proximal tubular cells from gentamicin-induced injury.  9th International Congress on Nutrition and Metabolism in Renal Disease, Vienna, Austria, August 29 - September 1, 1998.  Miner Electrolyte Metab.

 

  1. Qing DP, Ding H, Vadgama J, Wu Y, Kopple JD: Mechanisms of resistance to the actions of IGF-I on cardiomyocytes in rats with CRF: Role of cytosolic calcium.  9th International Congress on Nutrition and Metabolism in Renal Disease, Vienna, Austria, August 29 - September 1, 1998.  Miner Electrolyte Metab.

 

  1. Cheek D, Lipkowitz M, Kopple J, Pogue V, Rostand S, Wang SR and the AASK group: Risk factors for CV disease and history of stroke by region: Observations from the African American Study of Kidney Disease (AASK).  13th International Interdisciplinary Conference on Hypertension in Blacks, July 12-15, 1998.

 

  1. Hebert L, Appel L, Cleveland W, Greene T, Jamerson K, Kopple J, Pogue V: Cigarette smoking (CS) is associated with lower glomerular filtration rate (GFR) in African Americans (AA) with hypertensive nephrosclerosis (HN).  Am Soc Nephrol 31st Annual Meeting, October 25-28, 1998.  J Am Soc Nephrol 9:149A, 1998.

 

  1. Cohen AH, Santoro D, Kopple JD,Corry D: Diabetic nephropathy without other             manifestations of diabetes mellitus: Report of 11 cases diagnosed by renal biopsy, with follow-up. J Am Soc Nephrol 10:127A, 1999.

 

  1. Kopple JD, Hoppel CL, Casaburi R, Storer T, Sawelson S, Qing DP. Effect of exercise training on serum and skeletal muscle carnitine levels in maintenance dialysis patients.  J Am Soc Nephrol 10:263A, 1999.

 

  1. Kopple JD, Qing DP. Effect of L-Carnitine on nitrogen balance in CAPD patients.  J Am Soc Nephrol 10:264A, 1999.

 

  1. Qing DP, Tang ZY, Ding H, Storer T, Casaburi R, Sawelson S, Kopple JD:  Effect of exercise training of gene expression for IGF-1, IGF-R and IGFBP=s in skeletal muscle of maintenance hemodialysis patients. J Am Soc Nephrol 10:266A, 1999.

 

 

 

  1. Storer T, Casaburi R, Gottron C, Walsh D, Sawelson S, Kopple JD: Muscle strength and function improves with endurance exercise training in maintenance hemodialysis patients.  J Am Soc Nephrol 10:269A, 1999.

 

  1. Tang ZY, Qing PD, Storer T, Casaburi R, Sawelson S, Kopple JD:  Effect of exercise training on myostatin gene expression in skeletal muscle of maintenance hemodialysis patients.  J Am Soc Nephrol 10:269A, 1999.

 

  1. Mehrotra R, Kopple JD:  Increase in Serum Albumin Upon Initiation of Maintenance Hemodialysis: Evidence for Improvement of Nutritional Status. Am Soc Nephrol 33rd Annual Meeting, October 10-16, 2000.  J Am Soc Nephrol 11:287A, 2000.

 

  1. Lea JP, Appel LJ, Douglas JG, Faulkner M, Kopple JD, Lightfoot T, Zhang W: Nutritional Factors and Their Relationship to Renal Function in African-American Patients with Hypertensive Renal Disease. Am Soc Nephrol 33rd Annual Meeting, October 10-16, 2000. J Am Soc Nephrol 11:3287-A, 2000.

 

  1. Kalantar-Zadeh K, Kopple JD, Humphreys MH: A comprehensive, quantitative “Dialysis Malnutrition Score” based on SGA and laboratory values.  Am J Kidney Dis 35:16A, 2000.

 

  1. Kopple JD, Qing DP, Hoppel CL: Plasma carnitine concentrations in non-dialyzed patients with moderate renal failure.  Am J Kidney Dis 35:18A, 2000.

 

  1. Kalantar-Zadeh K, Lehn RS, McAllister CJ, Kopple JD; Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V>1.20. Submitted to the 2001 ASN/ISN World Congress of Nephrology, San Francisco, CA; October 2001.

 

  1. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH; Association between SF36 quality of life measures and nutrition, hospitalization and mortality in hemodialysis. Submitted to the 2001 ASN/ISN World Congress of Nephrology, San Francisco, CA; October 2001.

 

  1. Kalantar-Zadeh K, Kopple JD, Humphreys MH; Serum prealbumin has the strongest combined association with measures of protein intake, inflammation, and anemia in hemodialysisi patients.  Submitted to the 2001 ASN/ISN World Congress of Nephrology, San Francisco, CA; October 2001.

 

  1. Mehrotra R, Marwaha T. Appel M, Kopple: In chronic peritoneal dialysis patients with peritonitis, hospitalization or catheter removal are significantly associated with decline in serum albumin.  International meeting of ISPD.  Perit Dial Int 21(Suppl 2):S111, 2001.

 

  1. Mehrotra R, Marwaha T. Appel M, Kopple: In chronic peritoneal dialysis patients with peritonitis, hospitalization or catheter removal are significantly associated with decline in serum albumin.  International meeting of ISPD.  Perit Dial Int 21(Suppl 2):S111, 2001.

 

 

 

  1. Mehrotra R, Supasyndh O, Hurst L, Leonardi M, Bross R, Das D, Kopple JD: Relationship of Body Composition and Age in Patients on Maintenance Hemodialysis (MHD): Implications for Dietary Energy and Protein Requirements.  J Am Soc Nephrol 12:397A, 2001.

 

  1. Lea JP, Contreras G, Kopple JD, Schulman G, Wang S-R, Lightfoot T, Richardson A: The Use of Diuretic Therapy in Achievement of Blood Pressure (BP) Goals in the African-American Study of Kidney Disease and Hypertension (AASK).  J Am Soc Nephrol 12:486A, 2001.

 

  1. Kalantar-Zadeh K, Lehn RS, McAllister CJ, Kopple JD:  Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V>1.20.  11th International Congress on Nutrition and Metabolism in Renal Diseases, Nagoya, Japan: March 2002.

 

  1. Kalantar-Zadeh K, Khaleeli H, Supasyndh O, Kopple JD:  Association between SF36 quality of life and serum albumin, creatinine and total lymphocyte count in hemodialysis patients.  11th International Congress on Nutrition and Metabolism in Renal Diseases, Nagoya, Japan; March 2002.

 

  1. Yao Y, Wang H-Y, Supasyndh O, Qing P-Y, Tang .Z-Y, Abdelmalik ME, Ding H, Kopple JD: Effect of Hydrogen Ion Concentration on Skeletal Muscle Protein Turnover.  11th International Congress on Nutrition and Metabolism in Renal Diseases, Nagoya, Japan; March 2002.

 

  1. Kopple JD: Muscle Metabolism in Chronic Renal Failure. 11th International Congress on Nutrition and Metabolism in Renal Diseases, Nagoya, Japan; March 2002.

 

  1. Kopple JD, Kalantar-Zadeh K: The National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transhthyretin in Chronic Renal Failure.  First International Congress on Transthyretin in Health & Disease, Strausbourg, France; April 2002.

 

  1. Kalantar-Zadeh K, Lehn RS, Kopple JD: Impact of Malnutrition Inflammation Complex Syndrome on EPO Hyporesponsiveness.  National Kidney Foundation 2002 Clinical Meeting, Chicago, IL.

 

  1. Kalantar-Zadeh K, Kopple JD: Is serum homocysteine a nutritional marker in maintenance hemodialysis patients?  National Kidney Foundation 2002 Clinical Meeting, Chicago, IL.

 

  1. Kalantar-Zadeh K, Kopple JD: Total Plasma Homocysteine May Be a Nutritional Marker in Maintenance Hemodialysis Patients.  J Am Soc Nephrol 13:222A, 2002.

 

  1. Kalantar-Zadeh K, Kopple JD: Association Between Appetite and Inflammation, Anemia, EPO Dose, and Quality of Life in Dialysis.  J Am Soc Nephrol 13:223A, 2002.

 

  1. Kalantar-Zadeh K, Humphreys MH, Kopple JD: Association Between Type of Dialysis Access and Quality of Life in Maintenance Hemodialysis Patients.  J Am Soc Nephrol 13:397A, 2002.

 

  1. Pillon L, Piccoli A, Kopple JD: Biompedance Vector Analysis, Adequacy of Ultrafiltration and Kt/V.  J Am Soc Nephrol 13:414A, 2002.

 

  1. Appel LJ, Bakris G, Douglas-Baltimore J, Greene T, Kopple JD, Massry S, Wang X: The Relationship Between Achieved Blood Pressure (BP) and Renal Outcomes in the African American Study of Kidney Disease (AASK).  J Am Soc Nephrol 13:423A, 2002.

 

  1. Supasyndh O, Mehrotra R, Hurst L, Leonardi M, Bross R, Kopple JD: Predictors of Morbidity in Maintenance Hemodialysis.  J Am Soc Nephrol 13:627A, 2002.

 

  1. Mehrotra R, Supasyndh O, Kaysen G, Das D, Hurst L, Leonardi M, Bross R, Kopple JD: Relationship Between Demographic, Laboratory and Nutritional Measures and Co-Morbidity in Maintenance Hemodialysis (MHD): No Relationship with Markers of Inflammation.  J Am Soc Nephrol 13:617A, 2002.

 

  1. Supasyndh O, Mehrotra R, Das D, Hurst L, Leonardi M, Bross R, Kopple JD: Relation Between Serum Parathyroid Hormone and Age in Maintenance Hemodialysis Patients.  J Am Soc Nephrol 13:634A, 2002.

 

  1. Kalantar-Zadeh K, Lehn RS, McAllister CJ, Kopple JD: Impact of Malnutrition-Inflammation Complex Syndrome and Ace Inhibitors on Erythropoietin Hyporesponsiveness in Hemodialysis Patients.  J Am Soc Nephrol 13:582A, 2002.

 

278.            Storer T, Casaburi R, Gottron C, Walsh D, Kopple JD: Low Intensity Endurance Training Improves Muscle Function, Physical Performance, and FFM in Hemodialysis.  American College of Sports Medicine Meeting, San Francisco, CA, 2002. Med Science Sports Exercise 35:S231, 2003.

 

279.            Kalantar-Zadeh K, Block G, Kopple JD.  Association between appetite and inflammatory markers, anemia, EPO dose and quality of life in maintenance hemodialysis patients.  J Invest Med 51:S387, 2003.

 

280.            Kalantar-Zadeh K, Block G, Kopple JD. Is plasma homocysteine a cardiovascular risk factor or a nutritional marker in diabetic hemodialysis patients? Oral Presentation at ASAIO, abstract at ISN, June 2003.

 

281.            Kalantar-Zadeh K, Fonarow G, Coresh, J, Block G, Kopple JD; Identifying Populations with a Reverse Epidemiology of Cardiovascular Disease. Annual conference of the American College of Epidemiology (ACE), Annals of Epidemiology, November 2003.

 

282.            Norris K, Greene T, Kopple J, Lea J, Lipkowitz M, Miller E, Richardson A, Rostand S, Wang X, the AASK Study Group.  Baseline Predictors of Renal Disease Progression in the African American (AA) Study of Hypertension and Kidney Disease (AASK).  J Am Soc Nephrol 14:190A, 2003.

 

283.            Wang H, Kopple J, Taylor W, Storer T, Casaburi R.  Gene Expression for Myostatin is Increased in Skeletal Muscle of Maintenance Hemodialysis (MHD) Patients.  J Am Soc Nephrol 14:222A, 2003.

 

284.            Kopple JD, Fournier M, Wang H, Cohen A, Storer T, Casaburi R, Lewis MI.  Skeletal Muscle Structure and Oxidative Capacity in Maintenance Hemodialysis (MHD) Patients.  J Am Soc Nephrol 14:229A, 2003.

 

285.            Wang H, Kopple JD, Taylor W, Eleil H, Storer T, Casaburi R.  Gene Expression for Insulin-Like Growth Factors (IGF) in Skeletal Muscle of Maintenance Hemodialysis (MHD) Patients.  J Am Soc Nephrol 14:230A, 2003.

 

286.            Kalantar-Zadeh K, Maekawa N, Colman S, Kopple JD, Block G.  Is Hyperphosphatemia an Indicator of a Better Dietary Protein and Calorie Intake in Hemodialysis Patients?  Annual conference of the American Society of Nephrology, J Am Soc Nephrol 14:232A, 2003.

 

287.            Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD.  A Low, and Not a High, Total Plasma Homocysteine is a Mortality Risk Factor in Hemodialysis Patients. Annual conference of the American Society of Nephrology, J Am Soc Nephrol 14:261A, 2003.

 

288.            Kalantar-Zadeh K, Budoff MJ, Colman S, Kopple JD, McAllister CJ.  Exploring the Morality-Predictability of Serum Phosphorus in Hemodialysis Patients.  Annual conference of theAmerican Society of Nephrology, J Am Soc Nephrol 14:270A, 2003.

 

289.            Norris K, Bourgoignie J, Gassman J, Hebert L, Middleton J, Phillips R, Randall O, Rostand S, Sherer S, Toto R, Wright J, Wang X, Kopple J, Lewis J, Greene T, the AASK Study Group.  Cardiovascular Outcomes in the African American (AA) Study of Hypertension and Kidney Disease (AASK).  J Am Soc Nephrol 14:673A, 2003.

 

290.            Kalantar-Zadeh K, McAllister CJ, Liu E, Lehn RS, Kopple JD.  Iron Store Indices Predict Mortality in Hemodialysis Patients.  Annual conference of the American Society of Nephrology, J Am Soc Nephrol 14:705A, 2003.

 

291.            Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD.   Self-Reported Subjective Appetite Correlates with Inflammation, Nutrition, and Anemia and Predicts Quality of Life and Mortality in Dialysis Patients.  J Am Soc Nephrol 14:715A, 2003.

 

292.            Kalantar-Zadeh K, Lehn RS, Kopple JD.  High Total WBC Count and Low Lymphocyte Percentage Predict Prospective Mortality in Hemodialysis Patients.  Annual conference of the American Society of Nephrology, J Am Soc Nephrol 14:717A, 2003.

 

293.            Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G.  Comparing Mortality-Predictability of Serum Interleukin-6, Tumor Necrosis Factor, C-Reactive Protein, and Malnutrition-Inflammation Score in Hemodialysis Patients.  Annual conference of the American Society of Nephrology, J Am Soc Nephrol 14:720A, 2003.

 

294.            Kalantar-Zadeh K, Fonarrow G, Coresh J, Block G, Kopple JD.  Identifying Populations with a Reverse Epidemiology of Cardiovascular Disease.  J Am Soc Nephrol 14:834A, 2003

 

 

 

295.            Kalantar-Zadeh K, Liu E, Maekawa N, Gjertson DJ, Kopple JD.  Comparing the Mortality-Predictability of Laboratory Indicators of Nutritional Status in Hemodialysis Patients.  J Am Soc Nephrol 14:839A, 2003.

 

296.            Kopple JD, Casaburi R, Storer T.  Maintenance Hemodialysis (MHD) Patients Display Improved Exercise Capacity, Muscle Function and Physical Performance with Low Intensity Endurance Training.  J Am Soc Nephrol 14:857A, 2003.

 

297.            Pillon L, Kopple JD, Picolli A.  Estimating Vascular Refilling Pressure with Bioimpedance Vector Analysis.  J Am Soc Nephrol 14:865A, 2003.

 

  1. Westra W, Mehrotra R, Krediet R, Kopple JD. High protein needs in continuous cyclic peritoneal dialysis (CCPD) patients: Not due to dialysate protein losses. Perit Dial Int; 24 (suppl 1):

 

  1. Kalantar-Zadeh K, Bross R, Zitterkoph J, Colman S, Gjertson DW, Kopple JD: Comparing four body composition assessment methods for body fat measurement in dialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:591A, 2004.

 

  1. Kalantar-Zadeh K, Kamranpour N, Kopple JD: Association between novel HDL inflammatory/anti-inflammatory properties with body mass index in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:172A, 2004.

 

  1. Shinaberger CS, Kilpatrick RD, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Exploring time-dependent associations between urea dynamic calculated protein intake and cardiovascular mortality in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:385A, 2004.

 

  1. Kilpatrick RD, Greenland S, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Time-dependent association between dialysis dose and cardiovascular mortality in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:2A, 2004.

 

  1. Kuwae K, Kilpatrick RD, McAllister CJ, Budoff MJ, Kopple JD, Kalantar-Zadeh K: Malnutrition-inflammation complex confounds associations between serum phosphorus and calcium and mortality in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:381A, 2004.

 

  1. Kuwae N, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Impact of malnutrition-inflammation on the association between serum potassium level and mortality in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:391A, 2004.

 

  1. Kalantar-Zadeh K, Daar ES, Kopple JD, Miller LG: Association between hepatitis C infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:622A, 2004.

 

 

 

 

  1. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Gjertson DW, Greenland S, Kopple JD: Population attributable mortality risk for albumin <3.8 g/dL: how many lives can be saved if hypoalbuminemia can be corrected in hemodialysis patients? 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:382A, 2004.

 

  1. Kalantar-Zadeh K, Horwich TB, Fonarow GC, Anker SD, Kopple JD: A low, rather than a high, serum LDL cholesterol is associated with increased mortality in hemodialysis patients even after controlling for inflammation. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:173A, 2004.

 

  1. Kalantar-Zadeh K, Kopple JD, Stringer WW: A matched comparison of serum lipid levels in hemodialysis patients vs. non-ESRD controls. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:192A, 2004.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Kopple JD, Greenland S: Time-dependant association between body mass index and cardiovascular mortality in hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:126A, 2004.

 

  1. Kalantar-Zadeh K, Chow J, Braglia A, Cockram DB, Kuwae N, Kwon O, Kopple JD: An anti-inflammatory and anti-oxidant nutritional supplement for hypoalbuminemiac dialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:192A, 2004.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Kopple JD: A Low, rather than a high, systolic blood pressure is associated with increased mortality among hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:586A, 2004.

 

  1. Kalantar-Zadeh K, Kamranpour N, Kopple JD: Serum paraoxonase and LDL oxidation measurement in maintenance hemodialysis patients. 37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:173A, 2004.

 

  1. Wang H, Taylor WE, Kopple JD:  Skeletal muscle insulin-like growth factor binding protein (IGFBP) –2 and –3 mRNA levels in maintenance hemodialysis patients.  37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:818A, 2004.

 

  1. Wang H, Taylor WE, Kopple JD:  Skeletal muscle insulin-like growth factor-I (IGF-I) and IGF-I mRNA in maintenance hemodialysis patients.  37th annual conference of the American Society of Nephrology; J Am Soc Neph 15:624A, 2004.

 

  1. Levey, AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, Kopple JD:  Effect of low protein diet on progression of kidney disease in the modification of diet in renal disease Study A:  Long-term follow-up.  37th annual conference of the American Society of Nephrology, J Am Soc Neph 15:586A, 2004.

 

 

 

 

  1. Levey AS, Greene T, Sarnak MJ, Wang X, Beck GJ, Kusek JW, Collins A, Kopple JD:  The effect of very low protein diet on progression of kidney disease and mortality in modification of diet in renal disease Study B.  37th annual conference of the American Society of Nephrology, J Am Soc Neph 15:586A, 2004.

 

  1. Kalantar-Zadeh K, Chow J, Braglia A, Cockram DB, Kuwae N, Kwon O, Kopple JD: Ingestion of Oxepa and Nepro Thrice Weekly During Dialysis Improves Hypoalbuminemia in Maintenance Hemodialysis Patients. 12th International Congress on Nutrition and Metabolism in Renal Disease; Abano Terme (Padova-Venice), June 19-22, 2004, Jul 2004.

 

  1. Kalantar-Zadeh K, Kilpatrick R, Kuwae N, McAllister CJ, Gjertson D, Greenland S, Kopple JD: Revisiting mortality-predictability of serum albumin in maintenance hemodialysis patients: population attributable mortality risk for albumin less than 3.8 mg/L. 12th International Congress on Nutrition and Metabolism in Renal Disease; Abano Terme (Padova-Venice), June 19-22, 2004, Jul 2004.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Kopple JD: Reverse Epidemiology of Hypertension in Dialysis Patients: Bad Gone Good? Hypertension, 2004.

 

  1. Kuwae N, McAllister C, Gjertson D, Greenland S, Kopple J, Kalantar-Zadeh K: Mortality predictability of serum potassium in dialysis patients. Am J Kid Dis, 2004.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, Gjertson DW, Greenland S, McAllister CJ, Kopple JD: Is a low or high serum phosporus a mortality predictor in hemodialysis patients. Annual conference of the National Kidney Foundation; Am J Kid Dis, 2004.

 

  1. Wang X, Lewis J, Appel L, Cheek D, Contreras G, Faulkner M, Glassman J, Lea J, Kopple JD:  Validation of serum Creatinine (Ser)-based outcomes for longitudinal studies of CKD. J Am Soc Nephrol 16:69A, 2005.

 

  1. Hatamizadeh P, Regidor DL, Kopple JD, Kalantar-Zadeh K:  Association between baseline serum Creatinine and all-cause and cardiovascular mortality in maintenance hemodialysis patients. J Am Soc Neph 16:290A, 2005.

 

  1. Kalantar-Zadeh K, Kopple JD, Kamranpour N, Navab M:  Novel HDL inflammatory/anti-inflammatory properties correlate with total body fat in hemodialysis patients. J Am Soc Neph 16:273A, 2005.

 

  1. Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Longitudinal associations between changes in calcium-phosphorus product and survival in maintenance hemodialysis patients. J Am Soc Neph 16:47A, 2005.

 

  1. Kalantar-Zadeh K, Regidor DL, Nissenson AR, McAllister CJ, Kilpatrick RD, Aronovitz J, Kovesdy CP, Kuwae N, Lee GH, Kopple JD:  Association between changes in hemoglobin over time and survival in hemodialysis patients. J Am Soc Neph 16:489A, 2005.

 

  1. Workeneh BT, Rondon H, Ayehu G, Hu Z, Fernando A, Wang H, Kopple JD, Du J, Mitch WE:  Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions indlucing kidney failure. J Am Soc Neph 16:713A, 2005.

 

  1. Wu DY, Kilpatrick RD, Dadres S, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Association between serum bicarbonate and death in hemodialysis patients: Is it better to be acidotic or alkalotic? Hemodialysis International 9:110, 2005.

 

  1. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Kopple JD, Greenland S: Mortality predictability of longitudinal changes of serum albumin in hemodialysis population [National Kidney Foundation 2005 Spring Clinical Meetings]. Am J Kid Dis 45:A33, 2005.

 

  1. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Greenland S: Effect of weight change over time on cardiovascular mortality in hemodialysis patients [National Kidney Foundation 2005 Spring Clinical Meetings]. Am J Kid Dis 45:A33, 2005.

 

  1. Shinaberger CS, Kilpatrick RD, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Association between changes in urea kinetic based protein intake over time and mortality in hemodialysis patients [National Kidney Foundation 2005 Spring Clinical Meetings]. Am J Kid Dis 45:A33, 2005.

 

332.            Song HY, Wang H, Zhang S, Kopple JD: Effect of exercise training on skeletal muscle myosin heavy chain mRNA levels in maintenance hemodialysis patients.  [ASN 38th Annual Renal Week Meeting]. J Am Soc Nephrol 16:713A, 2005.

 

333.            Kopple JD, Wang H, Taylor WE, Casaburi R, Storer TW: Skeletal muscle myostatin mRNA is decreased with exercise training in maintenance hemodialysis (MHD) patients.  [ASN 38th Annual Renal Week Meeting]. J Am Soc Nephrol 16:717A, 2005.

 

334.            Kalantar-Zadeh K, Kuwae N, Wu, DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD: Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. J Am Soc Nephrol 16:717A, 2005.

 

335.            Kalantar-Zadeh K, McAllister CJ, Wu DY, Shinaberger CS, Kopple JD:  Association between serum bicarbonate and cardiovascular death in hemodialysis patients. J Am Soc Nephrol 16:717A, 2005.

 

336.            Wang H, Zhang S, Song HY, Konishi T, Kopple JD:  High proton concentrations suppress phosphorylation of p70 S6 kinase in cultured myocytes.  [ASN 38th Annual Renal Week Meeting]. J Am Soc Nephrol 16:719A, 2005.

 

337.            Wang H, Song HY, Konishi T, Zhang S, Kopple JD:  Skeletal muscle phosphorylated AKT in maintenance hemodialysis (MHD) patients.  [ASN 38th Annual Renal Week Meeting].  J Am Soc Nephrol 16:719A, 2005.

 

 

 

338.            Kalantar-Zadeh K, Nissenson AR, Regidor DL, Kilpatrick RD, McAllister CJ, Aronovitz J, Lee GH, Kopple JD:  Association between administered erythropoietin and its dose variations over time and survival in hemodialysis patients. J Am Soc Nephrol 16:731A, 2005.

 

339.            Appel L, Agodoa L, Bakris G, Gabbai F, Gassman J, Greene T, Kopple JD, Kusek J, Lipkowitz M, Norris K, Rahman M, Rostand S, Schulman G, Wang X, Wright J:  Relentless progression of hypertensive chronic kidney disease (CKD) despite excellent blood pressure (BP) control and use of angiotensin converting enzyme inhibitor (ACEI) thereapy: results from the African-American study of kidney disease and hypertension (AASK) cohort study. J Am Soc Nephrol 17:54A, 2006.

 

340.            Mehrotra R, Bross R, Konishi T, Appell M, Kopple JD:  What is the optimal aterial pH for protein balance in automated peritoneal dialysis (APD) patients?  11th Congress of the International Society for Peritoneal Dialysis (ISPD), 2006. Perit Dial Int. 26:S41, 2006.

 

341.            Wu DY, Kovesdy CP, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Unexpected association between higher serum chloride and greater survival in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:78A, 2006.

 

342.            Regidor DL, McAllister CJ, Kovesdy CP, Kopple JD, Kalantar-Zadeh K:  Mortality-predictability of serum LDH and AST (GOT) in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:169A, 2006.

 

343.            Kalantar-Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M:  Association of the novel HDL-inflammatory index with quality of life and prospective death risk in hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:27A, 2006.

 

344.            Kalantar-Zadeh K, Mehrotra R, Regidor DL, McAllister CJ, Kopple JD:  Should serum phosphorus be controlled by decreasing dietary protein in CKD?  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:76A, 2006.

 

345.            Kilpatrick RD, DeRose SF, Kovesdy CP, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Serum triglyceride and cardiovascular mortality in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:321A, 2006.

 

346.            Kalantar-Zadeh K, Kilpatrick RD, DeRose SF, Kovesdy CP, McAllister CJ, Kopple JD: Persistency of paradoxical association between hypercholesterolemia and survival in subgroups  of maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17: 739A, 2006.

 

347.            Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, McAllister CJ:  Utility of serum aspartate aminotransferase for detection of hepatitis C infection in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:414A, 2006.

 

348.            Kalantar-Zadeh K, Regidor DL, Kovesdy CP, McAllister CJ, Kopple JD:  Which serum potassium range is associated with the best survival in maintenance hemodialysis patients?  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17: 727A, 2006.

 

349.            Song HY, Wang H, Fournier M, Storer T, Casaburi R, Lewis M, Kopple JD:  Effect of exercise training on skeletal muscle myosin heavy chain insoform expression in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:78A, 2006.

 

350.            Kopple JD, Wang H, Bross R, Konishi T, Kalantar-Zadeh K:  Dietary protein requirements in maintenance hemodialysis patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:725A, 2006.

 

351.            Wang H, Kalantar-Zadeh K, Weng M, Kopple JD:  Effect of dietary protein intake on gene expression of growth factors in skeletal muscle of maintenance hemodialysis (MHD) patients.  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17: 726A, 2006.

 

352.            Mehrotra R, Bross R, Konishi T, Appel M, Tsoi L, Kopple JD:  What is the optimal arterial pH for protein balance in automated peritoneal dialysis (APD) patients?  [ASN 39th Annual Renal Week Meeting], 2006. J Am Soc Nephrol 17:724A, 2006.

 

353.            Kalantar-Zadeh K, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S, Kilpatrick RD:  Hepatitis C virus and death risk in hemodialysis patients. Am J Kid Dis 47:B1-B18 (NKF Spring Clinical Meetings April 19-23, 2007, Chicago IL), 2007.

 

354.            Kalantar-Zadeh K, McAllister CJ, Kilpatrick RD, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S:  Dialysis vintage and risk of hepatitis C virus infection. Am J Kid Dis 47:B1-B18 (abstract #72, NKF Spring Clinical Meetings April 19-23, 2006 (Chicago, IL), 2007.

 

355.            Streja E, Kopple JD, Kovesdy CP, McAllister CJ, Nissenson AR, Kalantar-Zadeh K:  Is high platelet count responsible for increased death risk in dialysis patients with hemoglobin >13 g/dL?  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:696A, 2007.

 

356.            Kalantar-Zadeh K, Streja E, Kopple JD, McAllister CJ, Kovesdy CP:  High platelet count is associated with lower iron stores and higher ESA done in Hemodialysis patients: A possible explanation for hemoglobin-survival paradox?  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:81A, 2007.

 

357.            Regidor DL, Kopple JD, McAllister CJ, Kalantar-Zadeh K:  Iron saturation ratio above 30% is associated with improved ESA responsiveness in maintenance Hemodialysis patients.  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:81A, 2007.

 

358.            Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Jing J, McAllister CJ, Kopple JD:  High serum alkaline phosphatase level is associated with cardiovascular mortality in maintenance Hemodialysis patients.  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:88A, 2007.

 

 

 

 

359.            Kalantar-Zadeh K, Kovesdy CP, Streja E, Jing J, Derose SF, McAllister CJ, Kopple JD: Nutrition/inflammation explains greater survival in black maintenance Hemodialysis patients.  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:89A, 2007.

 

360.            Kalantar-Zadeh K, Regidor DL, McAllister CJ, Kopple JD:  Higher serum ferritin levels up to 1,200 ng/ml enhance erythropoietin responsiveness in maintenance Hemodialysis patients.  [ASN 40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:279A, 2007.

 

361.            Deleaval P, Teta D, Vianey-Saban C, Claustrat B, Kopple JD, Fouque D:  Early drop and plateau plasma amino-acid during Hemodialysis (HD) session. [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:482A, 2007.

 

362.            Wang H, Storer T, Casaburi R, Fournier M, Kopple JD:  Skeletal muscle ubiquitin ligases atrogin-1mRNA is decreased with exercise training in maintenance Hemodialysis (MHD) patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:484A, 2007.

 

363.            Wang H, Tara S, Kalantar-Zadeh K, Kopple JD:  Effect of dietary protein intake on gene transcripts for ubiquitin ligases atrogin-1 (MAFbx) in skeletal muscle of maintenance Hemodialysis (MHD) patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:484A, 2007.

 

364.            Supasyndh O, Viroonudompol D, Satirapoj B, Chaiprasert A, Tanachatvej V, Aramwit P, Kopple JD:  Muscle mRNA level of growth factors over expression in Hemodialysis patients after short course oral anabolic hormone.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:489A, 2007.

 

365.            Kalantar-Zadeh K, Kovesdy CP, Duong U, Shapiro M, McAllister CJ, Kopple JD:  Serum alkaline phosphatase and 3-year mortality in 7,596 chronic peritoneal dialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:490A, 2007.

 

366.            Regidor DL, Kovesdy CP, Jing J, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Baseline serum alkaline phosphatase >100 IU/L is associated with increased death risk in diverse subgroups of maintenance hemodialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:491A, 2007.

 

367.            Shinaberger CS, Kopple JD, Kovesdy CP, McAllister CJ, Greenland S, Kalantar-Zadeh K:  The ratio of administered paricalcitol dose to serum PTH level is associated with survival in maintenance Hemodialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:498A, 2007.

 

368.            Duong U, Mehrotra R, Kovesdy CP, Khawar O, Shapiro M, McAllister CJ, Kopple JD, Kalantar-Zadeh K:  Examining the mortality-predictability of hemoglobin A1c in chronic peritoneal dialysis patients in the USA.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:697A, 2007.

 

369.            Kalantar-Zadeh K, Kovesdy CP, Khawar O, Shapiro M, McAllister CJ, Kopple JD, Mehrotra R:  Examining the association between serum ferritin and survival in chronic peritoneal dialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:697A, 2007.

 

370.            Kalantar-Zadeh K, Mehrotra R, Kovesdy CP, Jing J, Shapiro M, McAllister CJ, Kopple JD:  Serum albumin and survival in a large cohort of chronic peritoneal dialysis patients in the USA.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:698A, 2007.

 

371.            Kalantar-Zadeh K, Cianciaruso B, Pota A, Enia G, Paoletti E, Panarello G, Strippoli P, De Vecchi A, Querques M, Viglino G, Brunorii G, Kopple JD:  Subjective global assessment of nutrition predicts 14-year mortality in peritoneal dialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:698A, 2007.

 

372.            Streja E, Kopple JD, Kovesdy CP, Regidor DL, McAllister CJ, Kalantar-Zadeh K:  Survival advantages of Hispanic ethnicity in maintenance Hemodialysis patients: Hispanic paradox within paradox.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:720A, 2007.

 

373.            Kalantar-Zadeh K, Bunnapradist S, Regidor DL, Streja E, Pillon L, McAllister CJ, Kopple JD:  Greater interdialytic fluid retention is associated with poor survival in maintenance hemodialysis patients.  [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:724A, 2007.

 

374.            Mehrotra R, Khawar O, Duong U, Shaprio M, McAllister C, Kopple JD, Kalantar-Zadeh K:  Serum phosphorus and mortality in chronic peritoneal dialysis patients. [40th Annual Renal Week Meeting], 2007. J Am Soc Nephrol 18:740A, 2007.

 

375.            Khawar O, Mehrotra R, Duong U, et al. Serum calcium and survival in a large USA cohort of chronic peritoneal dialysis patients. Perit Dial Int 2007 [abstract];27 Suppl 3:S11.

 

376.            Khawar O, Mehrotra R, Duong U, et al. Serum calcium and mortality in chronic peritoneal dialysis patients. Perit Dial Int 2007 [abstract];27 (suppl).

 

377.            Khawar O, Mehrotra R, Kovesdy CP, et al. Serum ferritin and survival in 6,712 chronic peritoneal dialysis patients. Perit Dial Int 2007 [abstract];27 (suppl).

 

378.            Duong U, Mehrotra R, Kovesdy CP, et al. Hemoglobin A1C and survival in chronic peritoneal dialysis patients with diabetes mellitus. Perit Dial Int 2007 [abstract][oral presentation];27 (suppl).

 

379.            Vargas RB, Jones L, Terry C, Kopple J, Norris KC:  Community partnered approaches to enhance chronic kidney disease prevention and early intervention (abstract #74, NKF Spring Clinical Meetings April 2-6, 2008 Dallas, TX).

 

380.            Miller JE, Streja E, Kovesdy C, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K :  Time-dependent association between dialysis dose and 5-year survival in contemporary maintenance hemodialysis patients (abstract #165, NKF Spring Clinical Meetings April 2-6, 2008 Dallas, TX).

 

381.            Hechter RC, Streja E, Mehrotra R, Kovesdy C, McAllister CJ, Robertson J, Kopple JD, Jing J, Kalantar-Zadeh K (abstract #193 NKF Spring Clinical Meetings April 2-6, 2008 Dallas, TX).

 

382.   Streja E, Cai Hechter R, Kovesdy CP, Robertson JA, McAllister CJ, Kopple JD,    Kalantar-Zadeh K: Does nutrition and inflammation status account for greater survival in black maintenance hemodialysis patients? Am J Kid Dis [National Kidney Foundation 2008 Spring Clinical Meeting, April 2-6, 2008, Dallas, TX] 2008 [Abstract] 51:B1-B36.

 

383.     Rambod M, Kovesdy CP, Kopple JD, Kalantar-Zadeh K: Mortality predictability of serum prealbumin in maintenance hemodialysis patients in a 5-year cohort. Am J Kid Dis [National Kidney Foundation 2008 Spring Clinical Meeting, April 2-6, 2008, Dallas, TX] 2008 [Abstract] 51:B1-B36.

 

 384.    Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple J, Kalantar-Zadeh K: Five-year mortality-predictability of the malnutrition-inflammation score in maintenance hemodialysis patients. J Am Soc Nephrol 2008 [ASN abstract];19:SA−FC431 (oral presentation).

 

 385.   Rambod M, Bross R, Zitterkoph J, Benner D, Pithia J, Colman S, Kovesdy CP, Kopple J, Kalantar-Zadeh K: Comparison between the malnutrition-inflammation score and laboratory markers of inflammation in predicting mortality in hemodialysis patients. J Am Soc Nephrol 2008 [ASN abstract];19:SA−FC437 (oral presentation).

 

 386.   Miller JE, Kovesdy CP, Van Wyck D, Kopple JD, Kalantar-Zadeh K: Mortality predictability of the 5−year time-averaged serum calcium in 151,555 maintenance hemodialysis patients. J Am Soc Nephrol 2008 [ASN abstract];19:F−PO1819.

 

 387.   Bross R, Rambod M, Zitterkoph J, Kovesdy CP, Oreopoulos A, Kopple JD, Kalantar-Zadeh K: Estimating total body fat by four body composition assessment methods in maintenance hemodialysis patients. J Am Soc Nephrol 2008 [ASN abstract];19:SA−FC435 (oral presentation).

 

 388.   Shinaberger CS, Kopple JD, Kovesdy CP, McAllister CJ, Greenland S, Kalantar-Zadeh K: The ratio of paricalcitol dose to pth in maintenance hemodialysis patients may mitigate confounding by indication. [XIV International Congress on Nutrition and Metabolism in Renal Disease, Marseilles , France  June 11  – 15, 2007] 2008 [abstract]

 

389.    Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Kovesdy CP, Kalantar-Zadeh K: Is controlling serum phosphorus by decreasing protein intake beneficial or harmful in maintenance hemodialysis patients? [XIV International Congress on Nutrition and Metabolism in Renal Disease, Marseilles , France  June 11  – 15, 2007] 2008 [abstract]

 

390.    Rambod M, Dezfuli A, Kovesdy CP, Kopple CP, Kalantar-Zadeh K: Association between changes in serum transthyretin over time and mortality in maintenance hemodialysis patients. [XIV International Congress on Nutrition and Metabolism in Renal Disease, Marseilles , France  June 11  – 15, 2007] 2008 [abstract]

 

391.    Miller JE, Streja E, Kovesdy CP, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K: Time-dependent association between dialysis dose and 5-year survival in contemporary maintenance hemodialysis patients. Am J Kid Dis [National Kidney Foundation 2008 Spring Clinical Meeting, April 2-6, 2008, Dallas, TX] 2008 [Abstract];51:B1-B36.

 

392.    Cai Hechter R, Streja E, Mehrotra R, Kovesdy CP, McAllister CJ, Robertson JA, Kopple JD, Jing J, Kalantar-Zadeh K: Comparing mortality of chronic peritoneal and maintenance hemodialysis patients in the 21st century up to 5 years. Am J Kid Dis  [National Kidney Foundation 2008 Spring Clinical Meeting, April 2-6, 2008, Dallas, TX] 2008 [Abstract];51:B1-B36.

 

393.    Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K: Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008;19:2193-2203.

           

394.     Kalantar-Zadeh K, Streja E, Kovesdy CP, Nissenson AR, Kopple JD: Mortality-predictability of weight gain vs weight loss over 6 months in maintenance hemodialysis (MHD) patients. Am J Kidney Dis 2009 [NKF abstract];53:A73-A73, Meeting Abstract: 202.

 

395.    Youngmee Kim RM, Rachelle Bross, Joel D Kopple, Allen R Nissenson, Csaba P Kovesdy, and Kamyar Kalantar-Zadeh: Association of lean body mass with serum creatinine in hemodialysis patients. J Am Soc Neph 2009 [ASN abstract]

 

396.    Nazanin Noori KK-Z, Csaba P Kovesdy, Debbie Benner,  and Joel D.Kopple,       : High mid-arm muscle circumference is independently associated with greater survival in maintenance hemodialysis patients. J Am Soc Neph 2009 [ASN abstract]

 

397.    Nazanin Noori JDK, Debbie Benner, and Kamyar Kalantar-zadeh   Potassium intake and 5-year mortality in maintenance hemodialysis patient. J Am Soc Neph 2009 [ASN abstract]

 

398.    Nazanin Noori JDK, Debbie Benner and Kamyar Kalantar-Zadeh    High phosphorus intake is associated with poor survival in maintenance hemodialysis patients. J Am Soc Neph 2009 [ASN abstract]

 

399.    Kamyar Kalantar-Zadeh ES, Rajnish Mehrotra, Stephen F Derose, Jennie Jing, Allen R Nissenson, Joel D Kopple, and Csaba P Kovesdy: Survival of high body mass index based on the 5-year average of all thrice-weekly measured post-dialysis dry weight in over 120,000 hemodialysis patients. J Am Soc Neph 2009 [ASN abstract]

 

400.    Elani Streja RM, Joel D Kopple,  Allen R Nissenson, Csaba P Kovesdy, and Kamyar Kalantar-Zadeh: Serum creatinine and five-year survival in 138,773 maintenance hemodialysis patients. J Am Soc Neph 2009 [ASN abstract]

 

 

 

401.   Nazanin Noori, Kamyar Kalantar- Zadeh, Csaba P Kovesdy, Rachelle Bross; Debbie Benner, Joel D Kopple: Association of dietary phosphorus to protein ratio with mortality in hemodialysis patients. Am J Kidney Dis 2010 [abstract NKF Spring Clinical Meeting]

 

                       

                 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revised: 7/7/10

CVACADEM JDK.doc

MS WORD